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ABSTRACT 
Lawsonia intracellularis is the causative agent of proliferative enteropathy (PE). 
PE is an important disease of weaner and grower pigs causing degrees of diarrhoea 
and negative effects on feed intake and weight gain. In-feed antibiotics are routinely 
used to control PE disease outbreaks. However, increasing restrictions to antibiotic 
use is being implemented in various pig producing countries. Therefore, alternatives 
to improve resistance while promoting growth performance are ideal. To limit the 
establishment of infection and increase profitability of pig production, disease 
prevention needs both nutritional and immunological strategies and well as effective 
sanitary measures. Since 2006, in the Australian market, a live attenuated Lawsonia 
intracellularis vaccine has been used to reduce clinical signs and PE lesions and 
reduce L. intracellularis shedding in faeces. However, the systemic and local 
immunological responses to a standard vaccine dose are poorly characterised. In the 
absence of proof that vaccinated pigs are protected from PE, veterinarians are 
unwilling to remove antibiotic medication for fear of acute haemorrhagic PE in adult 
pigs. Additionally, feeding strategies as alternatives to antibiotics, such as beta-glucan 
have been proposed as a possible option, but no study has investigated the effect of 
phytase on immune responses in growing pigs. The research in this thesis addresses 
studies to immune-based investigation of factors affecting the induction of immune 
responses following vaccination with L. intracellularis. Results revealed that the use 
of an oral standard and ten times dose of L. intracellularis vaccine protects pigs 
against PE disease by reducing lesions, shedding in faeces and clinical signs. 
However, intramuscular delivery also protected pigs against PE. Immunological 
responses to L. intracellularis vaccination, particularly IgG and cytokines response 
were observed after oral, intraperitoneal and intramuscular L. intracellularis 
vaccination. However these were highly variable, highlighting the difficulties in 
finding suitable biomarkers. The effect of adding S. cerevisae yeast beta-glucan and 
microbial phytase to weaner diet affected on mucosal and systemic L. intracellularis 
vaccination local immune response.  
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 Chapter 1 Introduction 
Diarrhoea and enteric diseases that principally affect young weaner and grower 
pigs are significant problems facing the pork industry worldwide. They directly affect 
the profitability of pig production, not only due to the death of some animals, but also 
due to the negative impact on growth, feed conversion efficiency and increasing 
production and medication costs incurred. To limit the establishment of infection and 
safeguard the profitability of pig production as in-feed antibiotics are progressively 
withdrawn, disease prevention needs both nutritional and immunological strategies 
as well as effective sanitary measures. The research in this thesis investigates factors 
affecting the induction of mucosal immune responses following vaccination with 
Lawsonia intracellularis.  
Proliferative enteropathy (PE) or ileitis, is caused by the obligate intracellular 
bacterium Lawsonia intracellularis (Lawson et al., 1993). It is one of the most 
important causes of diarrhoea in weaner and grower pigs (Jacobson, 2003). The 
disease commonly causes a range of clinical signs from acute haemorrhage to chronic 
diarrhoea (Lawson and Gebhart, 2000). Clinical and subclinical cases (with no 
apparent clinical signs) are commonly accompanied by a decrease in feed intake, 
slower rate of weight gain and poorer feed conversion rate (Collins et al., 2010b; 
Paradis et al., 2012). The economic losses to pig producers are not only from poorer 
performance but are also due to the costs of controlling the disease. Previous 
economic models have estimated that PE costs pig producers around US$ 20 million 
dollars annually or around AU$ 7.00 per pig (Holyoake et al., 1996; Bronsvoort et al., 
2001). However, these reports did not take into account the economic impact of 
subclinical PE and the cost of controlling the disease. More recently, subclinical L. 
intracellularis infection was estimated to reduce profitability by AU$ 8.33 per pig if 
80% of the herd were affected, while clinical infection reduced profitability by AU$ 
13.0 per pig when as few as 16% of pigs are clinically affected (Holyoake et al., 
2010a). In contrast, the cost of controlling PE by vaccination (Enterisol® Ileitis, 
Boehringer Ingelheim) was estimated to be AU$ 2.70 per pig.     
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Post-mortem diagnosis of PE relies on the combination of gross lesions and 
histopathological lesions (e.g. stained with haematoxylin and eosin, HE or with a 
monoclonal antibody against L. intracellularis). However, recovery from PE within 
three to four weeks means that pathology is only a useful means of diagnosis in pre-
slaughter pigs or very sick animals. Ante-mortem diagnostic tests, such as serology 
and PCR, are now routinely used for diagnosis, but are also useful for estimating the 
prevalence of L. intracellularis infection in pig herds. The prevalence of L. 
intracellularis in faeces (by PCR) has been reported to range from 20 to 75% in 
positive herds of large pig producing countries such as the United States, Brazil and 
Denmark (Chiriboga et al., 1999; Stege et al., 2004; Armbruster et al., 2007).  
However, 4.5%, 30% and 37.6% of the herds in Spain, Taiwan and Norway were also 
tested as PE positive, respectively (Chang et al., 1997; Pozo et al., 1998; Flo et al., 
2000). Positive faecal PCR results are usually indicative of L. intracellularis presence, 
either currently or in recovery stages while high seroprevalence indicates that pigs 
were previously exposed to L. intracellularis. Serological analysis by indirect 
immunofluorescence (IFAT) or ELISA tests revealed that approximately 60 to 100% 
of the farms in the United States, the European Union and Australia were positive for 
L. intracellularis antibodies (Chouet et al., 2003; Class and Bilkei, 2004; Holyoake et 
al., 2010b). 
In Australia, PE is traditionally controlled in pig herds with in-feed antibiotic 
medication (Holyoake et al., 2010b). Although antibiotics are effective in controlling 
PE outbreaks, care needs to be exercised in the use of antibiotics to avoid the 
emergence of bacterial resistance to antimicrobials. Over the last 2 decades the 
European Union (EU) has increasingly restricted the use of antimicrobial growth 
promoters in animal production. Currently, the United States is also expanding its 
program of restricting the use of antibiotics while in Australia specific 
recommendations for the appropriate use of antibiotic in food producing animals 
have been established (JETACAR, 1999; USDA, 2007; NARMS, 2010). Therefore, in 
order to prevent PE infection an alternative to antibiotics is required.   
Such an alternative to L. intracellularis infection may be through vaccination of 
pig herds with a commercially available oral live vaccine (Enterisol® Ileitis, 
Boehringer Ingelheim). However, while this vaccine has been demonstrated to reduce 
clinical signs and lesions of PE (Kroll et al., 2004; McOrist and Smits, 2007), the 
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systemic and local immune responses to a standard vaccine dose are poorly 
characterised (Donahoo, 2009). In the absence of proof that vaccinated pigs are 
protected from PE, some producers are unwilling to remove antibiotic medication for 
fear of acute haemorrhagic PE in adult pigs. Therefore, in the first part of this 
doctorate (Chapters 4 and 5) trials were designed with the objective being to 
measure the immune response of vaccinated and challenged pigs in an effort to 
identify immune markers for vaccination and protection. 
 Additionally, nutritional strategies have been suggested as alternatives to 
antibiotic growth promoters (Gallois et al., 2009; Heo et al., 2013; Pluske, 2013). The 
addition of β-glucan in pigs diets has been shown to improve growth performance 
(Dritz et al., 1995; Decuypere et al., 1998), increase functional activity of 
macrophages and neutrophils (Hiss and Sauerwein, 2003; Sonck et al., 2010) and 
increase release of pro-inflammatory cytokines (Young et al., 2001; Xiao et al., 2004). 
Conversely, some components of pig diets such as the phytate-P can reduce growth 
performance. The addition of the enzyme phytase to pig diets can improve phytate-P 
digestibility, nutrient absorption and increase pig growth rates (Selle and Ravindran, 
2008). However, the information on its effects on the immune response to 
vaccination is limited, but increases in serum lymphocyte numbers have been 
observed when phytase was added to nutritionally marginal broiler diets (Liu et al., 
2008). It is possible that the increased bioavailability of nutrients in the gut (with 
phytase) will allow additional nutrients to be redirected for immune cell growth and 
replication. Thus, this trial was designed to observe the effect of phytase and beta-
glucan in weaner pigs diets on the immune response to L. intracellularis vaccination 
and growth performance (Chapter 6). 
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AIMS 
 
The work presented in this thesis is from a series of animal studies intended to 
investigate the dynamics of immunity for L. intracellularis using a commercial vaccine 
and its effects of nutritional additives. The first objective was to determine the 
immunological responses of weaner pigs to a L. intracellularis vaccine at the local 
intestine mucosa and systemically in serum. The second objective was to investigate 
whether different routes and dose concentrations of a L. intracellularis vaccine 
provide equivalent protection to pigs against a virulent L. intracellularis challenge. 
Characterisation of an associated immune response that might predict successful 
induction of protection was also a part of this objective. In a following study the aim 
was to determine whether any immune response detected after different routes of 
vaccination are correlated with successful induction of protection (prior to 
challenge). A third study, investigated the effects of dietary yeast and phytase on the 
local and systemic immune responses of pigs after vaccination with L. intracellularis. 
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Part 1- Proliferative enteropathy in pigs 
2.1 Background and Aetiology to proliferative enteropathy 
disease 
Twenty years after the association of porcine proliferative enteropathies with 
the presence of an intracellular bacterium within the ileal epithelial cells by electron 
microscopy (Rowland and Lawson, 1973), the causative agent was successfully 
cultured in vitro (Lawson et al., 1993). This intracellular bacterium, previously known 
as Campylobacter-like organism, Ileal symbiont intracellularis, and Ileobacter 
intracellularis was then established in a new genus Lawsonia and species 
intracellularis (McOrist et al., 1995a). The final classification was achieved using 
molecular taxonomic methods on the 16S rRNA gene, positioning the causal organism 
(Lawsonia intracellularis) with 81% similarities to Desulfovibrionacea family from the 
delta subdivision of Phylum Proteobacteria (Gebhart et al., 1993). It has unique 
characteristics as a Gram-negative bacterium (around 1.5 µm in length and 0.34 µm 
in width), with curved or sigmoid rod shape (Lawson et al., 1993), single and 
unipolar flagellum, but no fimbriae or spores (McOrist et al., 1995a). 
2.2 Clinical aspects of the proliferative enteropathy disease 
Proliferative enteropathy has been reported in a number of animals, but clinical 
signs differ between them. Most species are affected with diarrhoea and poor growth. 
However, clinical signs such as fever, peripheral oedema and colic are present in 
affected horses (Pusterla and Gebhart, 2009), but not in pigs or other affected 
animals. While the clinical signs may slightly differ between horses and pigs, post-
mortem examinations show similar thickening of sections of the small intestinal wall 
in both species (Vannucci et al., 2012a). 
In pigs, proliferative enteropathy (PE) can affect animals from post weaning 
until adult life. Clinical signs can range from acute to chronic and subclinical, 
presenting as various degrees of diarrhoea and reduced growth rates (Ward and 
Winkelman, 1990; Paradis et al., 2012). The acute presentation of proliferative 
haemorrhagic enteropathy (PHE) affects mainly adult pigs between 4 and 12 months 
of age (Ward and Winkelman, 1990). Pregnant sows may abort following infection 
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and mortality can reach 50% in severe outbreaks (Love et al., 1977; Mauch and 
Bilkei, 2005). This haemorrhagic syndrome can start with pigs becoming pale and 
having severe diarrhoea and malaena and if it is not treated may result in death (Love 
and Love, 1979). However, sudden death may also occur without symptomatic signs 
(Love and Love, 1979). Other pathologies during the finisher to adult phase can 
present similar signs of severe diarrhoea such as swine dysentery (Brachyspira 
hyodysenteriae) and Salmonellosis (Salmonella Typhimutrium) (Straw et al., 2006). In 
addition, non-pathogenic occurrences can lead to haemorrhagic diarrhoea such as in 
chronic intestinal bleedings (McOrist and Gebhart, 2006).  
Porcine intestinal adenomatosis (PIA) commonly affects weaners and growers 
observed as persistent chronic diarrhoea (Ward and Winkelman, 1990), but can 
cause mortality (Rowland, 1975). PIA presents as reduced weight gains and non-
uniformity in weight among 6 to 12 weeks old pigs (Lawson and Gebhart, 2000). 
Gogolewski et al., (1991) described a marked ill-thrift (weight gain less than half of 
the weekly mean weight gain from non-infected pigs) and diarrhoea in grower pigs 
affected with PIA. PIA needs to be differentiated from other diseases that cause 
diarrhoea during the weaning and growing phase such as post-weaning diarrhoea 
(Escherichia coli), Spirochetal colitis (Brachyspira pilosicoli) and Salmonellosis 
(Jacobson, 2003).  
Clinical signs of proliferative enteropathy have been reported to improve 
gradually after a week (Yates et al., 1979), however, pigs can also progress to necrotic 
enteritis and regional ileitis which can lead to death (Ward and Winkelman, 1990). In 
necrotic enteritis the mucosa is destroyed resulting in extensive coagulative necrosis 
of the epithelium (Rowland, 1975), with yellowish-grey lesions on the mucosal 
surface (Rowland and Hutchings, 1978). The animals that survive this episode of 
necrotic enteritis may progress to regional ileitis (Rowland, 1975; Lawson and 
Gebhart, 2000). Regional ileitis is a progressive granulation tissue proliferation in the 
lamina propria and submucosa (Rowland, 1975; 1978). 
The subclinical form of PE is considered to be the most common in pigs, but is 
difficult to recognize due to the absence of clinical signs. However, production 
parameters are negatively affected, such as reduced feed intake, lower rate of daily 
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live weight gain and poor feed conversion efficiency (FCE)(Collins et al., 2010b; 
Paradis et al., 2012). Poor growth in affected pigs results in an increased number of 
days to slaughter (Brandt et al., 2010). The dose of L. intracellularis pigs are exposed 
to will impact on the severity of clinical signs, including weight gain and FCE.  In a 
study by Paradis et al, (2012), six different groups of pigs were challenged with 10 
fold dilutions of mucosal homogenate L. intracellularis between 104 to 108 and their 
performance compared to uninfected controls. Excretion of L. intracellularis was 
detected in all pigs, starting from 14 days post-challenge. Consistently poor 
performance was observed in all challenged groups, even those given the lowest 
dose, 104 L. intracellularis, with a 37% reduction in average daily weight gain and a 
27% increase in FCE during the 21 day trial period relative to non-challenged pigs 
(Paradis et al., 2012). Similarly, Collins et al., (2010b) reported a reduction in feed 
intake and large variation in final body weight of pigs that were subclinically infected 
(without diarrhoea and positive for Lawsonia-PCR and immunofluorescence antibody 
test (IFAT)) after an experimental challenge with 5.9 x 109 L. intracellularis compared 
with an uninfected cohort.   
2.3 Epidemiology 
2.3.1 Pig to pig transmission and risk factors 
The principal mode of transmission of Lawsonia intracellularis is direct contact 
between affected and susceptible pigs (Jordan et al., 2004) and through the faecal-
oral route (Collins et al., 2000). Transmission also occurs through contact with L. 
intracellularis contaminated environments (Collins et al., 2013), but may also be 
transmitted by rodents (Collins et al., 2011). Pigs clinically affected with PE can shed 
at least 3 x 108 L. intracellularis per gram of faeces (Collins et al., 2011), so less than 
one gram of infected faeces is required to infect naive pigs (Collins et al., 2001). The 
infection of a single pig within a group or pen is likely to result in the infection of 
susceptible pigs that are in contact, as sentinel pigs became infected 8 days after they 
were housed in contact with pigs inoculated with 105 of pure culture L. intracellularis 
(Jordan et al., 2004). Similarly, in a natural PHE outbreak, L. intracellularis infection 
was transmitted between breeding stock to young adult pigs, where the movement of 
breeding stock between units was performed (Love et al., 1977). L. intracellularis 
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infection was observed in naive pigs after they were introduced to dirty pens (Collins 
et al., 2013) or dosed orally with 10g of faeces containing 106 to 107 L. intracellularis 
from naturally infected pigs (Collins et al., 2000). In both of these studies it was 
observed that L. intracellularis survived in faeces in contaminated pig pens for at 
least 2 weeks at temperatures between 9°C and 18°C. Therefore, the combination of 
pigs shedding large numbers of bacteria in faeces, the prolonged survival of the 
bacteria in the environment, together with the small doses required to initiate an 
infection strongly favours the transmission of infection within the herd. 
Farm management factors such as animal grouping, feed management, buying 
replacement stock, stocking density, age, and hygiene have been shown to influence 
the risk of L. intracellularis infection (Smith et al., 1998; Bronsvoort et al., 2001; Stege 
et al., 2001; Collins and Love, 2003). For instance, Collins and Love (2003) observed 
the risk of L. intracellularis infection was six times greater in a continuous flow 
management pig production system when compared to an all-in-all-out management 
program. Additionally, an all-in-all-out management system has often been shown to 
provide protective factors against other post-weaning intestinal pathogens infections 
(Madec et al., 1998). Proper hygiene such as cleaning and disinfecting pens between 
pig groups has been shown to eliminate L. intracellularis and prevent transmission of 
infection to a second group of naive pigs introduced to cleaned pens (Collins et al., 
2013).  
Smith et al. (1998) studied risk factors for PE using a postal survey of 319 
British herds. Breeding herd size greater than 500 sows, concurrent enzootic 
pneumonia, replacement boars from selected nucleus herds and use of slatted floors 
above deep sunken pits were important factors associated with owner-reported PE 
on the farm during the three year survey. However, the authors’ point out that 
possibly the farm owners relied only on slatted floors to clean pens. Another study, 
which included a questionnaire survey, production records and faecal PCR analysis, 
demonstrated that the use of new buildings and recent mixing of pigs were 
associated with PE outbreaks by grouping affected and susceptible pigs (Bane et al., 
2001). A cross sectional study in Danish pigs herds showed that the use of 
commercial feed products increased  the risk of L. intracellularis infection when 
compared to batch production systems using home-mixed feed (Stege et al., 2001). 
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Bronsvoort et al., (2001) surveyed 184 herds in the United States by collecting 
serum from breeding sows and grower to finisher pigs and testing them for L. 
intracellularis antibodies (by IFAT) and linked the results with questionnaire data 
from respective farms. Risk factors associated with PE outbreaks in breeding herds 
included seropositivity to L. intracellularis during the grower-finisher phase (48.9% 
positive herds), a continuous flow system for the farrowing unit, and younger sow 
parity. On the other hand, risk factors for a PE outbreak in grower-finisher herds 
included seropositive status of the breeding unit (66.9% positive herds), a high 
number of pigs entering the facilities, the use of concrete slats as flooring, and 
intensive indoor management.   
2.3.2 Mechanical and vector transmission 
Others sources of infection, such as mechanical and biological vectors may also 
be of significant consequence for the re-introduction of L. intracellularis to new herds 
(Jensen et al., 2005). The potential for L. intracellularis transmission via fomites like 
boots, overalls, brooms and shovels has not been reported. However, transmission of 
L. intracellularis infection has been reported despite preventive measures, such as 
separate clothing and disinfecting footbaths being used (Winkelman et al., 1998; 
Jordan et al., 2004).  
Transmission of L. intracellularis infection is also likely via biological vectors 
where wild and domestic animals shedding L. intracellularis in their faeces could 
transmit the infection to naive pigs, if they come into contact with infected faeces. 
Lesions of PE have been reported in the intestines of hamsters (Jonas et al., 1965), 
rabbits (Hotchkiss et al., 1996), ferrets (Fox and Lawson, 1988), lambs (Cross et al., 
1973), horses (Duhamel and Wheeldon, 1982), guinea pigs (Muto et al., 1983), deer 
(Cooper et al., 1997), macaques (Klein et al., 1999), dogs (Leblanc et al., 1993), cows, 
giraffes and porcupines (Herbst et al., 2003). However, it is more likely that animals, 
such as wild pigs, rodents, insects and birds, are possible vectors due to their close 
contact with pig farms. Highlighting the potential for external vectors, Tomanova et 
al., (2002) described the detection of L. intracellularis in 29.6% of ileal tissues from 
wild pigs using nested PCR and 51.6% of these were seropositive for L. intracellularis 
in the Czech Republic. In Australia, L. intracellularis antibodies have been detected in 
feral pigs (91.5% of pigs tested were positive) within 10 km of two large scale 
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commercial piggeries in southern Queensland state (Pearson, 2012). On the other 
hand, Pusterla et al., (2008) was not able to detect L. intracellularis infection in 
Brewer’s blackbird (Euphagus cyanocephalus) found around livestock farms. 
Experimental infections with L. intracellularis in chickens (Gallus gallus) and 
sparrows (Passer domesticus) did not cause detectable histological lesions of PE 
(Collins et al., 1999; Viott et al., 2013). However, proliferative lesions have been 
detected in other avian species such as ostrich (Struthio camelus) and emu (Dromaius 
novaehollandiae) (Cooper et al., 1997; Lemarchand et al., 1997).  
The presence of L. intracellularis in the intestines of rodent captured on PE 
positive farms implicates rodents as potential biological vectors (Friedman et al., 
2008). Collins et al., (2011) also reported L. intracellularis excretion from 70.6% of 
rodents captured on PE positive pig farms, with up to 1010 organisms excreted per 
gram of rat faeces. However, although these studies could not prove if rats were the 
infective source for pigs or vice versa, it is clearly an important avenue for 
contamination, particularly where rodents are in close contact with pigs. Similarly, 
the potential mechanism of disease spread within herds through positive flies has 
been raised since the detection of Lawsonia-DNA from 22% to 75% of all adult flies 
collected from 14 seropositive pig farms in England (McOrist et al., 2011). The Musca 
domestica (house fly) and Eristalis sp. (hoverfly or flower fly) were the most common 
positive species captured among farms (and in closest proximity to pigs). However, 
although the study did not determine the amount of viable DNA or the flight distance 
of these flies, it indicates the potential for spread of L. intracellularis contamination 
within herds.  
2.3.3 Prevalence of PE 
PE is an endemic disease that is widespread across every continent involved in 
pork production and occurs in many different production systems. Prevalence is 
determined either by the use of L. intracellularis-specific serology assays such as 
indirect immunofluorescent antibody test (IFAT), immunoperoxidase monolayer 
assay (IPMA) or by molecular assays such as the polymerase chain reaction (PCR) 
(Guedes et al., 2002b; Jensen et al., 2005).  
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Infection prevalence differs depending on the sample and assay used. For 
instance, the amplification of L. intracellularis DNA from faeces by PCR was 
demonstrated between 14 and 40 days after 107 L. intracellularis challenge (Collins 
and Love, 2007). While after the same challenge the detection of serum IgG 
antibodies against L. intracellularis were observed two weeks after (28 days) and 
persisted until 70 days post-challenge (Collins and Love, 2007). These assays may be 
used as a tool to estimate the timing of infection (Guedes, 2008). Molecular testing 
(PCR) has been reliably used to detect L. intracellularis DNA in actively infected pigs, 
while the L. intracellularis specific antibodies indicate previous exposure to infection 
(Jacobson et al., 2004).  
In Australia, a cross-sectional study of finisher pigs from 63 herds across all 
states determined that 100% of the herds tested were positive for L. intracellularis 
antibodies (Holyoake et al., 2010b). Similarly, a longitudinal study of natural L. 
intracellularis infection in five large Danish grower pig herds also revealed that 
seroconversion had occurred in all herds, and that 75% of pigs examined by faecal 
PCR were actively infected (Stege et al., 2004). Specific L. intracellularis serum 
antibodies were also found in 100% of the grower-finished herds tested in Korea 
(Lee et al., 2001) and 90.9% of 174 pig farms in United States (Armbruster et al., 
2007). In a US study, faecal shedding of L. intracellularis occurred most commonly in 
grower and finisher pigs, with the reported prevalence of L. intracellularis infection 
ranging from 8 to 67% of pigs positive (Armbruster et al., 2007). 
The prevalence of lesions during slaughter from seropositive farms with 
subclinical infection has been reported as 1.5% (Brandt et al., 2010). The low gross 
lesion prevalence at slaughter age (at 26 weeks of age) was likely due to lesion 
resolution, as severe histopathological changes were observed in five euthanized 8 
weeks old pigs (Brandt et al., 2010). In more severe outbreaks of PHE, thickening of 
the mucosa was observed in 72.8% of slaughter age pigs (van der Heijden et al., 
2004). Jensen et al., (1999) recommend monitoring of slaughter pigs (110 kg) by 
visual and palpatory demonstration to identify pigs with increased thickening of the 
ileum. These techniques correlate with the presence of L. intracellularis (by IHC), but 
are not a reliable guide to the prevalence of PE in herds.   
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2.4 Lawsonia intracellularis entry and recovery  
The presence of intracellular L. intracellularis bacteria within the apical 
cytoplasm of enterocytes is highly correlated with proliferation of cells as observed 
by electronic microscopy (Rowland, 1975; McOrist et al., 1995b). The preferential 
localization of L. intracellularis in the ileum has been demonstrated by IHC (Boutrup 
et al., 2010), but L. intracellularis can spread and colonise other sections of the 
intestinal tract such as the jejunum, colon and caecum (Smith and Lawson, 2001; 
Jensen et al., 2006). Possible factors for the preferential colonisation of the ileum 
sections might include the presence of specific receptors, a favourable physiological 
environment for L. intracellularis or simple mechanical reasons such as longer 
exposure to the intestinal epithelium (Boutrup et al., 2010). The ability of some 
Gram-negative intracellular bacteria, like Yersinia enterocolitica (Autenrieth and 
Firsching, 1996) and Salmonella spp. (Clark et al., 1994) to exploit M cells (Microfold 
cells) to penetrate the host epithelium, and the presence of early lesions of PE in the 
mucosa overlying the Payer’s patches (PP) (Lomax et al., 1982) suggests that L. 
intracellularis could also utilise a similar strategy. Alternatively, L. intracellularis 
could enter crypt enterocytes directly by forming single membrane bound vacuoles 
(McOrist et al., 2006a), as well as through loose membrane junctions (McOrist et al., 
1995b). 
The identification of specific receptors or adhesins for Lawsonia intracellularis 
remains speculative, with proposed entry mechanisms inferred by extrapolation 
from other pathogens. McCluskey et al., (2002), identified an outer membrane 
protein (OMP) Lawsonia surface antigen (LsaA) from cultured L. intracellularis and 
from bacteria present in ileal tissues of infected animals. They demonstrated that the 
LsaA gene was expressed in early infection and the protein was synthesized by L. 
intracellularis during infection (McCluskey et al., 2002). In addition, the analysis of 
the genetic sequence of L. intracellularis identified some homologous regions to 
membrane factors of Yersinia sp. (Yop and LvrV) and these may indicate that the type 
III secretion system (T3SS) is present in L. intracellularis and is expressed during 
infection (Hueck, 1998; Alberdi et al., 2009). This secretion system is common in 
enteropathogenic Gram negative bacteria, presenting as a needle-like protein 
structure that has important pathogenic role by forming pores in the host cell 
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membrane, as well as evading host’s innate immunity by down-regulating 
inflammation (Autenrieth and Firsching, 1996).  
Under normal conditions, enterocytes lining the intestine divide by mitosis and 
mature as they migrate from the crypt to the tip of the villus, where they are involved 
in absorption of nutrients as they mature (Friendship, 1989). It is thought that L. 
intracellularis preferentially adheres to the immature epithelial cells. However, the 
mechanism by which L. intracellularis inhibits normal crypt cell differentiation is not 
yet understood. During recovery from infection, the restoration of normal epithelium 
occurs by elimination of the infected enterocytes and multiplication of uninfected 
adjacent cells (McOrist et al., 1996; MacIntyre et al., 2003). Resolution of lesions 
starts approximately three to four weeks after infection (Smith and McOrist, 1997; 
Winkelman et al., 2002) and is dependent on the initial infection dose. Higher average 
PE lesion length (171cm) 20 days after pigs were inoculated with 1010 L. 
intracellularis was observed in comparison with lower length (5cm) lesions from pigs 
inoculated with 108 L. intracellularis (5cm) (Guedes et al., 2003). The presence of L. 
intracellularis antigen has been reported in the intestinal lumen following resolution 
of L. intracellularis induced lesions where infected cells have been lysed and shed 
(van der Heijden et al., 2004).  
2.5 Pathology of the porcine proliferative enteropathies 
The thickening of the intestinal mucosa is the most noticeable macroscopic 
alteration of all forms of PE. Intestines affected with PHE may also have a solid clot of 
blood in the intestinal lumen (Figure 1a), as well as thickening of mucosa and 
oedema. In PIA cases, the macroscopic lesions can present as severe thickening of the 
mucosa (“cerebroid aspect”) and relatively free from inflammation as shown in 
Figure 1b. By comparison, enteric bacteria such as Escherichia coli can affect small 
intestines and present severe areas of inflammation (Fairbrother and Gyles, 2012). In 
more severe cases of coagulative necrotic enteritis, clearly defined fibrin deposits will 
be present in the intestinal lumen (Love et al., 1977). In mild cases, the changes may 
be subtly characterized by oedema associated with focal proliferative lesions. 
 
32 
 
1a) 1b) 
 
 
Figure 1: Porcine small intestine. (1a): Proliferative haemorrhagic enteropathy (PHE). Observe 
mucosa thickened and presence of blood in the lumen (arrow). (1b): Porcine intestinal 
adenomatosis (PIA), with marked thickening of intestinal mucosal with small reddening area 
(circle). (Photographs courtesy of Prof. Dr. Roberto M. C. Guedes, Department of Veterinary Clinic and 
Surgery, Minas Gerais Federal University, Belo Horizonte, Brazil). 
 
Lesions of PE at the ultra-structural level, show the presence of vibrio-shaped 
intracellular bacteria in the apical cytoplasm of enterocytes, which can be visualised 
with Warthin-Starry silver staining, monoclonal antibodies to L. intracellularis or 
electron microscopy (Rowland, 1975; McOrist et al., 2006a). The villus-crypt 
structures are elongated with proliferation of enterocytes (Figure 2), marked 
reduction or loss of goblet cells and/or presence of exudate in the crypt lumen 
(Lawson et al., 1993; Lawson and Gebhart, 2000). Compared with normal crypts, 
which are a single layer of cells, affected crypts are often 5, 10 or more cells deep 
(McOrist et al., 2006a). Electron microscopic studies of experimentally and naturally 
infected pigs (Rowland, 1975; Love et al., 1977) have shown that highly infected 
enterocytes usually have short, irregular microvilli compared with healthy animals.  
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Figure 2: Ileal section of a pig experimentally infected with L. intracellularis: H&E staining, left 
figure (10 x magnifications) showing normal tissue with areas of characteristic PE lesions of 
crypt enterocyte proliferation (arrows).  Right figure the proliferation of enterocytes with loss of 
goblet cells and exudate within crypt lumen (100 x mags.). 
2.6 Diagnostic test for Lawsonia intracellularis infection 
Diagnosis of PE by routine culture from faeces is not feasible because L. 
intracellularis is an obligate intracellular bacterium that is fastidious in its culture 
requirements (Lawson et al., 1993). The non-specific nature of clinical signs of PE 
makes a differential diagnosis difficult. Other enteric infections such as Brachyspira 
hyodysenteriae, Brachyspira pilosicoli, haemolytic E. coli and Salmonella spp. may also 
cause diarrhoea and reduced weight gains in growing pigs (Jacobson, 2003).  
Diagnosis of PE is based on a combination of gross lesions and histopathology 
lesions associated with more specific immunohistochemistry. Although severe 
lesions in the terminal jejunum and ileum are easily seen, the more common 
moderate to mild lesions may be harder to detect (Guedes et al., 2002c). The 
presence of proliferation of enterocytes on routine haematoxylin and eosin (H&E) 
staining is a good indication of PE infection. However, in recovering pigs PE lesions 
may not be present. Immunohistochemistry of intestinal tissues from the ileum using 
an antibody specific for L. intracellularis antigen allows the visualization of the 
bacteria within intestinal crypts early in the infection and in the lamina propria late 
in the course of disease (Guedes and Gebhart, 2003a). However, the monitoring of PE 
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prevalence in herds through post-mortem tests of slaughter age pigs have the 
tendency to be underestimated because most lesions in the infected pigs have 
recovered by slaughter time (van der Heijden et al., 2004; Brandt et al., 2010). 
Therefore, an ante-mortem diagnostic test, such as serology and PCR, specific for L. 
intracellularis is beneficial for diagnosing L. intracellularis infection in pig herds.    
An indirect fluorescent antibody test (IFAT) using L. intracellularis antigen from 
PE affected mucosa or cultured bacteria has been used to detect IgM, IgA and IgG 
responses in serum and mucosa of naturally and experimentally infected pigs  
(Lawson et al., 1988; Guedes and Gebhart, 2003b; Donahoo, 2009). A modified IFAT 
using cultured L. intracellularis and peroxidase labelled antibody (immunoperoxidase 
monolayer assay, IPMA), was used to detect L. intracellularis specific serum IgG in 
field and experimentally challenged pigs (Guedes et al., 2002b; Marsteller et al., 
2003). However, for larger numbers of diagnostic samples a high throughput 
diagnostic technique is practical. Epidemiology studies have employed a commercial 
ELISA (Bioscreen® Enterisol Ileitis ELISA, GmbH, Münster, Germany) to determine 
the prevalence of L. intracellularis antibodies (Holyoake et al., 2010b; Jacobson et al., 
2011b; Collins et al., 2012). This blocking ELISA detects serum IgG antibodies to L. 
intracellularis (Keller et al., 2006). To ensure high specificity, the blocking ELISA is a 
direct sandwich ELISA with L. intracellularis specific monoclonal antibodies used to 
bind L. intracellularis to wells. Specific antibodies in pig serum are captured with a 
peroxidase-conjugated L. intracellularis monoclonal antibody (Keller et al., 2006). 
This commercial ELISA is reported to have a sensitivity of 90.5% and specificity of 
83% relative to an indirect fluorescent antibody test (IFAT) in pigs experimentally 
challenged with L. intracellularis (Collins et al., 2012).    
The polymerase chain reaction (PCR) assay is a diagnostic test to detect the 
presence or absence of L. intracellularis DNA in faeces and tissues. Several studies 
using PCR assays have been used to monitor the dynamics of disease in both 
experimental and naturally infected pigs (Jones et al., 1993; Knittel et al., 1998). The 
lowest quantity of L. intracellularis in faeces that conventional PCR has been reported 
to detect is 103 L. intracellularis per gram of faeces (Jones et al., 1993). The diagnostic 
sensitivity has been reported to be highly variable (between 36 and 100%) (Pedersen 
et al., 2010).  This may be due to sample quality and the presence of inhibitory factors 
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in faeces (Nathues and Beilage, 2008). However, this test is unable to quantify the 
numbers of L. intracellularis in faecal samples. More recently real-time PCR (qPCR) 
methods have been developed that allow quantification of L. intracellularis relative to 
faecal standards seeded with known numbers of L. intracellularis (Lindecrona et al., 
2002; Nathues et al., 2009; Collins et al., 2011). In a previous study, Collins et al 
(2011) used qPCR to detected between 104 and 108 L. intracellularis per gram of pig 
faeces on farms. The correlation between quantification of bacterial load and 
indication of clinical disease and histological findings have been studied by Pedersen 
et al., (2012). They demonstrated a positive correlation between histopathology and 
L. intracellularis numbers in faeces of pigs with diarrhoea.  
2.7 Lawsonia intracellularis dynamics of infection  
2.7.1 Infective doses  
The dynamics and severity of L. intracellularis infection are closely related to 
the initial challenge dose (Guedes et al., 2003; Collins and Love, 2007). The minimal 
infective dose was evident in a study by Collins et al., (2001), where groups of weaner 
pigs were challenged with either 103, 105, 107, 1010 L. intracellularis and compared 
with a negative control group. Doses as low as 103 L. intracellularis induced faecal 
shedding of the bacteria from day 26 until day 54 post-challenge (by PCR), even 
though the serum L. intracellularis IgG response (IFAT) was delayed up to 56 days 
after challenge.  Similarly, pigs inoculated with 105 L. intracellularis by experimental 
challenge (Collins and Love, 2007) or orally vaccinated (Guedes and Gebhart, 2003b) 
also showed delayed bacterial faecal shedding (from 19 to 63 days) and delayed 
serological responses (from 35 until 91 days) when compared with pigs inoculated 
with higher doses of L. intracellularis (1010 and 109, respectively).  
The earliest serological response to L. intracellularis was 14 days post challenge 
and faecal shedding after one week in pigs inoculated with higher doses of 109 and 
1010 L. intracellularis (Collins et al., 2001; Riber et al., 2011b). Higher doses (109) of L. 
intracellularis from intestinal homogenates (Guedes et al., 2003; Collins et al., 2007) 
and pure culture (Vannucci et al., 2012b) also induce clinical signs of PE including 
diarrhoea and reduced weight gains from 14 to 21 days post-challenge. In moderate 
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challenges with 107 L. intracellularis, clinical signs of diarrhoea were still observed, 
but with less severe diarrhoea over a shorter duration (day 19-21) (Collins and Love, 
2007). Faecal shedding of L. intracellularis was observed between day 14 and day 40, 
and antibodies between day 28 and day 70 after challenge (Collins et al., 2001; Collins 
and Love, 2007). Four pigs challenged with a pure culture of L. intracellularis 
containing 106 organisms remained clinically healthy throughout the trial but two 
pigs had gross PE lesions and all four pigs had IHC evidence of L. intracellularis 
antigen 22 days after challenge (McOrist et al., 1993).  
2.7.2 Immunity to re-infection   
A number of studies have demonstrated that once pigs recover from infection, 
they are immune to re-infection with L. intracellularis (Collins and Love, 2007; Riber 
et al., 2011b; Cordes et al., 2012). In one trial, by Collins and Love (2007), groups of 
pigs challenged with 105 to 1010 L. intracellularis were monitored for 70 days to 
determine when faecal shedding ceased. At 70 days post primary challenge, all 
groups were given a second challenge with 1010 L. intracellularis. All previously 
challenged pigs were protected from re-colonization regardless of the initial dose of 
L. intracellularis. On the other hand, naive controls exhibited persistent faecal 
shedding of L. intracellularis (from 7 to 23 days), diarrhoea and a serum IgG response 
(Collins and Love, 2007). The replication of B and T cells, the production of antibodies 
against L. intracellularis after first exposure, and the generation of memory cells have 
been speculated as the mechanism to inactivate the antigen prior to entry and avoid 
colonization after a second challenge (Collins and Love, 2007; Cordes et al., 2012). 
Accumulation of secretory IgA has been demonstrated (by IHC) in the apical 
cytoplasm of proliferating enterocytes, macrophage-granulocytes and in cell debris in 
the crypt lumen of PE-affected pigs (McOrist et al., 1992). An increasing L. 
intracellularis IgG serum immune response were also detected in re-challenged pigs 
(Collins and Love, 2007). In a later re-challenge study, Riber et al., (2011b) initially 
challenged pigs with 109 L. intracellularis from PE–affected mucosae followed by 
antibiotic (tiamulin) treatment.  Seven weeks post-challenge, pigs were re-challenged 
with 1010 Lawsonia intracellularis. Pigs were protected from re-infection as 
demonstrated by the absence of faecal shedding of L. intracellularis and low 
concentrations of antigen in intestinal mucosa of re-inoculated pigs compared with 
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infection infected controls. In addition, no increases in acute phase protein (C-
reactive protein and haptoglobin) concentrations were observed. In a similar study, 
whole blood IFN-γ concentrations increased ten-fold in re-challenged pigs, indicating 
a memory recall immune response to L. intracellularis (Cordes et al., 2012). 
Therefore, the protection against PE disease re-exposure provides the basis for 
vaccine strategies formulation utilized to control PE disease.  
Part 2- Porcine immunological responses to infection  
2.8  Innate and adaptive immunity to enteric pathogens in pigs 
Within the intestinal tract, the mucosal layer consists of secretory and 
absorptive epithelium and is the primary physical barrier against external antigens. 
Innate immunity is constitutive of an array of lectins, C-reactive proteins, β-defensins, 
macroglobulins and complement system (Sauerwein et al., 2007). It is the first 
differentiation between self  from non- self products by recognition of conserved 
microbial structures (pathogen associated molecular patterns, PAMPs)(Kumar et al., 
2009). The main leucocytes involved in this process are granulocytes (e.g. 
neutrophils), phagocytes (monocytes and macrophages) and natural killer cells (NK). 
These cells and also enterocytes possess membrane receptors called Toll-like 
receptors (TLRs) to recognize PAMPs on infectious agents, such as the outer 
membrane lipopolysaccharide (LPS) molecules in Gram-negative bacteria and β-
glucan from fungi and yeast (Abreu and Targan, 1996). Specifically, TLR subsets have 
been reported to recognise extracellular bacterial components (TLR 1, 2, 4, 5, 6 and 
10), bacterial flagellin (TLR 5) and intracellular components (TLR 3, 7, 8) in pigs 
(Uenishi and Shinkai, 2009; Emery and Collins, 2011). The role of TLRs in immunity 
has been elucidated by identifying functional single-nucleotide polymorphisms 
(SNPs), TLRs and immunity against specific pathogens. For instance, Toka et al., 
(2009) demonstrated in vitro that TLR7 was associated with increased IFN-γ 
production and activation of porcine NK cells against foot and mouth disease virus.  
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The consequence of binding TLRs to epithelial cells and phagocytosis of 
antigens results in the secretion of a range of inflammatory cytokines (IFN-γ, IL-6, 
TNF-α, IL-12) by T and B lymphocytes (Bailey, 2009; Abreu, 2010). For instance, 
increasing movements of macrophages (by MIF), neutrophils (by IL-8) and dendritic 
cells (CCL20) were expressed in ileal sections 3 h after pigs were orally challenge 
with pathogenic Salmonella sp (Skjolaas et al., 2006). These pro-inflammatory 
cytokines also stimulate the liver to produce acute-phase proteins, increase the 
release of amino acids from muscle tissue, and may induce fever and loss of appetite 
(Murtaugh et al., 2009). Eventually, migration of macrophages and dendritic cells 
(antigen presenting cells, APC’s) into the lymphoid tissues (e.g. Payers patches and 
lymph nodes) occurs with consequent antigen presentation to T and B lymphocytes 
and activation of adaptive immunity.  
Innate immunity is antigenic nonspecific and produces a short lived response. 
On the other hand, while the adaptive immunity takes longer to be induced (5 to 7 
days) it provides a more effective and antigenic specific response (Rothkötter et al., 
1999). The classical anamnestic response to adaptive immunity is by developing 
antigenic memory and protection (and boost immunity) against re-exposure to the 
same pathogen (Figure 3). The adaptive immune response enables the production of 
antibodies against specific antigens by B lymphocytes (humoral immune response) 
and the generation of cytotoxic and helper T lymphocytes in infected cells (cell-
mediated immune response) (Ogra et al., 2005; Abbas et al., 2010). 
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Figure 3: Primary and secondary antibody responses induced by a first and second vaccine 
exposure. Note that the secondary response is faster and greater that the primary response and it 
is specific for antigen A. 
The presence of large clusters of immune cells (B and T lymphocytes), as well as 
dendritic cells and macrophages, along the intestinal epithelium and lamina propria 
(LP) have been described in pigs (Stokes et al., 1994; Burkey et al., 2009). In naive 
animals, the specific immune response will initiate once antigen presenting cells 
(APC’s) bind and present antigens to naive or sensitised T cells by expressing the 
major histocompatibility complex (MHC) in organised lymphoid tissues (Stokes et al., 
1994; Ogra et al., 2005). APC’s and T cells in the mucosa can migrate to the 
mesenteric lymph nodes (MLN’s) via the afferent lymphatic circulation, where clonal 
expansion will occur and memory antigen-specific cells can be generated. In other 
words, upon encountering with specific antigen, B cells are stimulated (by T cells) to 
divide into plasma and memory cells (Moser and Leo, 2010). Sensitised cells then re-
circulate in the body via blood and fluids reaching the infection site. The pathogen is 
then attacked by phagocytosis or cytotoxicity and apoptosis through local production 
of cytokines (T cells) or antibodies (B cells) (Bailey, 2009; Moser and Leo, 2010).  
2.8.1 Antibody and cellular mediated immunity (CMI) 
Antibodies (immunoglobulin) are basically Y shaped proteins, produced by B 
cells, to recognize and eliminate a given antigen. The antibody class (e.g. IgM, IgG, 
IgD) is important to determining the capacity of a given antibody to reach the site of 
infection and recruit the adequate effector mechanism (Janeway et al., 2001). The 
most direct way in which antibodies can protect from pathogens or toxic products is 
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by binding to them and thereby blocking their attachment to the epithelium and 
avoiding antigen colonization (Stokes et al., 1994). The distribution of different 
antibodies classes within ileal section has been observed in an earlier study where 
IgA (42%) and IgM (7.5%) and occasional IgG (2.5%) staining (IHC) was detected in 
ileal crypt and lamina propria of adult pigs (Butler et al., 1981). After initial exposure 
the antigen-antibodies, such as IgM and IgG are observed locally and systemically. For 
instance, Taenia solium specific IgM response on intestinal mucus was observed by 
Western blotting one week after pigs were infected with 10.000 Taenia eggs (Tsang 
et al., 1991). Following IgM disappearance, IgG increases were observed after 3 
weeks (Tsang et al., 1991). Similarly, anti- E. coli IgM antibody response in serum 
increased and declined rapidly in the first 2 weeks after weaner pigs were challenged, 
following by gradual increase in serum concentrations of IgG antibodies (Porter and 
Hill, 1970). IgM possess high avidity and is effective in activating the complement 
system (C3b)(Wellek et al., 1976). IgG antibody has a more amplified function such as 
binding to antigen via agglutination and also opsonising pathogens, as well as 
activating the complement system (Wellek et al., 1976). In addition, IgA presence 
within fluids and membrane mucosa in adult pigs  have been described (Lamm et al., 
1996) and are attributed to disease protection (Jemmott and McClelland, 1989). For 
instance, the use of a dendrimeric peptide suspension protected pigs against 
challenge with foot-and-mouth disease virus and induced high titres of specific virus 
neutralizing antibodies and IgA response locally and systemically compared with 
non-infected controls pigs (Cubillos et al., 2008).  
The generation of cytotoxic and helper T lymphocytes in infected cells, includes 
a series of mutual complex interaction to control infection as summarized in Figure 4. 
CD4+ T cells subpopulation stimulate CD8+ cytotoxic T cells or macrophage to kill 
cells through intracellular pathogens (Th1 pathway). The Th2 pathway is essential to 
control immune activation, prevent auto-immune destruction and activate allergic 
responses to parasites (Charerntantanakul and Roth, 2006; Moser and Leo, 2010). 
Th1 and Th2 pathways are mostly mediated by the secretion of cytokines. CD4+ Th1 
cells produce mainly IL-2, IFN- γ and TNF-α promoting cell-mediated immune 
responses against intracellular pathogens, while the CD4+ Th2 subset produces IL-4, 
IL-5, IL-6 and IL-10 cytokines activate the antibody specific production (IgE) by B 
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cells to aid in the clearance of extracellular bacteria and parasites (Ogra et al., 2005; 
Emery and Collins, 2011). The IL-2, IFN- γ ,and TNF-α and also IL-1β  mediate the 
initial inflammatory response to the acute phase proteins, increases blood flow and 
vascular permeability (Burke-Gaffeyy and Keenan, 1993). The expression of mRNA 
encoding for IFN-γ and TNF-α in lung tissues have been demonstrated one day after 
pigs were experimentally infected with porcine respiratory reproductive syndrome 
(PRRS) virus (Shi et al., 2010). On the other hand, up-regulation of Th2-type  genes 
(CCR3, ARG1, MUC5AC, IL-4, IL-5, IL-13) in colonic sections was observed in pigs 5 
weeks after Trichuris suis nematode infection (Kringel et al., 2006). However, 
interactions are more complex than this, as for instance, in porcine B cells cultures, 
the secretion of IgG isotypes (IgG1 and IgG2) in presence of Th1 and Th2 type 
cytokines, confirmed that IL-10 promotes IgG1 and IFN-γ promotes IgG2 (Crawley et 
al., 2003). 
Transforming growth factor-β (TGF-β) controls the initiation and resolution of 
inflammatory responses through the regulation of lymphocyte activation, promoting 
T cell survival and inducing IgA class switching in B cells (Schluesener et al., 1990). 
For instance, mice injected with anti-TGF-β1 in spleen and liver became susceptible 
to listeriosis, whereas the administration of human TGF-β1 enhanced their 
resistance, even though level of IFN-γ, TNF-α and IL-6 were reduced in these animals 
(Nakane et al., 1996). Therefore, together with immunoregulatory T cells (T-reg) and 
Th-17 cells, TGF-β is involved in the tolerance and regulation in the gut (Moser and 
Leo, 2010). T-reg are CD4+T cells that secrete predominantly TGF-β and IL-10 
(Fontenot and Rudensky, 2005) and contribute to dampening macrophage function 
and maintaining homeostasis (Bailey, 2009). T-reg also express the transcription 
factor FoxP3 and the surface receptor CD25 (the IL-2 receptor α-chain), through 
involvement with NK, T and B cells, control the immune response against self or 
exogenous antigen (Fontenot and Rudensky, 2005). Meanwhile, Th17 cells are 
related to γδ-T cells and produce IL-17 and IL-22 which influence neutrophilia, tissue 
remodelling and repair (Emery and Collins, 2011). CD4+ effector T cells and Th17 
cells have been found in mucosa surfaces and act against bacterial and fungal 
infections by secreting IL-17 and expressing CCR6 and IL-23R signalling receptors 
(Weaver et al., 2007).  
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Figure 4: The role of T helper (Th) cells in immunity. CD4+ Th cells play a multiple role as: Th1 
cells by secreting IL-2 and IFN-γ cytokine, Th2 by secreting IL-4 and IL-10 cytokines. As well as 
stimulating a regulatory activity by releasing of TGF-β, IL-17 cytokines. 
2.9  Immune responses to Lawsonia intracellularis vaccination 
and virulent challenge 
The L. intracellularis immune response is most probably initiated after the 
pathogen is captured by dendritic cells and macrophages and presented to T-
lymphocytes in lymphoid tissues. Consequently, dendritic cells and monocytes 
recruitment leads to activation of CD4+ Th1 cells and later production of secretory 
IgA (Abreu, 2010). Humoral and cellular immune responses in pigs naturally or 
experimentally infected with L. intracellularis have been measured by immunoassays 
and gene expression studies (Collins et al., 2001; Guedes and Gebhart, 2003b; Collins 
and Love, 2007; Jacobson et al., 2011a; Riber et al., 2011a; Cordes et al., 2012). In an 
initial study using serological immunofluorescence tests with a crude filtered 
Campylobacter–like antigen suspension, it was demonstrated that growing pigs with 
naturally severe PHE lesions had predominantly IgM responses, which persisted for 8 
weeks, with less marked IgG and IgA responses (Lawson et al., 1988). Similarly, 
Holyoake et al., (1994), struggled to detect significant differences in IgG titres 
between uninfected and challenged pigs (mucosal homogenate from PHE-affected 
pigs) using an IgG ELISA test with whole L. intracellularis as the antigen. This work 
was additionally hampered by the difficulty in identifying naive pigs for negative 
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control sera. A subsequent study was able to improve the sensitivity and specificity of 
IgG detection, employing an immunofluorescent (IFAT) test based on L. intracellularis 
co-cultured in IEC-18 mammalian cells (Knittel et al., 1998). The IFAT was able to 
detect serum specific IgG antibodies in 90% of pigs 3 weeks after virulent challenge 
with cultured L. intracellularis (Knittel et al., 1998). More recently, the reliability of a 
commercial ELISA to detect Lawsonia intracellularis IgG antibodies in pigs serum 
with subclinical PE after experimental challenge (109) has been also described during 
the 35 days trial (Collins et al., 2012). Similarly, L. intracellularis specific IgG 
antibodies have been detected (1:25 titre) in ileal mucosa 21 days after piglets were 
vaccinated with attenuated L. intracellularis suspension (Donahoo, 2009).  
Secretory IgA is promoted as an important defence mechanism against 
enteropathogenic bacteria by blocking antigen adhesion to the mucosal epithelium 
(Lawson et al., 1988; Jemmott and McClelland, 1989; Husband et al., 1996). 
Accumulations of IgA have been demonstrated (by IHC) in the apical cytoplasm of 
proliferating enterocytes in the crypt lumen and Peyer’s patches from pigs with 
clinical cases of PIA and PHE (Lawson et al., 1979; McOrist et al., 1992). However, 
minimal concentrations (1:4 titre) of L. intracellularis specific IgA (by IPMA) were 
detected in intestinal lavage 22 days after 108 cultured L. intracellularis were given 
orally to weaner pigs (Guedes and Gebhart, 2010). Similarly, total faecal IgA was also 
minimal (<200ng/mg of faeces) in 10 week old pigs after primary (109) and re-
challenge (1010 L. intracellularis) inoculation (Cordes et al., 2012). Additionally, the L. 
intracellularis specific IgA in serum increased slowly with peak 4 weeks (100 OD%) 
after primary challenge, being undetectable after 7 weeks (<5 OD%) (Cordes et al., 
2012). However,  significant increase in L. intracellularis specific IgA in serum of pigs 
following 1010 L. intracellularis re-inoculation was not detectable (Cordes et al., 
2012).  
Early lesions of PE contain few infiltrating inflammatory cells, indicating the 
initial epithelial cell nature of the infection and the lack of an inflammatory stimulus 
(McOrist et al., 1992). The lack of inflammation associated with non-haemorrhagic PE 
in pigs is possibly due to the limited numbers of CD8+CD25+ T lymphocytes observed 
within intraepithelial lymphocytes cells (IELs) and the lamina propria (McOrist et al., 
1992; MacIntyre et al., 2003). Descriptive immunocytological studies of intestinal 
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tissues sections of pigs clinically affected with PE reveal a mild infiltration of 
cytotoxic CD8+ T cells, macrophages and B lymphocyte carrying MHC class II 
structure 14 days after 108 L. intracellularis challenge (MacIntyre et al., 2003). 
However, moderate infiltrations of CD8+CD25+T lymphocytes have been observed in 
pigs suffering from severe PHE (McOrist et al., 1987),  suggesting that more severe 
cases can induce infiltration of cytotoxic cells. However, the expansion of CD8+ and 
CD4+ cell populations (reduced ratio of non specific CD4:CD8 T cells) have been 
observed in ileal samples 3 to 4 weeks after experimental L. intracellularis challenge 
(109) (Cordes et al., 2012). In addition, high concentrations of IFN-γ were associated 
with increased numbers of L. intracellularis specific IFN-γ producing CD8+ cells in the 
serum of PE infected pigs (Cordes et al., 2012).  
A significant role for IFN-γ in immunity against PE disease has been implicated 
in mouse and pig challenge models (Smith et al., 2000; Guedes and Gebhart, 2003b). 
Mice without IFN-γ receptor (IFN-γ R-) were substantially more susceptible to PE 
disease outbreaks and more extensive lesions as observed by immunohistochemistry 
compared with wild type mice (IFN-γ R+) after oral infection with 107 cultured L. 
intracellularis (Smith et al., 2000). The generation of antigen-sensitised (CD4+ and 
CD8+) lymphocytes and the production of L. intracellularis specific IFN-γ following 
incubation of L. intracellularis antigen with peripheral blood mononuclear cells 
(PBMC) has been reported in pigs within 14 days of challenge with 109 virulent L. 
intracellularis in 12 weeks old pigs (Guedes and Gebhart, 2010; Cordes et al., 2012). 
Guedes et al., (2003b) also detected L. intracellularis specific IFN-γ producing cells by 
ELISPOT, in porcine PBMC until 13 weeks post-vaccination with 105 L. intracellularis. 
In horses, IFN-γ gene expression in all vaccinated foals was significantly higher after 
60 days following oral vaccine administration compared to IFN-γ gene expression in 
control unvaccinated foals (Pusterla et al., 2012a). L. intracellularis as intracellular 
organism stimulate IFN-γ, leading to the clearance of infection or imputing disease 
severity (Cruz et al., 2006). However, cytokine gene expression was limited and did 
not correlate with clinical signs, lesions or antibody response in naturally infected 
PHE and PIA pigs (Jacobson et al., 2011a). But the gene encoding for insulin-like 
growth factor binding protein 3 (IGFBP-3) was up-regulated in two pigs with 
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prominent mucosal proliferation (PIA and PHE) and also in L. intracellularis infected 
McCoy cells (Oh et al., 2010).  .  
Delayed-type hypersensitivity (DTH) responses can be induced by a number of 
intracellular bacteria, such as Brucella abortus, Listeria monocytogenes and 
Mycobacterium bovis (Abourebyeh et al., 1992; Bercovich, 2000). The mechanism by 
which DTH responses are observed is due to secondary exposure to the pathogen and 
activation of antigen-specific Th1 T cells to secrete especially IL-2 and IFN-γ that will 
mediate the hypersensitivity reaction (Abourebyeh et al., 1992). In a L. intracellularis 
trial by Guedes et al, (2010), DTH were detected 20 days after pigs experimentally 
infected with 108 cultured L. intracellularis. The DTH reactions were observed in a 
dose dependent manner 24 hours after intradermal injections with 107 to 109 L. 
intracellularis treated by formalin fixation, sonication or extracts of outer membrane 
proteins (Guedes and Gebhart, 2010). In other diseases, such as Brucella abortus, 
responses are typically within 48 to 72 hours in sensitized hosts no matter the dose 
used  (Bercovich, 2000).  
Part 3- Principles of mucosal vaccination 
2.10 Introduction to porcine mucosal vaccination 
The activation, replication and differentiation of T and B cells lymphocytes 
leading to the generation of memory cells which respond and provide protection 
against specific pathogens are desirable for successful immunization (Meeusen et al., 
2004). Mucosal immunity refers literally to the immunity induced at the mucus-
covered epithelial surfaces typically present in the gastrointestinal, upper respiratory 
and lower reproductive tracts (McGhee and Kiyono, 1994; Meeusen et al., 2004; 
Sedgmen et al., 2004). Additionally, identifying an immune marker that correlates to 
the protective mechanism to be induced by mucosal vaccines is ideal to facilitate 
vaccine design (Emery and Collins, 2011). Therefore, for the specific formulation of a 
vaccine, it is fundamental the information about the pathogen, such as how it infects 
the cells, and how the immune system responds to it, as well as practical 
considerations (e.g. costs of production and delivery). On the other hand, the 
maternal antibodies may also need to be considered, since their interference has 
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been related to vaccination failure (Hodgins et al., 2004). Additionally, factors to be 
considered in vaccine formulation include the administration route (parenteral vs. 
oral), antigen dosage and formulation (killed vs. live), the presence of adjuvants 
(saline vs. oil) (McGhee and Kiyono, 1994; Sedgmen et al., 2004). To induce 
protective responses against (extracellular) tetanus toxin, high titres of systemic 
antibody are required (Tregoning et al., 2005), while for mycobacterial infections 
such as tuberculosis, macrophage activated cell-mediated immunity and for influenza 
viruses, cytotoxic T cell responses and IFN-γ are important (Brodin et al., 2004).  
The success of live vaccines has been attributed to a mimic of natural infection 
without causing “severe” disease. Live vaccines are normally produced by attenuating 
an agent from field disease outbreaks by continuous sub-cultivation or 
chemical/radiation attenuation (Meeusen et al., 2004; Sedgmen et al., 2004). This 
produces an ability of the antigen to replicate and produce subclinical disease 
(depending dose) generating immune responses similar to the natural infection. 
Examples of available live vaccines for pigs include the porcine reproductive and 
respiratory syndrome (PRRS) vaccine (Porcilis® PRRS, MSD Animal Health) and 
Salmonella Choleraesuis vaccine (Enterisol® SC-54, Boehringer Ingelheim). These 
vaccines have been demonstrated to elicit a strong and rapid antibody and cellular 
immune responses (dominated by CD8+ T cell) resulting in lifelong immunity (at least 
3 months) with only one dose  (Husa et al., 2009; Martelli et al., 2009). However, if an 
attenuated live vaccine contains insufficient live organisms or replication is 
compromised (e.g. temperature of refrigeration), it may not provide sufficient 
stimulus to the immune system to induce a measurable response or immunity 
(Meeusen et al., 2007).  
Inactivated vaccines can contain antigen specific epitopes, fractions of protein, 
toxoids, subunits, DNA or whole viruses or bacteria (Meeusen et al., 2004). The 
immune response to an inactivated vaccines is mostly humoral (Watson, 1987), 
except when they are added with specific adjuvants (e.g. Complete Freund's 
adjuvant/CFA) (Holmgren et al., 2003). One of the benefits of using inactivated 
vaccines is the ability to amplify the responses against specific pathogens strains by 
combining different pathogens or different virulent factors in one unique suspension. 
For instance, the Actinobacillus pleuropneumoniae (App) vaccine (Porcilis® APP, MSD 
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Animal Health) is based on the outer membrane protein (OMP) with an additional 
three toxoids ApxI, ApxII and ApxII, that are produced by different strains found 
around the world (Tumamao et al., 2004). Another commercially available 
Clostridium perfringens Type C and Escherichia coli (K88, K99, 987P) bacterin 
(Scourmune-C® , Merck Animal Health) for use in pregnant gilts and sows have been 
shown to reduce neonatal diarrhoea in piglets when compared with unvaccinated 
sows (Cunningham et al., 2005). However, during inactivated vaccine development 
the addition of adjuvants or multiple immunisations are often required to achieve 
sufficient stimulus to generate suitable and sustained protection (Pavot et al., 2012). 
The use of recombinant DNA (or vector) vaccines is beneficial due to addition of 
specific pathogen genes. For example, an inactivated vaccine containing a killed 
baculovirus vector carrying a protective ORF2 antigen against Porcine Circovirus 2 
(PCV2) is commercially available (Porcilis® PCV, Merck Animal Health). Live vector 
and DNA vaccines have been shown to be effective against intracellular pathogens 
(bacterial and viral) at mucosal surfaces (Fort et al., 2008), possibly because they 
elicit intracellular antigen production and induce cell-mediated immunity which can 
inactivate or destroy infected target cells or prevent pathogen replication.  
2.11 The maternal immunity interference on vaccination 
Non-responsiveness to vaccination in young piglets to active immunisation has 
been previously associated with maternal immunity interference (Mengeling et al., 
1992; Lawhorn et al., 1994; Hodgins et al., 1999). The maternal antibody half-life for 
L. intracellularis in serum has been estimated to be between 3 to 6 weeks in serum of 
piglets (Holyoake et al., 1994; Guedes et al., 2002a).  Investigation on the efficacy of 
the L. intracellularis vaccine (Enterisol®Ileitis) when administered to 2 to 6 days old 
suckling piglets (from sows that were naturally exposed to L. Intracellularis) and 
challenged (108 organism) at 7 weeks of age, demonstrated the reduction on the 
duration of L. intracellularis faecal shedding but did not reduce intestinal lesions 
relative to non-vaccinated pigs (Donahoo, 2009). It is hypothesised that when live 
vaccines are administered orally to suckling pigs the antigen are not readily available 
due to neutralisation by maternal antibodies present in the intestinal tract of suckling 
animals (Siegrist, 2003). Therefore, piglets active immunisation strategies are 
normally delayed until passive immunity is declining but to not create a window of 
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opportunity for infecting diseases (around 4 to 6 weeks) (Emery and Collins, 2011). 
Alternatively, strategies to avoid this interference include using inactivated vaccines 
or alternative routes of vaccination such as passive vaccination (Emery and Collins, 
2011; Chase and Lunney, 2012).  
2.12 Route of vaccination on mucosal immune response 
The ultimate goal of vaccination is to induce a specific immune response at the 
local site of pathogen adherence and proliferation. Therefore, it is only logical that to 
avoid mucosal pathogens colonization, a mucosal vaccine delivery is the most likely 
to be successful in protecting against disease. The oral dosing is often related as the 
main mucosal vaccination route (Curtiss et al., 1996; Mirchamsy et al., 1996; Husa et 
al., 2009). This is based on the premise that the induction of IgA/IgG plasma cells will 
occur following antigen uptake at inductive sites (e.g. Peyer’s patches) in the gut 
mucosa (Mestecky et al., 2005; Roth, 2010). Pigs orally vaccinated with Salmonella 
Typhimurium live attenuated vaccine showed reduced intestinal lesions and 
increasing antigen specific IgG in serum after pigs were inoculated with 109 virulent 
Salmonella sp. compared with the unvaccinated group (Husa et al., 2009). However, 
alternative mucosal routes such as intranasal, intraperitoneal and intrarectal 
vaccinations have been also successful in protecting livestock against mucosal 
diseases (Muir et al., 1998; Pusterla et al., 2010; Riddle et al., 2011). Similar to oral 
vaccination, intrarectal and intranasal routes induce IgA responses at the local site of 
infection following antigen uptake within lymphoid follicles present at these sites 
(Sedgmen et al., 2004). In humans, intranasal delivery with a Shigella flexneri 2a 
lipopolysaccharide 50 subunit vaccine (LPS, IpaB, IpaC and IpaD) induced a fivefold 
increase in the concentrations of antigen-specific intestinal faecal IgA and IgG (Riddle 
et al., 2011). Similarly, intra-rectal vaccination using a live attenuated L. 
intracellularis vaccine has been found to induce increased specific L. intracellularis 
IgG responses in serum of horses (Pusterla et al., 2009).  
 In addition, the intraperitoneal route has also been demonstrated to induce 
mucosal immune responses against specific pathogens. For instance, intraperitoneal 
vaccination of a crude tetanus toxoids with either Freund’s adjuvants or oil-in-water 
adjuvants demonstrated a markedly improved anti-tetanus IgA antibody responses in 
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jejunum of chickens compared with an orally vaccinated group  (Muir et al., 1995). In 
a subsequent study in broilers, the intraperitoneal vaccination against Salmonella sp. 
produced protection and increased IgG and IgA serum responses that were 
comparable to those from orally vaccinated birds (Muir et al., 1998). Antigens 
delivered by intraperitoneal route act by reaching the serosal surface through 
diffusing across the peritoneal membrane and are absorbed via the lymphatic system 
and consequently drain to the mesenteric lymph nodes (Lukas et al., 1971). Pigs 
vaccinated intraperitoneally at 30 days and 60 days old with formalin killed 
Mycoplasma hyopneumoniae plus adjuvant had significantly fewer lung lesions and 
increasing serum M. hyopneumoniae specific IgG response than the non-vaccinated 
controls (Sheldrake et al., 1993).  
By contrast, non-mucosal routes of vaccination have also been related to 
vaccine protection against mucosal pathogens. For instance, Salmonella 
Typhimurium autogenous bacterin reduced the rate of pigs positive to Salmonella sp. 
shedding from 24% prior to intramuscular vaccination (d0) to 8.5% in marketing-age 
pigs (d49) (Farzan and Friendship, 2010). Presumably the mechanism by which 
intramuscular vaccination protects against mucosal pathogen is through the homing 
of activated immune cells from somatic sites and lymph nodes to mucosal tissues 
(Daynes et al., 1996), or more likely, by the diffusion of circulating antibody into 
mucosal tissues. In L. intracellularis trials, Dale et al., (1997) observed a 98.5% 
reduction in faecal L. intracellularis counts in four pigs that were vaccinated twice 
intramuscularly, 3 weeks apart, with killed L. intracellularis in incomplete Freund's 
adjuvant. The additional pigs were then inoculated with recombinant GroEL-Like 
protein and exhibited reduced faecal bacteria compared to infected controls.  
2.13 Lawsonia intracellularis vaccines 
Recently, a patent (WO/2009/127684) have has been registered presenting an 
inactivated Lawsonia intracellularis, Mycoplasma hyopneumoniae and porcine 
circovirus (PCV2) vaccine (Jacobs et al.,  (2011); Intervet/Schering-Plough Animal 
Health). This invention vaccine is constituted with inactivated Lawsonia 
intracellularis whole cells (1.7 x 108 cells/mL), PCV2 antigen with ORF2 expressed in 
baculovirus and inactivated whole M. hyopneumoniae antigen in an oil-in-water 
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adjuvant. The whole cell Lawsonia intracellularis vaccine was derived from a live 
isolate from a pig with PE and was inactivated by high temperature (100°C) and 
0.01% beta-propiolactone (Jacobs et al., 2011). In the first experimental trial using 
this vaccine, 2mL of the L. intracellularis whole antigen plus 19/21kD, 37kD and 
50kD outer membrane proteins (OMP) suspension was given twice intramuscularly 
(4 weeks apart) to 6 weeks old pigs. At 7 weeks post vaccination pigs were then 
orally challenged with a 108 L. intracellularis mucosa homogenate. Results showed 
higher L. intracellularis antibody concentrations (by IFAT) 4 weeks after vaccination 
comparing with the unvaccinated pigs. After the L. intracellularis challenge, pigs 
vaccinated showed significant reductions in L. intracellularis shedding and lesions 
relative to control animals. However, this vaccine is not yet commercially available.  
In the Australian market, a lyophilised Lawsonia intracellularis vaccine for pigs 
(Enterisol® Ileitis, Boehringer Ingelheim Vetmedica) has been available since 2006. 
The Enterisol® Ileitis is a live attenuated vaccine containing a L. intracellularis isolate 
derived from the ileum of a Danish sow with acute PHE (Kroll et al., 2004). The L. 
intracellularis isolate (B3903) was co-cultured in McCoy mouse fibroblast cells with 
repeated subculturing for attenuation (Knittel and Roof, 1999). The culture is 
harvested and the number of viable L. intracellularis is estimated using the dilution 
assay to quantify the number of bacteria required to infect 50% of cell hosts and 
induce pathological changes (TCID50). According to the Enterisol® Ileitis vaccine label 
information, one dose of reconstituted vaccine contains a minimum concentration of 
1x 104.9 TCID50 and a maximum of 1x 106.1 TCID50 L. intracellularis (Kroll and Roof, 
2007). 
  The Enterisol® Ileitis vaccine is recommended for use in weaned pigs 3-4 
weeks of age, and given via drinking water or drench gun (McOrist et al., 2006b). 
Since it is a live vaccine it is recommended that antibiotics should be removed from 
feed 2 days prior and 3 days post vaccination (Walter et al., 2005; McOrist et al., 
2006b). The manufacture’s also recommends, when giving the vaccine in drinking 
water, adding skimmed milk or sodium thiosulphate solution as a stabilizer prior to 
adding the vaccine (McOrist et al., 2006b). There is no withdrawal period prior to 
slaughter. The L. intracellularis vaccine has been shown to protect 3 week old pigs 
and older pigs against clinical signs and intestinal lesions (28 days) (Kroll et al., 2004; 
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McOrist and Smits, 2007). Increased herd uniformity and improved average daily 
weight gains of individual pigs between 20 to 34 g per pig per day have also been 
reported (Almond and Bilkei, 2006; Bak and Rathkjen, 2008). The onset of protection 
occurs as early as 3-4 weeks post-vaccination and lasts for at least 17 weeks (Guedes 
et al., 2003); however, a direct correlation between immune responses and the level 
of protection have not been clearly established and is the focus of this thesis.  
Part 4- Nutrition and mucosal immunology 
2.14 Nutrition of the young pig 
 
The basic physiology of the digestive system comprises the physical and 
chemical break down of complex nutrients in feed into simple molecules and 
absorption of these molecules across the intestinal epithelium (Yen, 2001). The 
absorption of nutrients from the lumen of the gut begins with their transport, active 
or passive, across the membrane of enterocytes lining the mucosal surface, followed 
by passage across the cells or metabolism within cells and entry into the blood or 
lymphatic system (Yen, 2001; Böhme, 2002). Concomitantly the presence of immune 
cells, mucus and microbiota along intestinal epithelium act against attachment and 
colonization of pathogens (Bailey et al., 2005). Therefore, an efficient physiology of 
the gastrointestinal tract, such as motility, chemical digestion and absorption of 
essential nutrients, is critical to ensure optimum health and maintain growth and 
development of immunity. However, during post-partum and at weaning, piglets have 
to cope with many environmental and nutritional changes (Pluske et al., 1997).  
Initially the colostrum and milk intake in neonate piglets plays a crucial role in 
the piglets survival and development by providing energy (Le Dividich et al., 2007) 
and enabling maternal antibody immune transfer (Rooke and Bland, 2002). 
Colostrum and milk have high fat (21.9% and 62%, respectively) and protein 
(68.04% and 56%) contents (Lin et al., 2009). The intake of colostrum is directly 
correlated with piglet survival rate and growth performance (Le Dividich et al., 
2007). Lin et al., (2009) observed that 98.3% of proteins in the colostrum were 
utilised by neonatal piglets in the form of the amino acids; lysine, glutamine, leucine, 
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and threonine. Amino acids are known to be utilize in a range of processes, such as 
the formation of secretory mucins, biosynthesis of amino acid, glutathione peptide 
formation and nucleic acid composition (Halas et al., 2006; Stoll, 2006). 
Weaning piglets around 21 to 35 days of age is part of the routine farm 
management of intensive pig production systems. Weaning is a critical period in the 
young pig’s life as they are abruptly forced to adapt to new nutritional, 
immunological and psychological changes (Pluske et al., 1997). The innate and 
adaptive immune system of weaner pigs develop while passive immunity from sows 
is declining at weaning.  Additionally, piglets have to adapt from sow’s milk that is 
highly digestible to a dry and less digestible starch based diet containing complex 
protein and carbohydrates that also include anti-nutritional factors (Williams, 2003; 
Lalles et al., 2009). Dietary changes induce villus atrophy and crypt hyperplasia 
leading to reduced nutrient absorption and changes in the digestive enzymes profiles 
(Pluske et al., 1997). Therefore it is no surprise that increased pig morbidity and 
mortality occurs post-weaning with increased pathogen attachment and proliferation 
along the intestinal tract. Common endemic pathogens at this stage include E. coli, 
Salmonella spp. and L. intracellularis and rotavirus (Jacobson, 2003). All of these 
pathogens cause diarrhoea and reduced growth performance of piglets. Therefore, 
strategies to overcome these post-weaning challenges are important. Feed antibiotic 
growth promoters and/or mineral compounds such as zinc (ZnO) are known to be 
beneficial in reducing disease outbreaks and mortality (Verstegen and Williams, 
2002). However, due to food safety concerns and issues surrounding antibiotic 
resistance in humans, alternative strategies and feed additives are being investigated 
(de Lange et al., 2010; Kim et al., 2012; Heo et al., 2013; Pluske, 2013). These include 
using diet composition to offset some of the nutritional challenges presented at 
weaning (e.g. protein/amino acid content of diets)(de Lange et al., 2010) as well as 
the supply of immunomodulators (e.g. β-glucans, spray-dried plasma)(Halas et al., 
2006); and addition of feed additives (e.g. ZnO, organic acids, prebiotics and 
probiotics)(Pluske, 2013). For instance, the use of β-glucans to increase and 
modulate immune cells, protect against disease and increase growth performance has 
been discussed as a viable alternative to antibiotic use in mammals (Bohn and 
BeMiller, 1995; Brown and Gordon, 2003; Gallois et al., 2009).  
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2.14.1 Impact of Lawsonia intracellularis infection on digestion and 
absorption of nutrients 
The small intestine is around 4m long in neonatal pigs, 12m in weaner pigs and 
20m long in adult pigs (Yen, 2001). Morphologically, the presence of villi projecting 
into the intestinal lumen are lined with epithelial cells covered with a continuous 
single-layer of absorptive cells termed enterocytes (Böhme, 2002). Under normal 
conditions, enterocyte cells actively divide by mitosis, migrate and mature along the 
crypt-villus to the tip of the villi where they are involved in absorption of nutrients 
across the intestinal wall and into the bloodstream (Friendship, 1989). Eventually, 
mature cells are sloughed off into the lumen and replaced with new cells.  
Histopathology of L. intracellularis infected pigs shows proliferation of 
enterocytes and a marked reduction or loss of goblet cells (Lawson et al., 1993; 
Lawson and Gebhart, 2000). Therefore, it is expected that disturbance can also lead 
to reduction in nutrient absorption. Hamsters experimentally infected with 109 L. 
intracellularis were associated with a reduction in the absorption of protein, amino 
acids and Cl- and K- at 26 days post-challenge (Vannucci et al., 2010). The authors’ 
speculate that the effect of PE may have reduced expression or production of sodium-
dependent glucose transporter 1 (SGLT1) (Vannucci et al., 2010), therefore lowering 
intestinal absorption of nutrients and redirecting water into the intestinal lumen. 
Wong et al., (2009) also demonstrated impaired intestinal absorption of glucose in 
four PE affected foals using an oral glucose absorption test. Although this test is not 
specific, it clearly does suggest that L. intracellularis infection impairs the intestinal 
absorption of nutrients. Supporting this notion, when compared to healthy pigs, PE 
lesions in infected pigs resulted in an approximate 7% reduction in the amino acid 
digestibility in the terminal ileum of pigs (Rowan and Lawrence, 1982). Similarly, PE 
lesions have also been related to changes in enzyme activity of the brush border. For 
instance, pigs infected with PE showed reduced concentrations of Mg-ATPase and 
acid phosphatase activity in crypt cells (Eriksen and Landsverk, 1988). Similarly, PE 
severity has been directly correlated to reduced activity of alkaline phosphatase and 
amino peptidase enzymes in the ileum of pigs severely affected with PE compared 
with control pigs (Collins et al., 2009). Alkaline phosphatase and amino-peptidase 
enzymes have been demonstrated as essential in fat absorption and digestion of 
amino acids, respectively (Danielsen et al., 1995; Hansen et al., 2007). Therefore, L. 
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intracellularis infection possibly leads to alteration in the intestinal morphology and 
function, with possible impairment of nutrient digestion and absorption.  
2.15 Effect of diet on immune stimulation 
The immune system is dependent upon the redirection of dietary nutrients to 
meet the demand of immune cells for growth and replication, and this impacts 
directly on pig health and performance (Klasing, 2007). The deficiency of 
macronutrients or  micronutrients, such as zinc, selenium, iron, and antioxidant 
vitamins can lead to clinical disease, and alter immunocompetence and increase the 
risk of infection (Scrimshaw, 2007). Specifically, nutritional deficiencies can impair 
phagocyte function of innate immunity and cytokine production, as well as adversely 
affecting certain aspects of humoral and cell-mediated immunity (Klasing and Korver, 
1997; Korver and Klasing, 1997; Kidd, 2004). Impairment of these responses can 
compromise the integrity of the immune system, thereby increasing the animal’s 
susceptibility to infection. For instance, Zn deficiency affects many lymphocyte 
functions, antibody and cytokine synthesis (Peterson et al., 2008), recruitment of 
naive T cells and reduces the resistance to infection (McMurray et al., 1990). 
Therefore, nutritionists aim to feed pigs to optimize the supply of nutrients to 
guarantee growth and performance, health as well as improve resistance to disease. 
Antigen or cytokine receptor functions (such as CD79, CD21, CD23) on lymphocytes 
and phagocytic cells can be influenced by nutrients that affect membrane structure or 
transmembrane signalling functions (Scrimshaw and SanGiovanni, 1997; Scrimshaw, 
2007). Kegley et al., (2001) fed 3 weeks old piglets with one of four corn-soybean 
meal based treatment diets containing 0.16, 0.24, 0.32 or 0.40% available P to 
investigate the effect on immune function. Pigs were challenged with 
lipopolysaccharide (LPS) and the researchers demonstrated that increasing 
supplemental dietary available P increased the production of lymphocytes 21 days 
after challenge. In addition, dietary depletion of vitamin A in C57BL/6J mices 
decreased lymphoid dendritic cells, memory CD8+ cells and CD4+ T lymphocytes in 
spleen using a multicolour flow cytometry test (Duriancik and Hoag, 2010). 
Therefore, this result suggests that diet could not only be a cofactor to infection 
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resistance but may also be able to potentially influence immune responses to 
vaccination.  
2.15.1 β-glucan as immunomodulators for pigs 
Beta-glucans (β-glucan) are the most abundant polysaccharides found inside 
cell walls of yeast, bacteria, cereals, seaweed and fungi (Bohn and BeMiller, 1995). 
They contain D-glucose as structural components and, depending on the source, are 
linked by either 1,3 or/and 1,6 β-glycosidic bonds (Sonck et al., 2011). β-glucans 
extracted from the cell wall of Saccharomyces cerevisae yeast is the most common 
source of commercial preparations for use in pigs’ diet (e.g. Macrogard®, Glucagen®, 
EnergyPlus® and AntafermMG®). β-glucan derived from the Saccharomyces cerevisae 
yeast is composed mainly of β-1-3-glucan linkages (around 85%) and about, 3% β-1-
6-glucan linkages (Manners et al., 1974). In contrast, the structure of cereal derived 
glucans consist of β-1-3 and β-1-4 linkage, while bacteria presents only β-1-3 
linkages (Bohn and BeMiller, 1995). Besides the differences in the type of linkage, β-
glucans can vary in solubility, molecular mass and polymer charge (Volman et al., 
2008). The high molecular weight of β-glucans from fungi directly activate 
leukocytes, while low molecular weight β-glucans only modulate the response of cells 
when they are stimulated with cytokines (Brown and Gordon, 2005). The type of 
isolation of β-glucan, even if is derived from the same source, can influence the 
lymphocyte responses (Sonck et al., 2010). Therefore, variation between β-glucans 
will influence their physiological function and immune modulating effects. Sonck et 
al., (2010) incubated pig peripheral mononuclear blood cells (PMBCs) with each of 
seven β-glucans (100μg/mL) from different sources. Interestingly, the two products 
originating from S. cerevisae stimulated proliferation of lymphocytes, neutrophils and 
increased significantly concentrations of TNF-α and IL-1β (Sonck et al., 2010). 
Conversely, β-glucan from the bacterium Agrobacterium biobar did not activate 
monocytes or neutrophils, but stimulated lymphocyte proliferation and IL-10 
cytokine production (Sonck et al., 2010). More recently the same authors, in a similar 
experimental design demonstrated an enhancement of porcine dendritic cell (DCs) 
maturation by S. cerevisae beta-glucan (Sonck et al., 2011). It is possible that the 
extra-branching of the S. cerevisae (1, 3 and 1, 6) may increase the recognition by 
dendritic cells and macrophage receptors and be an important determining factor on 
56 
 
their stimulatory capacity (Volman et al., 2008). Variation in β-glucan 
supplementation responses can be also influenced by inclusion rate to diet. For 
example, while pigs fed diets with 0.25% S. cerevisae β-glucan (Macrogard®) 
increased average daily weight gain after 28 days, with no affect in cohort pigs 
supplemented with 1% β-glucan (Dritz et al., 1995). 
The activation of the mononuclear phagocyte system and protective 
inflammatory cytokines by β-glucans in humans and pigs has been directly correlated 
to innate immune responses (Decuypere et al., 1998; Brown and Gordon, 2001). 
Human whole blood incubated with soluble yeast β-glucan showed an increase in the 
production of pro-inflammatory cytokines, TNF-α, IL-6, IL-8 and monocyte tissue 
factor (Adachi et al., 1994; Young et al., 2001). At least four receptors have been 
identified for initial recognition of beta-glucans. With there being complement 
receptor 3 (CR3), lactosylceramide, scavenger receptors and dectin-1 (Brown and 
Gordon, 2001; Brown et al., 2003; Brown and Gordon, 2005). Between them, dectin-1, 
a C type lectin was described as the most important receptor in pigs (Sonck et al., 
2009). Dectin-1 belongs to the large family of pattern recognition receptors (PRRs) 
which identify conserved PAMPs (Brown and Gordon, 2001). These are expressed by 
various antigen-presenting cells, such as dendritic cells, neutrophils, macrophages 
and some T and B cells (Bohn and BeMiller, 1995), and modulate innate immunity by 
increasing cytokine production (Adachi et al., 1994). And possibly could lead to 
infection resistance. Glucan therapy by inoculating 1,3-β-D-glucan (150 mg/kg) 
intraperitoneally in mice prior to a 108 E. coli challenge, showed increased blood 
leukocyte activity and enhanced phagocytosis of E. coli (Williams et al., 1988). 
In pigs, an increase in PRRS specific IFN-γ concentrations (by ELISPOT) was 
detected in PBMCs of infected pigs after incubation with a β-1,3-1,6-glucan 
preparation (50 μg/mL) (Xiao et al., 2004). These authors suggest that β-glucan 
possibly enhanced Th1 specific immune responses, by increasing the maturational or 
activation state of sensitised T cells, as the effect in vitro was delayed until 50 days 
after infection (Xiao et al., 2004). In agreement with this notion, Shen et al (2009) 
also observed an increase in CD4+ T cells and IFN-γ secretion in the gut mucosa 21 
days after piglets were fed diets containing yeast culture (5g/ kg). However, 
concentrations of IgM, IgA or CD4+ and CD8+ T-cells in ileal tissues (by IHC) of 
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finishing pigs were not modified by β-glucan supplementation at 0.03% or 0.3% 
(Sauerwein et al., 2007). However, this may be related because a 2.5% β-glucan daily 
dose, given to newborn piglets for two weeks caused a significantly increased 
expression of TNF-α and IL-1β mRNA in ileal sections (Eicher et al., 2006).  
Additionally, seven day old piglets supplemented with a β-glucan derived from 
seaweed Laminaria digitata and Laminaria hyperborean, and yeast Saccharomyces 
cerevisae (650g β-glucan per kg of diet) did not express any pro- or anti-
inflammatory cytokines markers in the ileal epithelial cells (Sweeney et al., 2012). On 
the other hand, after an ex vivo LPS challenge, incubation of PBMC with Laminaria 
digitata beta-glucan showed enhanced expression of the IL-8 cytokine marker. This 
was also site-related, as the effect was reduced in the colon (Sweeney et al., 2012). All 
of these findings imply that the effects of β-glucan on porcine immunity depends on 
the source and processing (related to structure), dose and age of recipient, as well as 
site of analysis / infection in the gut and the duration of feeding. Therefore it is 
essential to decipher the literature carefully, but also essential to fully trial the effects 
of supplementation in vaccination and disease models to have a relevant and 
functional read-out.    
2.15.2 Microbial phytase potential effect on immunity 
Phytate salts (myo-inositol hexaphosphate; IP-6) occur naturally in plants and 
serves as the storage form of phosphorus P (Sharpe et al., 1950). The primary storage 
compartment of phytate in plants is seeds, which are used extensively in pig diets. 
However, phytate-P has a low bioavailability in monogastric animals (Simons et al., 
1990). Different feed ingredients vary in their concentration of phytate-P as well as 
the proportion of P that is present in phytate. For instance, the proportion of 
phosphorus present as phytate-P ranges from 67 to 86% in barley, maize, oats, 
canola, soybean, sorghum and wheat in Australian sourced pig and poultry feed 
ingredients (Selle et al., 2003). Therefore the composition of the diet influences the 
amount of available-P in the diet (Table 1).  
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Table 1:The mean of total P and proportion of phytate-P in total P and bioavailability of total P for 
pigs in common feed ingredients a. 
Feed ingredient 
Samples 
(n) 
Total P 
(g/Kg) 
Phytate-P, 
proportion of 
total P (%) 
P bioavailability 
for pigs (%) 
Barley 41 3.21 61.0 30.0 
Maize 45 2.62 71.6 13.0 
Sorghum 64 3.42 77.8 20.0 
Wheat 97 3.07 71.6 49.0 
Canola meal 28 9.72 66.4 21.0 
Cottonseed meal 21 10.02 77.1 10.0 
Soybean meal 89 6.49 59.9 27.0 
Rice bran 37 17.82 79.5 25.0 
Wheat bran 25 10.96 76.3 41.0 
a Table adapted from Selle et al., 2011. 
 
The main anti-nutritional effect of phytate occurs by interference with 
digestibility and chelation to nutrients directly affecting the absorption and 
utilization of nutrients (Simons et al., 1990; Selle et al., 2011). The formation of a 
insoluble Ca5-K2-phytate complex occurs at pH 5  (Simons et al., 1990) and  Cu2+, Pb2+, 
Zn2+ phytate complexes have been observed in small intestines of pigs (Cigala et al., 
2010). In addition, phytate has been shown to negatively affect the activity of α-
amylase and trypsinogen (Deshpande and Cheryan, 1984; Caldwell, 1992). 
The use of a phytase enzyme to break down phytate chelation releases nutrients 
bound to phytate and potentially increases their digestion and utilization in the gut. 
Phytase enzyme can be derived from intrinsic plant phytase (e.g. wheat), endogenous 
mucosal phytase (e.g. phytase generated by small intestines of some animals), gut 
microbiota or exogenous microbial phytase (e.g. feed enzyme) (Selle and Ravindran, 
2008). The production of phytases, their characteristics, and manipulation of thermo-
tolerance and gastric resistance are beyond the scope of this thesis but have been 
described in detail elsewhere (Ha et al., 2000; Pandey  et al., 2001). Briefly, microbial 
phytases have been demonstrated to degrade phytate-P in the acidic conditions of the 
stomach and small intestine of pigs (Yi and Komegay, 1996), by a series of 
dephosphorylation reactions and generation of a series of lower myo-inositol 
phosphate esters, resulting in inositol and inorganic P (Schlemmer et al., 2001). The 
addition of phytase to diets of monogastric animals has been shown to increase 
availability of P (Cromwell et al., 1995) and as well as other minerals (Lei et al., 1993; 
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Adeola et al., 1995; Biehl and Baker, 1996). Cromwell et al. (1995) observed an 
improvement in P absorption and an decrease of P excreted in faeces of growing pigs 
fed with soybean meal supplemented with Aspergillus niger derived phytase (5,000 
phytase units (FTU)/g). Similarly, Igbasan et al., (2000) demonstrated that two 
phytases derived from Aspergillus niger and E. coli both improved the total  
digestibility of P (33-34%) and Ca (18-20%) to similar extents in the intestines of 
weaner pigs offered maize-soy diets. Weaner pigs fed with a corn soybean meal diet 
supplemented with microbial phytase at 1350 FTU/g feed had improved 
bioavailability of Zn comparing with control groups without supplemented phytase 
(Lei et al., 1993). However, although the correlation with growth performance 
improvement by phytase  has been confirmed (Brana et al., 2006), the increased 
bioavailability of protein and amino acids by adding phytase to diets is not as 
consistent. Brana et al. (2006), compared the efficacy of phytases derived from A. 
niger or E. coli on P in growing pigs fed inadequate maize-soy diets for 130 days. At 
500 phytase units (FTU)/kg, both phytases improved weight gain (9.9%), feed 
efficiency (8%) and fibular ash (6.5%). Bohlke et al., (2005) reported greater amino 
acid digestibility in growing pigs fed low-phytate corn meal with phytase than 
responses from pigs fed normal corn meal and the enzyme. On the other hand, 
Johnston et al, (2004) and Woyengo et al. (2009)  indicated that phytase had a limited 
affect on the bioavailability of protein and amino acids at the terminal ileum of 
weaner pigs. 
Studies on the effects of phytase on immunological parameters and related to 
nutrition are very limited. Theoretically, the increased bioavailability of chelated 
nutrients should also increase the availability of nutrients for immune cell growth 
and replication. Lower molecular weight inositol phosphatase added to human cell 
lines (insulin secreting cells) increased  Ca2+ channel activity by initiating the uptake 
and phophorylation of glucose and regulation of adenosine triphosphate (ATP) 
activity as well as increasing the bioavailability of calcium (Larsson et al., 1997). 
Additionally, the free inositol IP6 molecule has been speculated to regulate cell 
division and differentiation (Menniti et al., 1993) and to stimulate respiratory burst 
and bacterial killing by releasing IL-8, TNF-α and IL-6 cytokines (Eggleton, 1999). 
Broilers fed a high phytate diet (0.44% phytate P) supplemented with E. coli-derived 
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phytase (1,000 phytase units (FTU)/kg feed) had a 3-fold increase in numbers of 
erythrocyte rosette forming cells at day 21 compared to the control group (high 
phytate diet 0.44% P). The percentage of CD4+ and CD8+ T lymphocytes subsets were 
also increased by phytase on day 28 after supplementation (Liu et al., 2008). These 
effects could also lead to a protective response. As observed previously, broilers fed a 
marginal diet supplemented with 500FTU/kg of phytase (0.35% P) and challenged 
with Eimeria acervulina (1,000 oocysts) showed less lesions when compared with 
infected birds fed control diets (Shaw  et al., 2011). In addition, increased IL-17 
mRNA gene expression in the duodenum in phytase supplemented broilers 
correlated with decreased pathogenicity on day 18 after challenge (Shaw  et al., 
2011). Ghahri et al., (2012) fed 14 to 42 day old broilers either an adequate or low 
calcium and nonphytate P (Ca-nPP) diet supplemented with a microbial phytase 
(600-1000 FTU/g feed, Natuphos®10000). They observed neutralising antibody 
titres against Newcastle disease vaccine in the marginal but not the adequate C-nPP 
diets, 14 and 42 days after vaccination (but not at other weekly intervals) (Ghahri et 
al., 2012). A search of the literature failed to identify and research investigating the 
effect of phytase on immune responses in growing pigs.  
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3.1 Housing conditions and husbandry  
Two experimental trials were conducted at Elizabeth Macarthur Agricultural 
Institute research unit (EMAI, NSW-DPI, Menangle, Figure 5). The experimental 
building has four rooms, with separated external and internal access and controlled 
waste management. Room temperatures were monitored during trials to maintain 
ideal ambient temperature by an automatic air conditioning system. The facility has a 
concrete slatted-floor and pens were constructed using interlocking, portable metal 
partitions and gates. Each pen was fitted with at least one nipple drinker and hopper 
feeder. 
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Figure 5: Pig research unit at Department of Primary Industries (DPI-NSW), Australia. Right 
figure shows internal room structure ready for the start of an experimental trial.   
 
Biosecurity measures were instigated and followed prior to and during trials. 
Each room and equipment were cleaned prior with a pressure hose and disinfected 
with Virkon® (Antec International, Sudbury, UK) to eliminate any possible bacterial 
and viral contamination. The protocols also minimised the risk of external spreading 
of Lawsonia intracellularis into the rooms, between rooms and vice versa. Before 
entry to the facility, personnel were required to change into a pair of protective 
boots, for internal use only and to use clean overalls daily. Other protective 
equipment (such as gloves, masks, glasses and earmuffs) was also used when 
required. In addition, to reduce cross-contamination between pens with different 
treatments, the sampling and treatment routines occurred in the order from the less 
to the most contaminated pens.  
3.2 Vaccine preparation 
The lyophilized Enterisol® Ileitis vaccines (Boehringer Ingelheim Pty Ltd.) were 
reconstituted according to the manufacturer’s instructions to either a standard (1x) 
dose (104.9TCID50) or ten times this (105.9TCID50). Briefly, 100 mL of sterile diluent 
was mixed toughly with lyophilized L. intracellularis antigen containing 
approximately 104.9 TCID50 L. intracellularis organism. For the ten times dose the 
antigen was diluted using 10 mL of sterile diluent and mixed (105.9 TCID50). 
Vaccination occurred within 30 minutes of reconstitution and left over of vaccine was 
discarded. The same batch vaccine was used for each experimental trial. 
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3.3 Preparation of L. intracellularis challenge inoculum 
The inoculum of L. intracellularis was prepared using L. intracellularis infected 
intestinal mucosa and quantified by Dr. Alison Collins at the EMAI-Microbiology 
laboratory (Collins et al., 1996; Collins and Love, 2007). Briefly, the intestinal mucosa 
derived from infected pigs with L. intracellularis (clinical PHE) was scraped and 
homogenized gently in sterile PBS. The extracellular material was separated by 
repeated washing in PBS and 0.5M EDTA and centrifugation until the supernatant 
was clear. The supernatant was retrieved and stored on ice in a sterile container until 
challenge. Prior to inoculation, the presence of the bacteria was confirmed by 
modified Ziehl Neelsen (MZN) staining. The number of L. intracellularis was 
calculated per dose by counting bacteria under the microscope after 
immunofluorescence antibody (IFA) staining. The inoculum suspensions were 
serially diluted with PBS from 1:2 to 1:64 and each dilution was fixed on slides. A L. 
intracellularis monoclonal antibody (IG4) was diluted 1:200 in PBS and incubated 
with the inoculum at 37°C for 30 minutes. Non-specific binding was removed by 
washing slides in PBS, and the slides were then incubated with 1:50 dilution of sheep 
anti-mouse IgG conjugated with FITC (Sigma, US). After incubation, slides were 
washed in water and examined by fluorescent microscopy at 1000X magnification. 
The number of fluorescing comma-shaped bacteria was counted for ten field 
diameters at two different dilutions and in duplicate wells. The number of bacteria 
per mL of inoculum was calculated using specific formula (Equation 1). 
Equation 1- Quantification of inocula 
Bacterial per mL = 
Mean number of bacteria per field diameter * dilution of inoculum 
5.94* 10-6 
 
3.4 Clinical scores 
During experimental trials, animals were assessed daily recording their clinical 
score: faecal consistency, body condition and behaviour (Appendix I). Faecal 
consistency was scored as, 1=normal, 2= soft (semi-solid), 3= watery, 4= presence of 
blood.  Behaviour was scored as 1=normal, 2= moderately depressed, standing, 3= 
severely depressed, lying down. Body condition score as 1=normal, 2= mildly gaunt 
(thin, hips and backbone noticeable), severely gaunt (hips and backbone very 
prominent).  
64 
 
3.5 Sampling procedures 
3.5.1 Blood and faeces 
Individual pigs were restrained in a cradle (pigs less than 15kgs) or by using 
a nasal snare (and standing) depending on their size. Blood was captured by 
venipuncture of the jugular vein using serum clot separator vacuum tubes 
(Vacuette®, Greiner BioOne, Austria). After collecting around 5 mL of blood, samples 
were left in 4°C cold room overnight and then centrifuged at 2000g for 20 minutes to 
separate blood clot. Serum samples were then poured off to sterile individual 
containers and stored frozen at -20°C until analysis. Around two grams of faecal 
matter were individually collected directly from the rectum using clean gloves for 
each animal. Samples were then stored in sterile containers and frozen at -20°C until 
further processing.  
3.5.2 Tissue section 
Intestinal tissues were collected at necropsy from the ileum 10cm proximal 
from the ileal caecal valve (ICV), the jejunum 40cm proximal to the ICV and the 
caecum, 5cm distal to the ICV. Tissues were divided with one part kept in 10% 
neutral-buffered formalin fixative and another in RNA stabilization suspension (RNA 
later, Ambion®, Life Technologies, US) at room temperature until analysis. A third 
tissue segment was snapped frozen using the fresh tissue freezing technique with 
optimum cutting temperature (OCT) compound (Tissue-Tek®, Sakura, US). Tissues 
were placed in a plastic mold containing OCT and quickly placed in a steel bowl on 
the top of dry ice pellets. To the bowl, isopentane (2-methyl butane) was slowly 
added and once frozen; the tissue moulds were stored in a -80°C freezer.    
3.5.3 Mucosa secretions 
Samples were collected 10cm from the ileal-caecal valve (ICV). The ileum 
was slit longitudinally and the intestinal mucosa was gently scraped with a sterile 
scalpel blade to collect the surface secretions. These were placed into 2 mL 
phosphate-buffered saline (PBS, pH 7.2) containing 0.2M EDTA. Each scraping was 
stored at -20°C. Prior to assay, mucosal scrapings were thawed and adjusted to a 
protein concentration of 25mg/mL. In this method, each sample was thawed in ice 
and transferred into sterile 2mL microfuge tubes containing approximately 200µL of 
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0.1 mm silicon beads (Biospec Products, Bartlesville, USA) for tissue disruption. Then, 
samples were vortex for 1 min five times, to solubilise the antibody in the tissue. 
Following extraction, samples were centrifuged at 11000g for 15 minutes at 6°C to 
separate the cellular debris and tissue from the soluble protein. After the supernatant 
was collected, the total protein concentration was estimated by reading the 
absorbance of each sample diluted 1:100 in sterile PBS using spectrophotometer set 
at 280nm (BioRad®, xMark™ Microplate Absorbance, US). All samples were 
standardised to 25mg/mL of total protein using sterile PBS and re-frozen until the 
day of analysis. 
 
 
Figure 6: Collection of ileal mucosa secretion by scraping gently with sterile scalpel blade and 
adding to sterile containers with PBS+ EDTA. 
 
3.6 Laboratory procedures 
3.6.1 Lawsonia intracellularis competitive ELISA test 
Sera and mucosal scrapings were assayed for Lawsonia intracellularis 
specific IgG antibody using a commercial competitive (blocking) ELISA kit 
(Bioscreen® Ileitis, GmbH, Münster, Germany). The principle of the test consists of 
serum and mucosa samples that contain L. intracellularis antibodies (mainly IgG) will 
bind to the L. intracellularis antigen coated to the plates (Kroll et al., 2005). And after 
a washing step in PBS, an anti- L. intracellularis monoclonal antibody (Mab) 
peroxidase conjugate is added. The conjugate will bind only to the free antigen 
epitopes (where Lawsonia-antibodies from the sample did not bind). After excess 
conjugate is eliminated in a second wash step, the addition of a substrate may react 
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with peroxidise linked to Mab forming a colour reaction. In this case, the absence of 
antibody will have an intense coloured reaction while the presence of anti-Lawsonia 
antibodies in the samples diminishes the coloured reaction in proportion to the 
antibody titre. The optical density (OD) of the wells was read bichromatically at 450 
and 630nm using a microplate spectrophotometer (BioRad®, xMark™ Microplate 
Absorbance, US). OD values were then used to validate run (negative controls ≥0.500, 
and the percentage inhibition of positive controls are ≥ 40%) and to calculate the 
percentage inhibition value (PI value) of the samples, determined by using the 
following formula: 
 
Equation 2- The percentage inhibition estimation equation for Bioscreen®. 
Percentage 
 inhibition (PI) = 
OD of negative control – OD of sample well 
*100 
OD of negative control 
 
According to manufacturer’s instructions, PI value greater than 30% were 
interpreted as positive to L. intracellularis antibodies and value less than 20% were 
negative. The sensitivity and specificity has been previously tested as 90.5% and 
83%, respectively Collins et al..(2012). 
3.6.2  “In house” modified direct ELISA test 
Lawsonia intracellularis specific IgM, IgG and IgA titres were assayed using 
an experimental modified direct ELISA developed specific for this project (Donahoo, 
2009) and re-validated for each trial in this thesis. Samples calculated by plotting OD 
values versus the dilution of standard controls the unknown samples were then 
estimated using a regression equation from the standard curve in each plate. The re-
validation of the ELISA efficiency, the R2 (coefficient of determination) parameter was 
calculated (R2≥0.98). Briefly, L. intracellularis coated plates (Bioscreen®Ileitis, GmnH, 
Münster, Germany) were blocked with 1.5% w/v skim milk powder for 2h at room 
temperature before washing three times in phosphate-buffered saline (PBS, pH 7.2) 
plus 0.05% v/v Tween®20 (Sigma-Aldrich, US) washing buffer in plate washer 
(BioTek® ELX405™, US). Serum or mucosal scrapings were serially diluted in 
blocking solution before adding (100μl) to wells in the plate. Samples were gently 
rocked for 1h at 37ºC before washing five times in washing solution. Subsequently, 
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labelled (HRP, Horseradish peroxidase) goat anti-porcine IgM, IgA and IgG 
(AAI39P/AAI40P/AAI41F, AbD Serotec, UK) polyclonal conjugate were added 
separately to relevant plates for 1.5 h at 37ºC before washing. The colour reaction 
was developed by adding substrate (TMB, Sigma-Aldrich, US) for 10 min before the 
reaction was stopped with 10μl of 2M sulphuric acid (Sigma-Aldrich, US). The optical 
density of the wells was read at 450nm using a microplate spectrophotometer 
(BioTek Instruments, Inc., US), with an established cut-off point of 0.250 OD, which 
was 2-fold higher than the negative sample (<0.120 OD). 
3.6.3 Porcine cytokines sandwich ELISA 
The estimation of each cytokine, in mucosal scrapings or in serum, was 
analysed using commercial sandwich ELISA kits (porcine Quantikine® ELISA, R&D 
systems, Minneapolis, USA) according to manufacturer’s directions. Basically, this 
assay is a quantitative sandwich immunoassay with a monoclonal antibody specific 
for the respective cytokine, pre-coated to the plate. After the addition of samples, 
control and standards, a second monoclonal antibody is added. The intensity of 
colour measured is in proportion to the amount of cytokine bound in the initial step. 
Using GraphPad®Prism software (v.4.02, 2004), the cytokine concentrations in 
pictograms (pg)/mL were calculated by plotting the OD readings bichromatically at 
450nm and 540nm against a titration curve produced from dilution of the standard 
control provided with the kit. The significance assessed by manufactures is 
summarized in the table below (Table 2). 
 
Table 2- The minimum detection dose range (MDD) recovery %, of porcine cytokines  in plasma 
according to the manufactures of the Quantikine® Elisa test kits (R&D Systems, US). 
Cytokines MDD (pg/mL) Recovery (%) Code 
IFN-γ 2.7-11.2 98.2 PIF00 
IL-6 0.68-4.3 96.5 P6000B 
TNF-α 1.8-5.5 99.1 PTA00 
TGF-β1 2.8-5.0 99.7 PMB100B 
IL-10 1.7-15.4 94.8 P1000 
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Figure 7: Porcine Quantikine® Elisa kit used for cytokine evaluation.  
 
3.6.4 Real-time PCR detection of L. intracellularis in faeces 
Extraction and purification of bacterial DNA from faecal samples (0.1g) was 
conducted using the MagMax DNA extraction kit (AM1939, A&B Applied Biosystems, 
California, US). A test sample of around 0.05-0.1g of faeces was diluted in 700μL of 
PBS, vortexed and centrifuged (100g for 3 secs). The main characteristic of this kit is 
the use of microspherical paramagnetic beads, which bind to nucleic acid. The beads 
with nucleic acids are captured by magnets, and other contaminants are washed 
away. The procedure delivers very consistent high quality RNA and DNA, as much as 
50μL (AM1939 protocol, A&B Applied Biosystems). 
Extraction products were analysed by quantitative PCR (qPCR) using primers 
(Li-ubi-F 5’GCT CAT ACC GAT TGT GTA ATG CA 3’; Li-ubi-R 5’GAA AAA CAG GCC GTA 
TCC TTG A 3’) and Taq Man probe (Li-ubi-probe 5’FAM-TAG CCA CAT CAA GTG TTC 
CAG CTG CAA G- TAMRA 3’) as described by Nathues et al., (2009). Briefly, PCR 
amplifications were carried out for each sample in 25μL volume. Each reaction 
contained 12.5 pmol of each primer and 5 pmol of the probe using a commercial real-
time PCR reagent (TaqMan® Universal PCR Master Mix). The PCR conditions involved 
a holding step at 95°C for 10 minutes followed by 40 cycles of 95°C for 15 seconds 
and 60°C for 45 seconds in a 7500 Real-Time PCR thermocycler (Applied Biosystems, 
US). The sensitivity and specificity has been previously reported in this laboratory as 
99% and 97%, respectively (Collins et al., 2011).  
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Amplification was plotted for each sample to demonstrate the intersection 
between the fluorescence reaction (ΔRn) and the PCR cycle number (Figure 8). Then 
the CT value line was drawn at initial point of the linear phase, for better reliability 
and to accurately estimate bacterial numbers (Nadkarni et al., 2002). The amount of 
amplified product approximately doubles in each cycle. As the reaction proceeds, 
enough amplified product accumulates to yield a detectable fluorescent signal 
(threshold cycle, CT). And to quantify numbers of the unknown sample a range of 
standards with known quantity were added to each run. Quantification standards 
were used by seeding five negative faeces with 106, 105, 104, 103, 102 L. intracellularis 
/ g respectively. And by plotting CT value versus the number of L. intracellularis 
seeded, the unknown samples were then estimated using a regression equation from 
the standard curve. To evaluate the PCR efficiency, the R2 parameter was calculated 
to provide a good confidence value. When R2≤0.98, results were not considered and 
the test repeated. 
 
Figure 8: Graphic representation of real-time PCR standards. ΔRn is the fluorescence signal 
strength plotted against PCR cycle number. The blue line indicates the threshold cycle value 
(CT=0.07032) at the initial point of the linear phase.    
 
3.6.5 Haematoxylin and eosin staining (HE) 
The tissue sections were processed at the veterinary pathology diagnostic 
services laboratory at University of Sydney. Briefly, the formalin fixed tissue was 
embedded in paraffin and sectioned at 4 µm in duplicate. Slides were then dewaxed 
in three steps with 100%, 95% and 75% ethanol and rehydrated with running tap 
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water. Tissue were then stained in Whitlock’s Haematoxylin for 3 minutes, then in 
Scott’s Blueing solution (alkaline solution of Mg2SO4 and NaCO3) for 3 minutes, rinsed 
under running tap water for 2 minutes and rinsed with 70% ethanol. Subsequently, 
the sections were counterstained in alcoholic Eosin Y for 30 seconds, dehydrated 
rapidly through 70%, 95% and 100% ethanol, cleared in xylol and mounted in DPX 
mounting media and cover-slipped (Figure 9). 
 
 
Figure 9: Small intestine HE staining, at 10x magnification with clear overall look at ileum villus 
crypt and goblet cells. 
   
3.6.6 Immunohistochemistry (IHC) 
Formalin-fixed tissues were stained by immunohistochemistry (IHC) with 
VPM53 Lawsonia intracellularis  monoclonal antibody (Boehringer Ingelheim 
Vetmedica, Ames, USA), and using the method described by Jensen et al., (1997). In 
each batch of IHC, a positive and negative control section was included. Initially, 
sections were dewaxed twice in xylene and once in absolute ethanol, following by 
blocking solution containing methanol peroxidase (30% v/v hydrogen peroxidase) 
for 10 minutes to inhibit endogenous peroxidase activity in the cells before being 
washed in reverse osmosis (RO) water. Sections were incubated in pre-warmed 
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trypsin digest (0.2% w/v Trypsin 250, 0.1% w/v calcium chloride dehydrate made up 
to 200mL with milliQ water) for 30 minutes at 37°C. Sections were washed twice in 
RO water, once in PBS, drained and placed in humidity chambers. To inhibit non-
specific binding, 150μL of blocking solution (0.5% w/v bovine serum albumin-BSA, 
1% v/v goat serum made up to volume with PBS) was added to each section and 
incubated at room temperature for 20 minutes. A plastic coverslip was placed over 
the top to ensure contact between the tissue section and the solution. Following 
rinsing of slides in PBS to remove the coverslip and draining, the VPM53 monoclonal 
antibody was diluted in PBS at 1:200. 15μL of antibody was applied to each slide with 
a coverslip and incubated for one hour at 37°C. The coverslip were removed in PBS, 
the slides flooded with PBS, drained and a HRP-labelled secondary antibody (Dako 
Cytomation Envision, Dako, Carpinteria, US) was applied at 150μL per slide with a 
coverslip and re-incubated for one hour at 37°C.  
      Chromagen working solutions were pre-prepared and stored. The 3-amino-
9-ethylcarbazole (AEC) was made into solution by adding 0.04g of AEC powder to 
4mL of N, N-dimethylformamide (DMF) and was stored in a light-proof container at 
room temperature. A 0.05M acetate buffer (5pH) was prepared by adding 0.82 grams 
of anhydrous sodium acetate to 200mL of milliQ water. At the end of the incubation 
period, the chromagen substrate was prepared by adding 150μL of AEC in DMF to 7.5 
mL of acetate buffer. Coverslips were removed in PBS and drained, following by 150 
μL chromagen applied with coverslip. Colour development and stoped after exactly 
12 minutes by washing sections twice in RO water and removing the coverslip. 
Section were stained in Mayer’s Haematoxylin for 3 minutes, washed twice in RO 
water and set to drain. They were mounted with aqueous mounting solution (Dako, 
Carpinteria, US), set to dry and placed in the dark until read (Figure 10).  
The blinded slides were scored by one operator under 10x magnification light 
microscope to estimate the proportion of intestinal crypt hyperplasia (H&E) and 
presence of L. intracellularis -specific antigen (IHC) within crypts. A total of fifteen 
fields was analysed for each section. 
 
72 
 
 
Figure 10: Immunochemistry staining (40x magnification) with positive areas of L. intracellularis 
antigen presence (brown) in ileal crypts. 
 
3.7  Statistical analysis 
Statistical analysis was performed in GenStat 13th ed. (2010). Raw data were 
initially screened with graphical observations and data summaries to locate overall 
tendencies, outliers and sample distribution using Microsoft Office Excel 2007-2010. 
Treatment differences were analysed by restricted maximum likelihood test (REML) 
and testing residuals for normality distribution. The REML test (linear mixed model) 
was chosen for its ability to analyse a wide range of data that involve more than one 
source of error variation and unbalance designs (Steel, 1997). Variables that did not 
fitted to the residual normality were log transformed to fulfil linearity assumptions. 
Pens, pigs ID and room were included as random effects when required. Unpaired 
variables were tested using Mann-Whitney U (Wilconox rank-sum) test correlations 
within groups at a 95% confident level (p<0.05). Qualitative data were categorised 
into binary data and then analysed using Generalized Mix Models (GLMM) for 
repetitive measures and two-sample binomial test for single measure (GenStat).   
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 Chapter 4 Systemic and mucosal immune responses 
following vaccination and challenge with Lawsonia 
intracellularis  
(Modified from: Nogueira MG, Collins AM, Donahoo M, Emery, D; (2013). Immunological 
responses to vaccination following experimental Lawsonia intracellularis virulent 
challenge. Veterinary Microbiology, 164:131-138.) 
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4.1 Introduction 
The Gram-negative intracellular bacterium Lawsonia intracellularis causes 
proliferative enteropathy (PE), characterized by diarrhoea and poor performance in 
growing pigs and severe haemorrhagic diarrhoea in finisher and breeding animals 
(Lawson and Gebhart, 2000). The most consistent macroscopic pathology of PE is 
thickening of the intestinal mucosa which is associated histologically with 
proliferation of immature enterocytes (Lawson and Gebhart, 2000). The clinical signs 
and lesions can be controlled using a commercial oral live attenuated vaccine 
(Enterisol®Ileitis, Boehringer Ingelheim) (Kroll et al., 2004; McOrist and Smits, 2007). 
This vaccine contains an attenuated L. intracellularis isolate (B3903; 104.9 
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TCID50/dose) originally isolated from the ileum of a Danish pig with acute 
proliferative haemorrhagic enteropathy (PHE) (Kroll et al., 2004). Protective 
immunity against re-infection is also apparent in recovered pigs (Collins and Love, 
2007; Riber et al., 2011b; Cordes et al., 2012).  
A conventional immunological approach to induce mucosal immunity against 
gut pathogens has involved oral vaccination or intraperitoneal inoculation (Muir et 
al., 1998). However, where antibody provides mucosal protection, high 
concentrations of serum IgG engendered by systemic vaccination have been effective 
against some intracellular bacteria. For example, Salmonella enterica serovar 
Typhimurium  bacterin administrated intramuscularly (IM) reduced lesions and 
shedding in naturally-infected pigs (Farzan and Friendship, 2010). Similarly, an 
intramuscular L. intracellularis  killed bacterin induced significant protection to PE 
after virulent challenge (Dale et al., 1997), and in a patent description, protection was 
induced after immunisation IM with killed L. intracellularis   (Jacobs et al., 2011).  
To identify immune responses which might indicate the successful induction of 
protective immunity following vaccination with Enterisol® Ileitis, this study 
measured local mucosal and systemic immune responses in the first 3 weeks after 
immunisation. Since local mucosal responses were marginal following a conventional 
single dose vaccination in a preliminary trial 1 (published in the paper Nogueira et al., 
2013,  but not in this thesis), pigs in trial 2 were vaccinated orally with a ten times 
dose (10x) of Enterisol®Ileitis. Local mucosal and systemic antibody and selected 
cytokine responses were measured and compared with those from piglets given the 
same dose of vaccine IM. To determine whether these responses could foreshadow 
protection, the remaining vaccinated cohorts were challenged and immunity was 
assessed by serological assays, reduction of clinical signs and intestinal lesions and 
the duration and magnitude of bacterial shedding in faeces.  
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4.2 Materials and Methods 
4.2.1 Animal Ethics 
All animal experiments were performed according to the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes, and approved by the 
University of Sydney and Elizabeth Macarthur Agricultural Institute Animal Ethics 
Committees (M09/10). 
4.2.2 Experimental design 
For trials 1 and 2, a total of 40 and 62 Landrace x Large White pigs, respectively, 
aged 3-4 weeks, were purchased from a commercial herd clinically and serologically 
negative for L. intracellularis. Piglets were transferred to a controlled environment 
research facility, with access to water and fed on weaner/grower diet (DE: 
15.3MJ/kg; CP: 20%; Fibre: 2.5%; Vella Stock Feeds, Australia) with no medication. 
Pigs were weighed (6.0±0.5kg) and randomly allocated into respective treatment 
groups (Table 3; trial 2) housed in separate pens under strict quarantine conditions. 
Pigs were monitored daily for body condition, clinical signs and abnormal behaviour.  
4.2.3 Lawsonia vaccination 
Prior to vaccination (d0) at 5 weeks of age, pigs were bled by jugular 
venipuncture and faeces were collected from individual pigs to confirm the absence 
of L. intracellularis or the presence of maternal antibodies that might interfere with 
vaccination. The lyophilised vaccine (Enterisol®Ileitis, Boehringer Ingelheim Pty Ltd., 
SA-122A-323) was reconstituted according to the manufacturer’s instructions to 
either standard (1x) dose (104.9TCID50) or ten times (105.9TCID50) concentrations. 
Pigs received the appropriate vaccine dose orally in 2.0mL diluent by drenching gun 
or by intramuscular inoculation (IM) in the right deltoid muscle (cervical area). 
Negative and positive control pigs were not vaccinated.  
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Table 3- Experiment design and groups in trial 2*. 
Experiment Group Li dose Route Li challenge 
N° 
pigs 
2a 
10xOral 105.9 TCID50 Oral No 6 
10xIM 105.9 TCID50 IM No 6 
Control - - No 4 
2b 
PC - - Yes 10 
1xOR 104.9 TCID50 Oral Yes 10 
1x IM 104.9 TCID50 IM Yes 10 
10xOR 105.9 TCID50 Oral Yes 10 
NC - - No 6 
   *Li: Lawsonia intracellularis; IM: intramuscular; PC: Positive control; NC: Negative control. 
 
4.2.4 Ten times vaccination trial with challenge infection 
4.2.4.1 Experiment 2a: Analysis of immune responses after vaccination 
Fifteen pigs aged 4 weeks were randomly assigned into three treatment groups: 
six pigs in each of groups 1 and 2 were orally vaccinated and IM vaccinated, 
respectively, with 10x dose of Enterisol®Ileitis vaccine and three pigs in group 3 were 
not vaccinated. Sera were obtained from each pig by venipuncture of the jugular vein 
before vaccination and necropsy. Seven pigs were randomly selected (3 from groups 
1 and 2, and one from group 3) and euthanized on d9 post vaccination, and the 
remainder on d17. At necropsy, the left and right pre-scapular lymph nodes were 
weighed and blood taken from the jugular vein. Ileal and jejunal tissue was sampled 
at 10cm and 1m from the proximal ileo-caecal valve (ICV), respectively, together with 
adjacent mesenteric lymph nodes (MLN). Each tissue and MLN sample (ca 2x2mm) 
was stored in 10% neutral-buffered formalin fixative until analysis.  In the adjacent 
segment, the intestinal mucosal secretions were collected by gently scraping the ileal 
mucosa with a sterile scalpel and placed into 2ml phosphate-buffered saline (PBS, pH 
7.2) containing 0.2M EDTA on ice. The scrapings were each stored at -20°C. Prior to 
assay, mucosal scraping samples were thawed and adjusted to a protein level of 
25mg of protein ml-1.  
4.2.4.2 Experiment 2b: Immune responses after challenge infection 
Forty-six pigs were randomly allocated into 5 treatment groups. Groups 1-3 (10 
pigs each) were vaccinated with 1x oral (1xOR- group1), 1x IM (1xIM- group 2), 10x 
oral (10xOR- group3), respectively, while 10 positive control pigs (PC- group 4) 
remained unvaccinated. The vaccination procedures were the same as described for 
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experiment 2a. Six pigs were kept unvaccinated and unchallenged as negative 
controls (NC- group 5). Four weeks after vaccination, each pig in groups 1-4 was 
dosed orally with L. intracellularis infected intestinal mucosa inoculum prepared and 
quantified as described elsewhere (Collins et al., 1996; Collins and Love, 2007). 
Briefly, pigs were fasted overnight, sedated with 0.2mg/kg of azaperone (Stresnil®, 
Fivet, Australia) and intubated with an oro-gastric tube to enable administration of 
25mL of the bacterial suspension containing around 109 L. intracellularis. Pigs were 
euthanized at a local abattoir 21 days post infection (21pi) where the gut was 
collected for analysis.  
Pig live weights were recorded before vaccination, at challenge and at necropsy 
to determine the average daily live weight gain. Sera were collected from each pig on 
days 0pi, 7pi, 14pi and 21pi while faecal samples from individual animals were 
collected on days 0pi, 7pi, 10pi, 14pi, 17pi and 21pi for a quantitative L. intracellularis 
PCR (qPCR). At necropsy, ileal samples were collected as for experiment 2a and 
preserved in 10% buffered formalin prior to staining with H&E and 
immunohistochemistry (IHC). Following histopathological analysis, 24 pigs were 
selected from all groups according to the percentage affected area and Lawsonia 
intracellularis shedding numbers. There were four negative controls, ten severely 
affected and ten infected but without lesions, and also their sera from days 0pi and 
21pi were tested for cytokines using porcine Quantikine® assay kits (Chapter 3).  
4.2.5 Antibodies and cytokines analysis  
Sera and mucosal scrapings were assayed in duplicate for the detection of L. 
intracellularis -specific IgM, IgG, IgA  and concentrations of the cytokines, interferon-
gamma (IFN-γ), interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor-
alpha (TNF-α) and transforming growth factor-beta1 (TGF-β1). L. intracellularis-
specific antibody was determined using a commercial competitive (blocking) ELISA 
kit (Bioscreen®Ileitis, GmbH, Münster, Germany) at a positive- negative cut-off of 
30% inhibition as recommended by the manufacturers. In addition, L. intracellularis-
specific IgM, IgG and IgA titres were assayed using an experimental modified direct 
ELISA developed for this project (Donahoo, 2009). The quantity of each of the 
cytokines IFN-γ, IL-6, IL-10, TNF-α and TGF-β1 in mucosal scrapings or serum was 
analysed using commercial sandwich ELISA kits (porcine Quantikine® ELISA, R&D 
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systems, Minneapolis, USA) according to the manufacturer’s directions (Chapter 3). 
The minimum limits of detection were 2.7 pg/mL for IFN-γ, 10 pg/mL for IL-6, 1.8 
pg/mL for IL-10, 2.8 pg/mL for TNF-α and 19.5pg/mL for TGF-β1. Concentrations 
were estimated by generating a logistic parameter curve using GraphPad®Prism 
software (v.4.02, 2004). 
4.2.6 Correlation of serum cytokines with PE disease severity   
The 20 infected pigs were selected from challenged groups according to the 
percentage affected area on IHC staining and L. intracellularis shedding in faeces 
(from subclinical to severe infection, Table 4). Cytokine concentrations were 
correlated with average weight gain, ileal lesions and quantities of Lawsonia 
intracellularis shed on days 14pi, 17pi and 21pi. 
Table 4- Groups selected for serum cytokine analysis and results correlated to respective 
percentage affected area of PE lesions(IHC and HE) and numbers of L. intracellularis shedding (Li 
g/faeces) on day 21 pi. 
Groups IHC and HE 
Li shedding 
(g/ faeces) 
No. samples 
Severe infection >10% 104-106 10 
Subclinical  infection 0-5% 102-104 10 
Negative controls 0% 0 4 
 *IHC: Immunohistochemistry expressed as percentage affected area; HE: Haematoxylin and eosin;  
 
4.2.7  L. intracellularis real-time PCR 
Extraction and purification of bacterial DNA from individual faecal samples 
(0.1g) were made using the MagMax DNA extraction kit (A&B Applied Biosystems, 
California, USA) (Chapter 3). Extraction products were analysed by real time PCR 
(7500 Real-Time PCR System; Applied Biosystems) using primers and Taq Man probe 
as described by Nathues et al., (2009). The sensitivity and specificity of the test in our 
laboratory have been reported by Collins et al. (2011) as 99% and 97%, respectively .  
4.2.8  Histological lesion scores in intestinal tissue 
Formalin-fixed tissues were stained with haematoxylin and eosin (H&E) (Luna, 
1968) and by immunohistochemistry (IHC) with VPM53 L. intracellularis  monoclonal 
antibody (Boehringer Ingelheim Vetmedica, Ames, USA) using the method described 
by Jensen et al., (1997). The blinded slides were scored by one operator under 10x 
magnification light microscope to estimate the proportion of intestinal crypt 
79 
 
hyperplasia (H&E) and presence of L. intracellularis -specific antigen (IHC) within 
crypts. A total of fifteen fields was analysed for each section.  
4.2.9  Skin testing for delayed type-hypersensitivity 
Delayed type hypersensitivity reactions were examined in individual pigs 20 
days after vaccination by intradermal (ID) injections of 0.2mL of sterile phosphate 
buffer saline (PBS, pH 7.2) (control) or around 105 L. intracellularis  in 0.2ml of 10x 
Enterisol® Ileitis in two areas between nipples. The sites were examined at 24h and 
48h and reactions were recorded as the diameter of erythema at the injection sites 
(Figure 11). 
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Figure 11: Delayed type hypersensitivity reaction test with intradermal injections of sterile 
phosphate buffer saline (control) or L. intracellularis vaccine. 
 
4.2.10 Statistical analysis  
Statistical differences were analysed among treatment groups and days post-
vaccination and challenge using Restricted Maximum Likelihood (REML, GenStat 
Release 13th Ed., Oxford, UK) at a 95% confidence level (P<0.05). Individual pigs were 
included as random effects in every analysis. Correlations between two unpaired 
variables were analysed using the Mann Whitney U test. 
4.3 Results 
4.3.1 Experiment 2a: Immune response to a ten times oral or 
intramuscular immunisation 
Prior to vaccination, all pigs were PCR negative and seronegative for L. 
intracellularis and did not exhibit diarrhoea or clinical signs of PE after vaccination. 
Pigs gradually increased weights between days 0 and 17 post-vaccination, however, 
without differences between treatments groups (Figure 12).  There was no evidence 
of gross or histopathological lesions of PE in ileal sections at necropsy (Figure 17). No 
significant differences between weights from left and right pre-scapular lymph nodes 
(P>0.05) and delayed type hypersensitivity reaction were minimal between animals 
at 20 days after vaccination (Table 5). 
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Figure 12: Predicted means for weight at each time point post-vaccination (days). (■) Negative 
Control (NC, blue), (■) ten-times oral (10xOR, red) and (■) ten-times intramuscular (10xIM, 
green). 
 
Table 5- Mean weights from the left and right pre-scapular lymph nodes (PLN, grams) and 
delayed type hypersensitivity (DTH) reactions measurements after L. intracellularis (Li) 
vaccination. 
Treatment 
Left PLN 
(grams) 
Right PLN 
(grams) 
DTH control PBS 
(mm) 
DTH Li vaccine 
(mm) 
10xOR 1.39 1.33 - <0.5 
10xIM 1.70 1.91 - <0.5 
NC 1.51 1.12 - - 
Increased concentrations of serum L. intracellularis IgG (direct) were detected 
in the orally and IM vaccinated pigs compared with the control group 3 between d9 
and d17 (P<0.001, Figure 13b). The serum IgG titres reached 85 (direct) and 24% 
inhibition (Bioscreen®) at day 17, and while similar values were detected in both 
vaccinated groups, they were significantly higher than control animals (33 and 7% 
inhibition, respectively in the two assays) (Figure 13). The orally vaccinated group 
produced serum IgM titres of 148 that was significantly higher (P=0.03) than those 
expressed by pigs in the IM and control groups (62 and 55, respectively, Figure 14). L. 
intracellularis -specific IgA titres in sera and in mucosal secretions from all pigs were 
not different and all data titres less than 4 using the modified ELISA test.  
In mucosal scrapings, higher titres of anti - L. intracellularis IgM on day 9 (270) 
were found in ileal scrapings from pigs vaccinated orally (P<0.001) and IgG on day 17 
(14%) for both oral and IM vaccinated animals (58 and 70, respectively) compared to 
control group (Figure 16a). Serum cytokines exhibited a large variation within 
animals from the same treatment group and no significant differences (P>0.05) 
between treatments were apparent (Figure 15).  In contrast, the concentrations of all 
five cytokines (IFN-γ, IL-6, IL-10, TNF-α, TGF-β1) in mucosal secretions from oral 
vaccinates significantly increased between days 9 and 17 over values in control and 
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IM vaccinates (Figure 16). The quantity of TNF-α and TGF-β1 in mucosal scrapings 
from oral vaccinates was significantly higher (P<0.05) than the concentrations found 
in IM and control pigs on day 17.  
a) Bioscreen®  b) direct 
  
Figure 13: Humoral immune response to L. intracellularis Bioscreen ELISA (a), Direct ELISA for 
IgG (b). Lines correspond to the mean percentage of inhibition (PI) for (a) and mean titre for (b) 
for each treatment: (▲) Negative control (green, n=4); (●) 10xOral (red, n=5); (■) 10xIM (Blue, 
n=6). * Superscript next to lines identifies significant difference between treatment and control 
groups (P<0.05). 
a) IgA b) IgM 
  
Figure 14: Humoral immune response to L. intracellularis IgA (a) and IgM (b). (▲) Negative 
control (green, n=4); (●) 10xOral (red, n=5); (■) 10xIM (Blue, n=6). * Superscript next to lines 
identifies significant difference between treatment and control groups (P<0.05). 
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Figure 15: The concentration of circulating (serum) cytokines (pg/mL) on days 0, 9 and 17 after L. 
intracellularis vaccination within treatments: Negative control (green, n=4); 10xOral (red, n=5); 
10xIM (blue, n=6). 
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a 
  
  
  
b 
  
Figure 16: Mean concentrations  for cytokines (pg/ml) and IgG (PI value) and IgM (Titre), L. 
intracellularis specific antibodies in (a) mucosal scrapings on days 9 (dark) and 17 (clear) and 
(b) in serum on days 0 (dark), 9  (shade) and 17 (clear) after ten-times oral (10xOral), 
intramuscular (10xIM) vaccination and unvaccinated (NC). Columns with a star on the top 
indicate statistical difference (P<0.05). 
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Figure 17: Ileum section of a pig (#B53), in HE staining, after 9 days orally vaccinated (10xOR) 
with L. intracellularis. 
 
4.3.2 Experiment 2b: Protective immunity to Proliferative Enteropathy 
All 40 pigs appeared clinically normal after challenge and there were no 
significant differences in average weight gain between groups over the 3 weeks 
following vaccination or challenge and over the entire 6 weeks of the trial (Table 6). 
Similar kinetics for the significant increases (P<0.001) in serum L. intracellularis IgG 
and IgA titres were observed in challenged animals (groups 1-4) compared to 
negative control animals in group 5 (Figure 18). There were no significant differences 
(P>0.05) in antibody titres between challenged groups. At day 21pi, all infected pigs 
were serologically positive for L. intracellularis -antibodies, with a mean P.I. of 48%.  
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Table 6- Average weight gains (kg) and approximate (±) standard errors (SE) of pigs between 
periods pre-challenge, post-challenge and total period of trial (d0: vaccination; d21: L. 
intracellularis challenge; d42: necropsy). 
Treatment 
Pre-challenge 
(d0-d21) 
Post-challenge 
(d21- d42) 
Total period 
(d0-d42) 
Positive Control 6.67 ± 0.52  9.44 ± 0.72  16.12 ± 0.91  
1xOR 6.09 ± 0.50  9.90 ± 0.68  16.00 ± 0.86  
1xIM 6.28 ± 0.50  8.82 ± 0.68  15.10 ± 0.86  
10xOR 6.76 ± 0.50  10.85 ± 0.68 17.61 ± 0.86  
Negative Control 6.40 ± 0.50  8.64 ± 0.70  15.04 ± 0.86  
P (<0.05) 0.877 0.206 0.272 
 
 
 
  
Figure 18: Predicted means for serum L. intracellularis-IgG (percentage inhibition, PI; left) and 
IgA titres (right) on days 0, 7, 14 and 21 in each group after L. intracellularis virulent challenge 
between groups ten-times oral (10xOR), one-time oral (1xOR) and intramuscular (1xIM), negative 
control (NC) and positive control (PC). 
There was a range of pathology noted at necropsy (Figure 20) and determined 
by subsequent histological (Figures 21 and 22) and immunohistological analyses 
(Figures 23 and 24). Assessments of protection based on estimations of the numbers 
of L. intracellularis shed in faeces and the % affected area in ileal sections revealed 
that the vaccination significantly (P<0.001) reduced L. intracellularis shedding when 
compared to positive control group. Pigs given the 10x oral vaccine were significantly 
(P<0.05) more protected than the other 2 vaccinated groups (Figure 19 and 25). 
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Figure 19: Estimation of Lawsonia intracellularis per gram of faeces at each time point post-
infection for each group (♦, blue) Positive Control (PC); (■, red) 1x Oral; (▲, green) 1xIM, and (X, 
purple) 10xOral. On the same sampling values without common superscripts (a-c) are 
significantly different (P<0.05). 
 
 
 
Figure 20: Small intestine section from a positive control pig (#Y67), unvaccinated, with 
characteristic proliferation 21 days after Lawsonia intracellularis challenge (arrow). 
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Figure 21: Ileal section from a pig (#G99) from group 1xIM presenting extensive crypt enterocytes 
proliferation and loss of goblet cells, 21 days after Lawsonia intracellularis challenge (circle).  
 
 
 
Figure 22: Proliferation of enterocytes in ileal crypt with loss of goblet cells and presence of 
exudate in the lumen (40 x mags) from pig (#O75) orally vaccinated (1xOR) and challenged 
(arrow).   
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Figure 23: Lawsonia intracellularis antigen staining (brown, 20x mag.) in ileal section by 
immunohistochemistry from pig (#Y77), unvaccinated, from positive control group 21 days after 
challenge. 
 
 
Figure 24: Ileal section in 40 times magnification from pig (#Y77), unvaccinated and challenged 
(positive control) with Lawsonia intracellularis antigen staining in the apical area of enterocytes 
(brown). 
 
 90 
 
 
 
Figure 25: Mean percentage affected area (+ SD) in the ileum for each group as determined by 
haematoxylin and eosin (shaded) and immunohistochemistry (clear) staining. a-c different letters 
differ significantly (P<0.05). 
 
4.3.3 Correlations between disease severity and serum cytokines 
The serum cytokine concentrations for IFN-γ, IL-6, IL-10 and TNF-α were 
variable and while there was a significant (P<0.05) increase in the level of each 
cytokine between days 0 and 21 post challenge in each of the 24 pigs tested, there 
was no correlation between cytokine concentrations and disease severity (P>0.05; 
Table 7). 
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Table 7- Serum cytokines concentrations (pg/mL) in individual pigs from groups (G) PE severe infection (S), 
sub-clinical infection (SB) and negative controls (NC) and the correlations between group*lesions*cytokines, 
group*Li-shedding-in-faeces*cytokines, group*ADG*cytokine. 
G ID 
Lesions ADG 
Li 
 
IFN-γ 
pg/mL 
IL-6 
pg/mL 
IL-10 
pg/mL 
TNF-α 
pg/mL 
  HE
% 
IHC
% 
kg g/f 0pi 21pi 0pi 21pi 0pi 21pi 0pi 21pi 
S G99 35 10 22.2 105-6 49.9 12.5 9.4 7.2 < 44.5 44.6 87.9 
S O81 31 15 16.0 105-6 9.1 70.9 16.6 50.9 < 50.4 < 149.1 
S G64 27 10 14.8 105 18.1 27.5 11.5 58.4 9.5 10.2 68.8 112.4 
S Y63 27 9 15.6 105 < 29.6 < 98.4 57.5 119.5 47.3 326.9 
S Y68 24 2 17.7 104-5 33.3 51.8 8.3 8.8 < 30.0 51.9 92.3 
S Y77 23 9 17.3 104-6 14.3 60.6 36.2 77.0 22.9 77.9 89.3 196.5 
S Y70 20 2 18.4 105 27.5 23.7 12.6 21.4 11.7 15.3 83.6 92.8 
S O54 19 7 18.4 104 126 133.9 12.1 60.1 < 16.9 18.0 60.8 
S B81 14 0 22.8 105 31.2 46.3 9.4 19.1 8.7 21.1 21.9 55.2 
S O100 11 1 14.5 106 29.3 3.2 3.6 58.4 < 79.0 28.4 109.9 
S G100 10 5 17.2 106 87.6 1.4 9.4 14.8 23.1 89.2 52.9 111.4 
Mean 
SEM 
22 6 18.0 105 43 42 13 43 22 50 51 127 
5.8 5 0.8  22.5 38.9 16.7 15.9 8.6 89.6 26.8 42.6 
SB Y83 5 0 17.4 104 < < 43.4 20.8 47.6 54.48 28.4 58.9 
SB Y65 2 0 9.7 105 5.1 29.6 7.2 75.4 < 17.56 48.7 363.2 
SB Y71 3 0 17.1 105 23.7 1.4 11.0 9.9 < < 18.0 62.6 
SB O77 0 0 14.2 105 31.2 46.3 9.9 9.4 23.8 38.5 21.0 206.2 
SB G98 0 0 9.5 104 < < 8.8 9.4 < 79.2 33.3 90.8 
SB Y73 2 0 17.5 104 27.5 12.5 90.8 4.1 45.3 78.4 38.7 96.7 
SB G53 0 0 15.7 103 3.2 31.2 10.4 11.5 < < 30.7 157.7 
SB O43 0 0 15.5 104 1.4 < 14.8 37.1 < 56.4 40.0 69.7 
SB B98 0 0 17.9 102 12.5 20.1 16.4 74.2 < 44.4 84.6 71.6 
SB O73 0 0 17.5 103 35.1 20.1 13.1 21.9 85 97.1 33.3 118.5 
Mean 
SEM 
1 0 15.0 104 17 23 23 27 50 58 38 130 
0.2 0 0.5  11.9 19.7 26.7 20.0 30.5 32.8 29.6 52.9 
NC B60 0 0 14.0 0 < 128.4 12.1 136.4 35.2 36.9 141 139.2 
NC B71 0 0 16.1 0 18.1 89.5 14.2 16.4 < < 46.9 115.0 
NC O88 0 0 11.3 0 23.7 133.4 24.7 45.1 < 47.2 37.3 84.6 
NC W81 0 0 19.6 0 < 27.5 13.1 5.7 < 52.1 60.8 101.1 
Mean 
SEM 
P (<0.05) 
0 0 15.0 0 21 95 16 51 35 45 72 110 
0 0 0.6 0 12.6 92.6 9.8 57.8 28.1 42.5 94.5 16.9 
<0.05 NS <0.05 NS NS NS NS NS NS NS NS 
G* lesions 
G*Li 
G*ADG 
NS NS NS NS NS NS NS NS 
NS NS NS NS NS NS NS NS 
NS NS NS NS NS NS NS NS 
NS: Not significant; Li: L. intracellularis; ADG: average daily weight gain; IHC: immunohistochemistry; 
HE: Haematoxylin and eosin;   
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4.4 Discussion 
This study monitored and detected dose-dependent increases in mucosal and 
serum IgM, IgG, IgA and cytokines following vaccination with Enterisol® Ileitis and 
subsequent challenge. Dose-dependent induction of protection against virulent L. 
intracellularis challenge was demonstrated by significant reduction in PE lesion 
scores and the magnitude and duration of bacterial shedding in faeces in all 
vaccinated pigs. As anticipated, oral vaccination induced local mucosal immunity with 
increased IgG and cytokine responses and tended to generate more comprehensive 
protection than IM vaccination.  
The analysis of protective immune responses to L. intracellularis is an area of 
considerable interest for the control of PE. Initial studies on the development of 
humoral and cell-mediated immunity (involving analysis of IFN-γ responses) have 
described similar kinetics to those found in the current study. Dose-dependency of 
humoral responses is well documented. Following vaccination with 104.9 TCID50 L. 
intracellularis, serum antibody responses were either undetectable (Kroll et al., 2004) 
or restricted to modest concentrations of L. intracellularis -specific IgG in ileal 
scrapings. Higher doses (105.9 TCID50 in this study) of vaccine or primary infection 
with 105-1010 L. intracellularis induced detectable concentrations of L. intracellularis -
specific IgG within 14 days after inoculation (Collins and Love, 2007; Riber et al., 
2011b). Consistent with previous analyses (Guedes and Gebhart, 2010; Jacobs et al., 
2011), mucosal IgA responses were of lesser magnitude and while the highest serum 
titres were generated by challenge control pigs (group 4), IgA titres were not boosted 
substantially by challenge of immunised animals. This could be dose related, as IgA 
accumulations have been demonstrated previously, by IHC, in apical cytoplasm of 
proliferating enterocytes from pigs with clinical cases of PIA and PHE (Lawson et al., 
1979; McOrist et al., 1992). The timing and duration of humoral responses is also well 
studied and relatively consistent. In the current study, a 10x dose oral vaccination 
elicited increased concentrations of IgM, IgG in ileal mucosal scrapings and elevated 
concentrations of IgM and IgG in serum. The systemic and local IgM immune 
response after 9 days post vaccination precedes IgG (Lawson et al., 1988) and has 
similar kinetics to increases in serum haptoglobin and C-reactive protein following 
primary infection with L. intracellularis  (Riber et al., 2011b). The induction of IgA 
was not detected in this study after vaccination with 105.9 TCID50 L. intracellularis, but 
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was apparent in serum from all pigs by 14 days after challenge with 109 L. 
intracellularis. The results agree with the detection of ileal IgA (McOrist et al., 1992) 
and L. intracellularis -specific IgA in intestinal lavage by 21 days after L. intracellularis  
infection (Guedes and Gebhart, 2010).  
In assessing the development and role of cell-mediated immunity in L. 
intracellularis  immunity, immediate and delayed skin reactions to intradermal L. 
intracellularis  antigen  were not detected in immunised pigs in this and previous 
reports (Guedes and Gebhart, 2003b, 2010). However, in contrast to a 1x dose or 
following IM vaccination, the local intestinal response induced by the 10x oral 
vaccine activated the production of each of the five cytokines assayed in ileal 
scrapings (IFN-γ, IL-6, IL-10, TNF-α and TGF-β1) with significant concentrations of 
TNF-α and TGF-β1 detectable by day 17 after vaccination. In mice, IFN- γ receptor 
knock-out animals (IFN- γ R-) had failed to resolve L. intracellularis infection after 35 
days whereas normal 129 mice were clear after 21days (Smith et al., 2000). This 
indicated a role for IFN-γ in immunity but while elevated, individual variations in the 
concentrations of IFN-γ found in immunised pigs in this trial precluded significant 
differences compared to control animals. Given the intracellular pathogenesis of L. 
intracellularis infection, subsequent studies have concentrated on the role of IFN-γ as 
evidence of cellular immunity and protection against re-infection (Guedes and 
Gebhart, 2010; Cordes et al., 2012). In pigs, the generation of antigen-sensitised 
(CD4+ and CD8+) lymphocytes was evident from the production of L. Intracellularis 
specific IFN-γ in peripheral blood mononuclear cells (PBMC) in 12-13 week-old pigs, 
within 14 days after infection. But was delayed in appearance in 5-6 week-old 
animals (Guedes and Gebhart, 2010; Cordes et al., 2012). It was noted that the pigs in 
the current trial were 5 weeks old when vaccinated and produced elevated cytokine 
responses within 17 days.  The differences in age-related responses could be 
explained by a number of factors including breed and nutrition, but may also reflect 
the time after vaccination (14 vs. 17 days). L. intracellularis specific IFN-γ producing 
cells were also detected by ELISPOT, in porcine PBMC, 4 to 13 weeks post vaccination 
(Guedes and Gebhart, 2003b) and after 15 days in horses vaccinated rectally with 106 
attenuated L. intracellularis (Pusterla et al., 2009). Three weeks after infection with 
5x 109 L. intracellularis , Riber et al., (2011a) detected increased amounts of IFN-γ in 
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the supernatant fluid after incubation of whole porcine blood with Lawsonia antigen 
and the inflammatory cytokine, IL-18. In contrast, limited microarray studies of pigs 
with varying concentrations of intestinal pathology did not reveal substantial 
activation of cytokine genes (Jacobson et al., 2011a). While the synthesis of the three 
“inflammatory” cytokines (IFN-γ from NK cells, IL-6, and TNF-α) would result from 
local infection and serve to activate the acquired immune system, including IFN-γ-
producing T-cells and IgG production. The quantities of IL-10 and TGF-β1 protein 
were also increased in the ileal scrapings.  This may indicate induction of local 
immunoregulation through T-reg cells (Chen et al., 2007; Bailey, 2009), and local 
restoration, given the role of TGF-β1 in wound healing in pigs (Quaglino et al., 1991). 
Increased concentrations of IL-10 and TGF-β1 are also consistent with detection of 
insulin-like growth factor binding protein 3 (IGFBP-3) during the immune priming 
following oral infection or vaccination with L. intracellularis (Jacobson et al., 2011a).  
To induce protective immune responses at mucosal surfaces, oral vaccination 
with live attenuated or killed/ subunit vaccines is the preferred protocol to block 
pathogen attachment or to neutralize local virulence factors by specific IgA or IgG 
antibody (Mestecky and McGhee, 1987; Husband et al., 1996). Attenuated live 
vaccines are used to generate protective immunity against intracellular pathogens. 
For L. intracellularis, oral administration has been effective, but rectal administration 
of 106.3 TCID50 L. intracellularis generated L. intracellularis specific IgG detectable 
responses in horses (Pusterla et al., 2009) and intraperitoneal (IP) vaccination 
against Salmonella Typhimurium has effectively immunised livestock (Muir et al., 
1998). When the quantitative and qualitative aspect of L. intracellularis challenge was 
determined by real-time PCR in faeces, the ten times oral vaccination (105.9 TCID50) 
elicited the greatest protection but the 1x intramuscular and 1x oral vaccines were 
also efficacious. Since L. Intracellularis enters and multiplies in immature (crypt) 
enterocytes (Lawson and Gebhart, 2000), the 1x IM protocol suggests that serum 
antibody can significantly reduce the number of L. Intracellularis available in the 
gastrointestinal tract prior to cellular entry. Results with inactivated or subcellular L. 
intracellularis vaccines would support this mechanism. Dale et al (1997) reported 
that faecal L. intracellularis  counts were reduced by 98.5% in four pigs vaccinated 
twice intramuscularly (IM), 3 weeks apart, with killed L. intracellularis in incomplete 
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Freunds adjuvant. Additional pigs inoculated with recombinant GroEL-like protein 
exhibited reduced faecal bacteria counts compared to infected controls (Dale et al., 
1997). In their patent, Jacobs et al., (2011) also reported the induction of significant 
protection against L. intracellularis challenge after two IM inocula were given 4 
weeks apart, of 2.8 x 108 killed L. intracellularis  in oil adjuvant. These researchers 
reported significant reductions in L. intracellularis shedding after initial IM 
vaccination of pigs with 50µg each of recombinant 19/21 and 37kDa outer 
membrane proteins (OMPs) or putative LPS in adjuvant. Dose dependent protection 
was achieved with vaccines containing killed organisms  where 5 x 107  L. 
intracellularis  elicited protection and 1.25 x 107  L. intracellularis  was ineffective 
(Jacobs et al., 2011). These results and the fact that IM administration of Enterisol® 
would be expected to kill the live L. intracellularis rapidly after inoculation, indicate 
that with sufficient antigenic stimulus, antibodies against L. intracellularis cells and 
components can protect against infection. Given the elevated serological titres at 
challenge, this presumably occurs by preventing intracellular entry. That significant 
mucosal protection can be induced by relatively small doses of live oral L. 
intracellularis without substantial serological titres (Kroll et al., 2004) would indicate 
both a dose-dependent and site-specific response.  
In the search for readily accessible biomarkers for immunity to L. Intracellularis, 
antibody responses have not been informative (Kroll et al., 2004; Cordes et al., 2012), 
with IgA responses low and ephemeral (Cordes et al., 2012). Skin tests are also 
unreliable (Guedes and Gebhart, 2010), as was found in this trial. In addition, the 
measurement of cytokine concentrations in body fluids such as serum and mucosal 
secretions is costly and is complicated by the dynamic responses to L. intracellularis 
in individual pigs where the variations between individuals are often greater than the 
responses within the treatment groups (Jacobson et al., 2011a; Cordes et al., 2012). 
Unlike cases where clinical signs have been correlated with serum IFN-γ, IL-6 and 
TNF- α in pigs experimentally infected with B. hyodysenteriae (Kruse et al., 2008), 
pigs with clinical signs of diarrhoea after natural infection with L. intracellularis  
showed high variability of TNF-α and TGF-β1 concentrations in sera and poor 
cytokine expression in intestinal tissues (Jacobson et al., 2011a). In contrast, this 
study documented increased TNF-α and TGF-β1 in mucosal secretions in pigs from 
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the 10x orally vaccinated group while individual variations in IFN-γ, IL-6 and IL-10 
precluded significant results. However, in this trial, an attempt was made to define an 
immune correlate between vaccination and protection. A sequential serological 
analysis of antibody and TNF-α in 24 pigs with varying concentrations of immunity as 
assessed by bacterial excretion and ileal histopathology did not reveal any significant 
associations. The results concurred with previous reports (Jacobson et al., 2011a; 
Cordes et al., 2012).  These contrasting findings highlight the difficulties associated 
with finding suitable systemic biomarkers which illuminate the immune status of 
mucosal tissues.  
In conclusion, this study was able to demonstrate the dose-dependent 
correlation to increased local and systemic IgG and IgM responses after vaccination 
and protection by reducing lesions and L. intracellularis shedding. Although 
protective immunity was also elicited when Enterisol®Ileitis was administrated IM, 
suggesting antibody-mediated neutralisation, the precise mechanisms and immune 
correlates underscoring the more comprehensive protection following oral 
vaccination are still not completely resolved.   
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 Chapter 5 The effect of route of vaccination with 
Lawsonia intracellularis on immune responses in weaner 
pigs 
(Modified from: Nogueira, MG; Emery, D; Collins AM (2013). Impact of route of administration 
on the mucosal immune response to Lawsonia intracellularis vaccine in pigs. Australian 
Veterinary Journal. Submitted.) 
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5.1 Introduction 
Lawsonia intracellularis is an obligate intracellular Gram negative bacterium 
that causes PE in pigs (McOrist et al., 1993). The major effects of PE infection in pigs 
includes poor growth, diarrhoea or sudden death (Lawson and Gebhart, 2000). It is a 
financially significant production problem estimated to reduce profitability from AU$ 
8 to 13.0  per pig (Holyoake et al., 2010a), requires continuous inclusion of antibiotics 
in the feed of grower and finisher pigs on farms to prevent the occurrence of clinical 
disease. The trial in the previous chapter has documented the humoral and cell 
mediated immune responses after experimental exposure with pathogenic L. 
intracellularis, and has been reported in other experimental and field trials (Guedes 
et al., 2002a; Collins and Love, 2007). Oral administration of live L. intracellularis 
vaccine reduces clinical signs and lesions of PE (Kroll et al., 2004), without generating 
consistently detectable systemic immune responses. Without evidence of vaccine 
induced protection, many veterinarians are unwilling to recommend the removal of 
antibiotic medication for fear of outbreaks of the haemorrhagic form of PE. Oral 
delivery of mucosal vaccines reliably induces immunity against enteric pathogens, 
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but protection has also been demonstrated after intraperitoneal (IP) or 
intramuscular (IM) administration (Djordjevic et al., 1997; Muir et al., 1998).   
As part of routine farm management, piglets are often vaccinated while they’re 
still suckling to overcome the need to remove antibiotics for 5 days around 
vaccination. In some herds, this leads to reduced vaccine efficacy because maternal 
antibodies transferred to the piglet in the sow’s milk can inactivate the vaccine 
(Hodgins et al., 1999). Efficacy data on intramuscular or intraperitoneal 
administration of the vaccine may allow producers to vaccinate and protect weaner 
pigs from ileitis without needing to remove antibiotics to treat other infections. In the 
previous experimental challenge trial, protection was successfully induced by IM 
vaccination against challenge with L. intracellularis (Nogueira et al., 2013 ). Potential 
correlates for protection were identified, but their specificity in the field needed to be 
tested. This is because weaner pigs face multiple challenges that would stimulate the 
immune system at the same time as L. intracellularis vaccination, including the 
introduction of solid feed and other infections such as haemolytic E. coli.  Therefore, 
efficient strategies to induce mucosal protection to a range of enteric diseases in 
young pigs is necessary, especially to complement nutritional additives and to 
replace the need for antibiotics in feed. To ensure that vaccines have effectively 
immunised animals prior to exposure to pathogens, knowledge of the protective 
immune response is also highly beneficial. In the search for an immune correlate with 
protection, and to further define the interaction between the routes of inoculation, 
this investigation compared local and systemic immune responses after oral, IM and 
IP inoculation of L. intracellularis vaccine in a trial on farm. 
 
5.2 Methods 
5.2.1 Code of Ethics 
This research was approved by the Animal Ethics Committees of the Elizabeth 
Macarthur Agricultural Institute (Department of Primary Industries-DPI) and the 
Sydney University (M12/03), Australia. 
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5.2.2 Farm health status and pre-screening 
The trial was conducted on a commercial piggery located in the state of Victoria, 
Australia between months of March and April of 2012. According to reports from the 
farm veterinarian (Dr. Hugo Dunlop, Chris Richards & Associates), the commercial 
farm consisted of 650 farrowing to finish batch unit, with an additional 2 grow-out 
sites. Pre and post weaning mortality were below 10% and 3.5%, respectively. Gilts 
and sows were routinely vaccinated against pathogenic neonatal E. coli, Glässers 
Disease and Streptococcus suis at introduction to the herd and 3 weeks prior to 
farrowing. The farm was free of Mycoplasma hyopneumoniae and Actinobacillus 
pleuropneumoniae (sv. 1, 5, 7. 15). Historically, Brachyspira hyodysenteriae and 
Ascaris suum have been present on this farm, but based on regular farm visits and 
slaughter inspections of pigs there has been no clinical evidence of their presence for 
the last 5 years. Clinical outbreaks of Glässer’s disease and Streptococcus suis 
occasionally occur from 11 weeks of age; they are treated using water medication. 
Post-weaning diarrhoea and PE infections has not been a significant problem of this 
farm, however, preventive antibiotics are used at strategic times post-weaning. In the 
routine management of the herds, progeny are normally vaccinated against 
proliferative enteropathy and porcine circovirus type 2 three days prior to weaning.  
Piglets are normally weaned at 22-24 days of age into an all-in-all-out room with 
controlled ventilation until they are 8 weeks of age and then are moved into a 
naturally ventilated grower facility until 16 weeks of age, where they stay until sale.  
Prior to the trial, a pre-screening selection was performed to observe the 
dynamics of Lawsonia intracellularis infection of this farm. Blood was collected from 
12 to 16 weeks old pigs for serological analysis (Bioscreen® Elisa) and pen pooled 
faeces from 24, 37, 53, 70 and 98 day old pigs were collected and screened to 
estimate numbers of L. intracellularis in faeces (qPCR). Results indicated that at 12 
weeks of age, 67% of the pigs tested were seropositive for L. intracellularis but this 
prevalence had declined to 13.3% at 16 weeks of age. The presence of L. 
intracellularis was observed in pooled faeces from 37, 53 and 70 days old pigs (from 
103 to 104 L. intracellularis per gram of faeces).     
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5.2.3 Experimental design 
Forty Landrace/ Large White crossbred piglets were selected at 21 days of age 
(5 days pre-weaning). Grouping of piglets was performed by randomly selecting four 
offspring from one sow and allocating one pig to each of the four treatment groups: 
oral (OR), intramuscular (IM), intraperitoneal (IP) and unvaccinated control groups 
(Figure 26). This was repeated for ten sows until each group had ten piglets. At 26 
days of age (just after weaning), 10 pigs were orally vaccinated with 2.0 mL of a ten 
times dose concentrate (105.9 TCID50) of L. intracellularis vaccine via drench gun 
(Enterisol® Ileitis, Boehringer Ingelheim, US). A second group was given the same 2.0 
mL dose IM via syringe in the right shoulder (21G needle) and the third group was 
vaccinated IP through the inguinal region in the lower half of the abdomen using a 
23G needle (d0) (Figure 27). The remaining 10 pigs were kept unvaccinated as a 
negative control group. Routine herd management was continued with sows and 
piglets given water and feed ad libitum. Antibiotics were removed from feed and 
water 3 days prior and 2 days after vaccination.  
 
 
Piglets Vaccination 
Vaccination 
route 
N° of Li per dose N° pigs 
1 Yes Oral 105.9 TCID50 10 
2 Yes Intramuscular 105.9 TCID50 10 
3 Yes Intraperitoneal 105.9 TCID50 10 
4 No - - 10 
Figure 26: On farm route of Lawsonia intracellularis (Li) vaccination.  
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                 Intraperitoneal Intramuscular 
 
 
 
 
 
Figure 27: Local of intraperitoneal and intramuscular routes of vaccine administration 
(Anonymous, 2010). 
 
5.2.4 Sample collection and analyses 
Blood was collected from individual pigs on day 0, 8 and 17 post-vaccination 
(pi) for further serological analysis. Necropsy of the pigs was performed 17 days after 
vaccination. All pigs were transported to Department of Primary Industries regional 
laboratory necropsy room (Bendigo, Victoria), where pigs were sedated (Xylazil IM 
1.5ml/pig) and euthanized (Lethobarb IV 1 mL/pig) by a DPI veterinarian. All post-
mortem sampling was conducted essentially as described in Chapters 3. Ileal tissue 
sections were placed in 10% formalin for histopathology and mucosal scrapings were 
collected and processed as previous described. Blood and mucosal secretions were 
assessed for L. intracellularis specific IgG antibodies (as percentage inhibition, PI%) 
using the Bioscreen® Ileitis ELISA (GmnH, Münster, Germany) and IgA was assessed 
with an in-house modified direct ELISA. PI values for greater than 30% were 
interpreted as positive for L. intracellularis antibodies and values less than 20% were 
deemed negative. The quantities of IFN-γ, TNF-α, IL-6, IL-10 and TGF-β1 cytokines in 
ileal secretions were analysed (Quantikine®ELISA kit; R&D Systems, US), with 
minimum limits of detection for this trial in pg/mL were; 3.8 (IFN-γ); 2.7 (TNF-α); 
15.3 (IL-6); 3.2 (IL-10); 2.8 (TGF-β1). 
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5.1 Statistical analysis 
The IgA titres and cytokines concentrations (pg/mL) were estimated by 
generating a logistic parameter curve using GraphPad®Prism software (2004). 
Statistical analysis was performed in GenStat 13th ed. (2010) using restricted 
maximum likelihood test (REML), testing each group vs. the controls; and also testing 
differences between vaccinated groups. Sow parity and individual pigs were included 
as random effects.     
5.2 Results 
5.2.1 Antibody responses 
Prior to vaccination, all piglets were seronegative for L. intracellularis 
antibodies. Increased Lawsonia intracellularis specific IgG in serum was detected in 
each vaccinated group (Figure 28; P<0.05) between day 0 and 17 post-vaccination 
(pv). By day 17 pv, pigs in the oral (28.9%), IP (11.7%) and IM (15.8%) vaccinated 
groups had produced a significant increase in L. intracellularis IgG antibody 
compared to the unvaccinated pigs (3.7%). However, only orally vaccinated pigs 
(9/10) were above the seropositive cut-off (30% PI).   
 
 
Figure 28: Predicted mean and standard errors for serum Lawsonia intracellularis IgG 
percentage inhibition (P.I.) value on days 0, 8 and 17 post-vaccination with Enterisol® via 
intramuscular (IM, ♦, red), intraperitoneal (IP, ●, green), oral ( , blue) and unvaccinated (x, 
purple) groups.  On day 17 means with different superscripts differ significantly (*, P<0.05). 
15
0
20
17
25
30
0
10
5
8
days
P
I v
a
lu
e
 (
%
)
 
 
* 
* 
* 
 103 
 
 
In the ileal mucosa, the majority of pigs in all vaccinated groups were above the 
cut-off value (PI: 30%) at day 17 pv, with positive values in oral (8/10), IP (8/10), IM 
(7/10), but also unvaccinated pigs (6/10) for L. intracellularis IgG antibody (Figure 
29). However, vaccinated pigs generated significant increases in L. intracellularis-IgG 
concentrations in the ileal mucosa when compared with unvaccinated pigs at day 17 
post-vaccination (Figure 30). In addition, oral and IP vaccination also generated 
significant (P<0.05) mucosal increases in L. intracellularis IgA, but the humoral 
immune response to IM vaccination was limited to increased IgG (Figure 30). 
   
  
  
Figure 29: Lawsonia intracellularis specific IgG antibody, as percentage inhibition values 
(% PI value) in ileal mucosa of individual pigs, 17 days after vaccination with L. intracellularis. 
The cut-off value of 30% is highlighted (red line).  
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Figure 30: Predicted means and standard errors for concentrations of Lawsonia intracellularis 
IgG (percentage inhibition, PI, %) and IgA (Titre) in ileal mucosa secretions at day 17 post-
vaccination. * Significant differences between treatment groups vs. controls. 
5.2.1 Mucosal cytokine responses 
The mucosal cytokines responses for individual pigs within groups are 
summarized in the Figure 31. In this on farm study, piglets generated significant 
(P<0.05) increases in mucosal concentrations of TNF-α after oral and IP 
immunisation and TGF-β1 after oral vaccination (P<0.05).  
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Figure 31- Mean and individual concentrations of cytokines Interferon-gamma (IFN-γ), 
Interleukin-6 (IL-6), Interleukin-10 (IL-10), Tumour Necrosis factor-alpha (TNF-α) and 
Transforming Growth factor-beta1 in ileal mucosal secretions. Significant differences (P<0.05) 
between means for the unvaccinated and treated pigs is shown by the star superscript. 
5.3 Discussion 
This study demonstrated that systemic and local mucosal immune responses 
after IP inoculation of the L. intracellularis vaccine paralleled those induced by oral 
vaccination. L. intracellularis specific IgG titres in serum significantly increased (P 
<0.05) from days 0 to 17 post vaccination in each vaccinated group. Oral dosing with 
live or attenuated vaccines has been shown to induce protective immune responses 
at mucosal surfaces which block pathogen attachment or neutralise local virulence 
factors by specific IgA or IgG antibody, but IP immunisation has been equally 
efficacious (Mestecky and McGhee, 1987; Husband et al., 1996). In this study, oral 
vaccination consistently elicited the highest mucosal responses. The oral route is 
often prescribed as the principal route to induce effective mucosal vaccination 
(Curtiss et al., 1996; Mirchamsy et al., 1996; Husa et al., 2009) on the premise that the 
induction of IgA/IgG plasma cells will occur following antigen uptake at inductive 
sites (e.g. Peyer’s patches) in the gut mucosa (Mestecky et al., 2005; Roth, 2010). For 
instance, pigs orally vaccinated with Salmonella Typhimurium live attenuated vaccine 
showed reduced intestinal lesions and increasing antigen specific IgG in serum after 
inoculation with 109 virulent Salmonella sp. compared with unvaccinated group 
(Husa et al., 2009). However, it was also anticipated from previous reports (Hall et al., 
1989; Husband et al., 1996; Muir et al., 1998) that the serosal surface of the intestine 
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and draining mesenteric lymph nodes may be accessed by IP delivery. This happens 
especially if the antigen is accompanied by an inflammatory adjuvant or bacterial 
components, and induces mucosal immunity with secretion of bioactive products into 
the intestinal lumen. Previously, IP vaccination with either Freund’s adjuvant or oil-
in-water emulsion adjuvants had been shown to protect pigs from lung lesions due to 
Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae (Hall et al., 1989; 
Djordjevic et al., 1997). Administration of antigen IP have been reported as being 
effective in stimulating IgA producing lymphocytes at Payer’s patches of pigs 
(Sheldrake et al., 1993). In other species, IP vaccination of crude tetanus toxoids 
preparation with either Freund’s adjuvants or oil-in-water adjuvants demonstrated a 
markedly improve anti-tetanus IgA antibody responses in the jejunum of chickens 
compared with orally vaccinated groups (Muir et al., 1995). Similar the results of our 
study, when Muir et al., (1998) vaccinated chickens against Salmonella sp. IP, the IgG 
and IgA serum responses were increased and comparable to oral vaccination and 
induced protection against disease. In addition, other accessible mucosa, such as 
intranasal and intrarectal approaches have been explored as alternative sites for 
delivering mucosal vaccines. For instance, foals were seropositive for Lawsonia-
specific IgG (by IPMA) 21 days after intra-rectal administration of an attenuated live 
vaccine of L. intracellularis (Enterisol®Ileitis) (Pusterla et al., 2010). In humans, 
intranasal delivery with Shigella flexneri 2a lipopolysaccharide 50 subunit vaccine 
(LPS, IpaB, IpaC and IpaD) increased by  five-fold, the concentrations of antigen-
specific intestinal faecal IgA and IgG (Riddle et al., 2011). However, the requirement 
for mucosal immunization to generate protective immunity against mucosal 
pathogens it is not essential, as this and the previous trials have demonstrated that L. 
intracellularis specific IgG immune responses were detectable at mucosal sites and in 
serum following systemic delivery (IM). This is consistent with other studies where 
pigs vaccinated intradermally with live attenuated porcine reproductive and 
respiratory syndrome (PRRS) virus and then naturally exposed to a heterologous 
European field strain showed reduced clinical signs and the development of cell-
mediated immunity (reactive NK cells, and antigen-specific γ/δ T and cytotoxic T 
lymphocytes) in the blood (Martelli et al., 2009). Protection from mucosal challenges 
with L.intracellularis has been also reported. For instance,  Dale et al., (1997), 
reduced faecal L.intracellularis counts by 98.5% in four pigs vaccinated twice IM, 3 
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weeks apart, with killed L. intracellularis in incomplete Freund's adjuvant (IFA). In 
that study, additional pigs inoculated with recombinant GroEL-like protein also 
exhibited reduced faecal bacteria counts compared to infected controls. Presumably 
the mechanism by which IM vaccination protects against mucosal pathogens is  
through the homing  of activated immune cells from somatic sites and lymph nodes to 
mucosal tissues (Daynes et al., 1996), or more likely, by the diffusion of circulating 
antibody into mucosal tissues. As observed in the earlier study (Chapter 4), pigs 
vaccinated IM elicited increased L. intracellularis IgG in the ileal mucosa providing by 
protection against a challenge with 108 virulent L. intracellularis. In this study, the 
majority of the pigs from all groups (including some in the unvaccinated group) were 
seropositive for L. intracellularis IgG antibodies, however, higher titres were derived 
in the vaccinated, compared to unvaccinated pigs.     
In this on-farm study, ileal antibody and cytokine responses generated 
following IP immunisation resembled those induced by oral, rather than IM routes of 
vaccination. The quantities of the inflammatory cytokines IFN-γ and IL-6 (16 and 60 
pg/mL) in the ileal secretions following oral vaccination were reduced by comparison 
with the previous pen trial in Chapter 4 (750 and 225 pg/mL), whereas 
concentrations of TNF-α and TGF-β1 were comparable. In this trial, significantly 
(P<0.05) increased mucosal concentrations of TNF-α and TGF-β1 were exhibited 
after oral and IP immunisation. Interestingly, cytokine concentrations were 2- to 200- 
fold lower in unvaccinated pigs relative to their vaccinated cohorts. Differences in 
immune responses between pen and farm trials are expected, as on farm, the 
environment is less controlled and concomitant infections are expected. Caged hens 
exhibited a significantly higher level of total antibody production (5.30 ± 0.23) for the 
3 weeks after inoculation with killed Newcastle disease viral vaccine compared to 
free-range hens (2.82 ± 0.26) (Hoffman et al., 2009). The prevalence of a soil fungus 
infection Paracoccidiodes braziliensis was also increased in free-range chickens, as 
measure by ELISA titres to the gp43 antigen (Oliveira et al., 2011). Although protein 
concentrations of mucosal secretions were standardised between studies and pigs 
did not show signs of diarrhoea and were healthy, the range of mucosal responses of 
individual pigs does vary substantially in on-farm trials (Hall et al., 1989). However, 
in this situation, the reduced responses for IFN-γ and IL-6 may reflect the use of 
 109 
 
antibiotics, the different gastrointestinal microflora in these piglets or the timing of 
sampling, but the aim was to highlight the response to the L. intracellularis vaccine. 
Cytokines such as IFN-γ have been involved in protective immunity against 
intracellular infections and this has been implicated for L. intracellularis. Specific IFN-
γ producing cells were detected by ELISPOT, in porcine peripheral blood 
mononuclear cells (PBMC), 4 to 13 weeks after vaccination with L. intracellularis 
(Guedes and Gebhart, 2003b). This method is more sensitive than analysis of mucosal 
secretions as it measures the response of primed T-lymphocytes after a second 
exposure to L. intracellularis antigen in vitro. Similarly, knockout mice for IFN-γ 
receptor (IFN-γ R-) were substantially more susceptible to disease outbreaks and 
more extensive lesions as observed by immunohistochemistry compared with wild 
type mice (IFN-γ R+) after oral infection with 107 cultured L. intracellularis (Smith et 
al., 2000). This implies a specific and direct protective effect of IFN-γ. In horses, IFN-γ 
gene expression in all Enterisol® vaccinated foals was significantly higher, 60 days 
following oral vaccine administration compared to IFN-γ gene expression in control 
foals (Pusterla et al., 2012a). The specificity of the cytokine response to vaccination in 
this trial was also supported by higher concentrations of TGF- β1, possibly related to 
local mucosal repair and immune regulation resulting from the limited infection 
associated with vaccine “take”. The TGF-β controls the initiation and resolution of 
inflammatory responses through the regulation of lymphocytes activation, promoting 
T cell survival and inducing IgA class switching in B cells (Schluesener et al., 1990). In 
pigs, a transient decrease in TGF- β1 concentrations at the intestinal villi epithelium 
was observed and associated with obvious intestinal villi atrophy and marked 
reduction of mucosal digestive enzyme activities (Mei and Xu, 2005), suggesting that 
changes would be expected with its intestinal infection like that caused by L. 
intracellularis. Consistent with its’ anti-inflammatory and regulatory role, porcine 
TGF- β1 suppressed human T-helper (Th)-cell activation through the inhibition of IL-
12 secretion and the induction of Th-cell apoptosis (Palmer et al., 2002). 
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 The comparable spectrum of immune responses generated after vaccination 
and the subsequent protection after challenge in the previous pen trial (Chapter 4), 
suggests that significant protection against L. intracellularis would be anticipated in 
each of the vaccinated groups in this study. The results from both trials would 
indicate that if specific antibody responses can be detected following vaccination, a 
protective level of immunity may have been induced against a moderate level of 
challenge. However, this would be expected to wane with time as the interval 
between vaccination and challenge increased. 
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6.1 Introduction 
In pig herds, the presence of proliferative enteropathy (PE) disease is 
associated with a range of clinical signs from acute haemorrhage to chronic diarrhoea 
and death (Lawson and Gebhart, 2000). The aetiologic agent is Lawsonia 
intracellularis an obligate intracellular bacterium. Histologically, the lesions in 
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infected animals consist of proliferating immature enterocytes containing 
intracellular L. intracellularis bacterial antigen (Lawson and Gebhart, 2000). Clinical 
outbreaks and subclinical cases (with no apparent clinical signs) are also 
accompanied by decreased feed intake, reduced weight gain and poorer feed 
conversion efficiency (Paradis et al., 2012). PE is also associated with reduced activity 
of digestive enzymes in the small intestine of pigs which may lead to decreased 
digestion and absorption of proteins from the lumen of the intestine (Rowan and 
Lawrence, 1982; Collins et al., 2009). Therefore, controlling PE is important to 
improve productivity, reduce animal losses and increase herd profitability. PE is 
traditionally controlled in pig herds with in-feed antibiotic medication which have 
been effective in controlling PE outbreaks (Tzika et al., 2009). However, with a 
complete ban on in-feed antibiotics in place inside the EU since 2006, pig producers 
are seeking alternatives to in feed antibiotics to control pathogens in pigs. An 
alternative to in-feed antibiotics for the control of PE is the commercially available 
attenuated live L. intracellularis vaccine (Enterisol® Ileitis, Boehringer Ingelheim). 
This vaccine has been shown to reduce the clinical signs and lesions of PE as well as 
the amount of L. intracellularis that is shed in faeces (Kroll et al., 2004). The 
Enterisol® Ileitis vaccine has been shown to increase herd uniformity and provide 
additional weight gains of between 20 to 34 g per pig/day (Almond and Bilkei, 2006). 
In the previous chapters, systemic and local immune responses were monitored and 
detected after vaccination by various routes with a ten times vaccine dose (Chapters 
4 and 5). The result showed an increase in L. intracellularis specific IgG antibody 
response in serum and mucosa, which could not be detected following administration 
of standard doses (Donahoo, 2009). The variability in local and systemic immune 
responses negated the detection of an immune-marker which correlated with herd or 
individual protection in pigs after vaccination. However, it was apparent that 
detection of either specific antibody or significantly increased concentrations of IFN-
γ following oral or IM vaccination would indicate protection from a field challenge. 
Pig producers are hesitant to remove preventive in-feed antibiotics without the 
guarantee of protection against PE. Therefore it was reasoned that feed additives 
which are proposed to boost immune responses could enhance the development of 
mucosal immune responses to detectable and consistent concentrations.  
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Phytase is frequently added to pig diets to improve phytate-P (inositol 
hexaphosphate, IP6) digestibility. However, other benefits to the use of phytase 
include increased  nutrient absorption, growth rates and possible enhanced 
immunity(Selle and Ravindran, 2008). These results are hypothesised to be 
associated with the extra phosphoric effects of phytase where the benefit to animals 
fed phytase extends beyond the role of just liberating phytate-P (Liu et al., 2008; 
Shaw  et al., 2011). While the precise mechanism of action is unclear, phytase could 
possibly increase immunity by releasing the nutrient-bound-phytate, increasing its 
bioavailability and absorption and promote growth or proliferation of immune cells 
(Scrimshaw, 2007).The inositol ring has also been shown to reduce pro-cancerous 
intestinal cell proliferation by increasing pro-inflammatory cytokine production 
(Wawszczyk et al., 2013) and inducing cellular apoptosis (Ferry et al., 2002) which 
may influence the pathogenesis of PE. Increases in blood lymphocyte numbers have 
been observed after 18 days when 500 FTU/kg of a microbial phytase was added to a 
high phytate (0.44% P) broiler diets (Liu et al., 2008). From the available literature, 
the effects of phytase on the mucosal immune responses in pigs have not been 
examined and will be investigated in this chapter.   
Another feed additive that has gained recent attention for its possible 
immunological benefits for animals is beta glucan (β-glucans). They have been 
identified as potential dietary supplements to offset the removal of antibiotic growth 
promoters.  Results in nursery pigs have shown improved growth performance and 
increased production of lymphocytes when diets were supplemented with 5g/kg of 
Saccharomyces cerevisae yeast culture (Shen et al., 2009). Glucans have been reported 
to increase the phagocytic activity of macrophage and neutrophils in human and 
porcine peripheral blood mononuclear cells (PBMCs) (Williams et al., 1986; 
Sherwood et al., 1987; Sonck et al., 2010). However, depending on their source and 
structure, the type of β-glucan used  influences the immune responses of animals  
(Sonck et al., 2011). For instance, reduced clinical signs and increased PRRS specific 
IFN-γ in PBMCs incubated with high molecular β-1,3-1,6-glucan preparation were 
observed 50 days after a challenge infection with PRRS virus (Xiao et al., 2004). Pigs 
fed diets supplemented with 600 ppm β-glucan prior to an ex-vivo E. coli 
lipopolysaccharide challenge showed increased cytokine production when compared 
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to intestinal tissues from non-supplemented pigs (Sweeney et al., 2012). The effect of 
β-glucan on specific mucosal responses to vaccines such as L. intracellularis has not 
been determined. Therefore, this trial assessed the individual and potential 
synergistic effects of adding phytase and β-glucan to diets on immune responses of 
pigs when given an attenuated L. intracellularis oral vaccine.   
6.2 Materials and Methods 
6.2.1 Animal Ethics 
All procedures involving the use of animals were approved by the Elizabeth 
Macarthur Agricultural Institute Animal Ethics Committee (M12-02), Australia. 
6.2.2 Experimental design and diets 
The experiment was conducted as a 2 x 2 x 2 factorial arrangement with 
phytase, β-glucan and vaccination as the main factors. Ninety-nine entire, male, 
Landrace X Large White crossbred weaner pigs were randomly allocated by weight 
(6.9 ± 1.7kg; BW ± SE) to one of eight treatment groups (Table 9). 
Table 8 – Experimental design and treatment groups. 
Groups 
Phytase 
(2000 FTU/kg) 
ß-Glucan 
(100ppm) 
Vaccination 
(105.9TCID50) 
N° of pigs 
G1  Yes Yes Yes 12 
G2 No Yes Yes 12 
G3 Yes No Yes 12 
G4 No No Yes 12 
G5 Yes Yes No 12 
G6 No Yes No 13 
G7 Yes No No 13 
G8 No No No 13 
Total    99 
  
Diets (Table 10) were offered in mash form without antibiotic growth 
promoters and were formulated to meet or exceed the requirements for all nutrients 
(NRC, 2012). Groups G1, G3, G5 and G7 had a third generation E. coli-phytase 
(Quantum® Blue phytase, AB Vista, UK) added (mean analysed activity of 2,007 
phytase units (FTU)/kg). The diets containing β-glucan (groups G1, G2 and G5, G6) 
were supplemented at the rate of 1g/kg of feed (AB Vista Feed Ingredients, 
Marlborough, UK) according to the manufacturer’s instructions. The β-glucan 
preparation (AB Vista, UK) was extracted from baker’s yeast, Saccharomyces 
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cerevisae and isolated by methods described by Haldar et al., (2011).  To calculate the 
apparent ileal digestibility (AID) coefficients for crude nitrogen (N) and minerals, an 
indigestible marker Celite 281 (Filchem Australia Pty Ltd, Australia) was added to 
diets at a concentration of 20 g/kg. 
Table 9- Ingredient and nutrient specification (g/kg) of the basal diet fed to grower pigs (as-fed 
basis). 
 Ingredient g/kg 
Wheat (fine) 557.3 
Soybean meal 153.3 
Canola meal 80.0 
Whey 80.0 
Millrun (Manildra) 66.6 
Spent oil 26.7 
Dicalcium phosphate 13.3 
Limestone (fine) 10.0 
Lysine HCl 5.23 
Vitamin-mineral premix1 2.52 
Betafin (betaine) 2.00 
L-threonine 1.22 
Salt 1.1 
Celite 20.0 
Calculated composition2  
Moisture, % 9.89 
DM, % 89.6 
CP 199.5 
Fibre 36.6 
Fat  49.5 
Ca  9.35 
Total P  7.23 
Phytate-P  3.01 
Ca:P 1.29 
Cal/D:P 2.05 
Total Sulphur  0.12 
Threonine 8.40 
Lysine  0.137 
Methionne,  0.041 
DE, MJ/kg 14.25 
1 Vitamin premix provided per kilogram of diet: Mg, 20mg; Na, 18.2mg; Cl, 23.2mg; Fe, 257mg; Mn, 114mg; Cu, 
198mg; Se, 714μg; Mo, 1.0mg;  Co, 932μg; I, 125mg; Vitamin B6, 103mg; Vitamin B12, 25μg; niacin, 78mg; folic, 
322 μg; biotin, 252mg; choline, 398μg; potassium, 6 mg; tyrosine, 6 mg; tryptophane, 23mg; arginine, 115mg; 
isoleucine, 8.2mg; phenylalanine, 8.7mg. 2Composition was calculated on the requirements for weaner pigs 
(NRC); 
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6.2.3 Pig housing and treatments  
Pigs aged between 3 to 4 weeks were purchased from a commercial herd 
(Young, NSW) clinically and serologically free of PE and housed in an 
environmentally controlled research facility. Pigs were placed in groups of 3 to 4 
animals in 4.0 x 4.5 m pens equipped with slatted-floors, a feeder and nipple drinker 
to provide ad libitum access to feed and water, respectively. The temperature in the 
room was controlled between 24 and 28°C as recommended by the Australian animal 
welfare standard and guidelines (Animal Welfare Working Group, 2007). After one 
week on the respective diets, pigs in G1, G2, G3 and G4 groups were orally vaccinated 
(d 0) via drench gun with 2.0 mL of Lawsonia intracellularis vaccine containing 105.9 
TCID50 organisms (Enterisol®Ileitis, Boehringer Ingelheim, US). The remaining 
groups (G5-G8) were not vaccinated.   
6.2.4 Sampling schedule 
On days 0, 7 and 25 post-vaccination (pv), individual pigs were bled by jugular 
venipuncture (5.0 mL) using serum clot separator vacuum tubes (Vacuette®, Geiner 
Bio-one, Australia) for serological analysis. On these days, faeces (approximately 2 g) 
were collected from individual pigs using clean gloves and stored in sterile containers 
(Techno-Plas®, Australia) and frozen at -20 °C until further analysis (Table 11).  
Table 10- Experimental days and sampling schedule 
 -7 -6  0 1  7 8  15  22  25  28 29 
 Feed starts Vacc.          Necropsy 
Faeces  √ √       √    
Blood  √ √       √    
Feed intake 
√ 
W0 
 √ 
   W1 
 
√ 
W2 
 
√ 
W3 
 
√ 
W4 
   
√ 
W5 
√ 
W5 
Weight √  √  √  √  √    √ √ 
Necropsy 
 Ileal Mucosa 
 Ileal Digesta 
 Ileal section 
 Carcass 
weight 
           √ √ 
 
After 35 days of feed consumption (d 28 pv), pigs from all groups were 
slaughtered at a local abattoir (Wollondilly, NSW) over two consecutive days. Entire 
gastrointestinal tracts were collected, placed in individually-labelled bags and 
transported on ice to Elizabeth Macarthur Agricultural Institute necropsy room for 
tissue collection. Briefly, ileal digesta was obtained by massaging caudally from 2 m 
to 10 cm anterior to the ileo-caecal valve (ICV) and placed in sterile containers and 
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kept at -20 °C until freeze-dried. Subsequently, a section of ileal tissue was cut and 
around 1 cm segment stored in 10 % neutral-buffered formalin fixative for 
histopathology. The adjacent segment was cut longitudinally and the intestinal 
mucosal secretions were collected by gently scraping the ileal mucosa with a sterile 
scalpel as previously described (Chapter 3). 
6.2.5 Production parameters 
Pigs were monitored daily for body condition, clinical signs of PE and abnormal 
behaviour. Pigs were individually weighed in electronic scales (Adam Equipment, 
South Africa) at the time of arrival and weekly during the trial to determine average 
daily live weight gain (ADG). Weekly feed consumption was calculated as the 
difference in the weight of feed supplied minus the feed remaining and was used to 
estimate the average daily feed intake (ADFI) and feed conversion ratio (FCR). At 
necropsy, the percentage dress weight for each pig was calculated as the hot standard 
carcass weight (HSCW) divided by the final live weight prior to slaughter multiplied 
by 100. 
6.2.6 Sample analyses 
Sera and mucosal scrapings were assayed in duplicate for the detection of L. 
intracellularis specific antibodies (IgG) using a commercial blocking ELISA 
(Bioscreen®Ileitis, GmbH, Münster, Germany). L. intracellularis-IgA was assayed using 
an experimentally modified direct ELISA (as described in Chapter 3). The quantities 
of cytokines IFN-γ, IL-6, IL-10, TNF-α and TGF-β1 in ileal mucosal secretions were 
analysed using a commercial sandwich ELISA Kit (porcine Quantikine® ELISA, R&D 
systems, Minneapolis, USA).  The minimum limits of detection for this study were 2.0 
pg/mL for IFN-γ, 1.7 pg/mL for IL-6, 17.2 pg/mL for IL-10, 1.7 pg/mL for TNF-α and 
8.1 pg/mL for TGF-β1. Concentrations were estimated by generating a logistic 
parameter curve using GraphPad®Prism software. To quantify bacterial excretion, 
purification of bacterial DNA from faecal samples (0.1g) was performed with the 
MagMax DNA extraction kit (A&B Applied Biosystems, California, USA). Extraction 
products were analysed by real-time PCR (7500 Real-Time PCR System, Applied 
Biosystems) using primers and Taq Man probe as described by Nathues et al., (2009). 
The sensitivity and specificity of the test has been reported by Collins et al., (2011) as 
99% and 97%, respectively.  
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6.2.7 Histological procedures 
Formalin-fixed tissues were stained with haematoxylin and eosin (H&E) (Luna, 
1968). The blinded slides were scored by one operator under 40x magnification light 
microscope to count the number of goblet cell crypts using a manual cell counter 
(Bantex, USA). A total of ten fields were analysed for each slide, with the first chosen 
randomly and then every second field to the right. The presence of proliferative 
affected area (%) was also noted and when positive an immunohistochemistry (IHC) 
stain, using a  VPM53 L. intracellularis  monoclonal antibody (Boehringer Ingelheim, 
US) was performed to confirm the presence of L. intracellularis -specific antigen 
within crypts (Jensen et al., 1997). 
6.2.8 Chemical analysis of diet and ileal digesta 
The ileal digesta samples were freeze-dried and all samples were ground 
(Retsch ZM 100, Retsch GmbH, Germany) to pass through a 0.5 mm screen prior to 
chemical analyses.  The nitrogen (N) contents of the minerals P, Ca, Cu, K, Mg, Mn, Na, 
Sr, Fe and Zn were determined in feed and dried digesta samples. Nitrogen 
concentration was determined by the Dumas method using a FP-428 nitrogen 
analyser (method 968.06, LECO® Corporation, St. Joseph, MI, USA) as described by 
Sweeney (1989). Samples were wet acid digested using nitric acid and hydrogen 
peroxide prior to the determination of mineral concentration by Inductively Coupled 
Plasma-Optical Emission Spectroscopy using a Perkin Elmer OPTIMA 7300 (Perkin 
Elmer Inc, Waltham, MA, USA) at the Mark Wainwright analytical centre (The 
University of New South Wales, Kensington, 2052). The acid insoluble ash component 
of dried diets and ileal digesta samples were determined according to the method of 
Siriwan et al., (1993). The apparent ileal digestibility (AID) coefficient of crude 
protein (CP) and minerals were calculated as described by Ravindran et al., (2001). 
Phytase activity was tested in the diet using an ELISA test kit (Envirologix, USA) as 
designated by the ESC Standard Analytical Method (#SAM099, ESC laboratories, UK). 
Phytase recovered in the diets was determined (Enzyme Services and Consultancy, 
Ystrad Mynach, UK) according to the method of Engelen et al. (2001), modified to 
determine activity specifically from the exogenous phytase. One phytase unit is 
defined as the amount of enzyme required to liberate 1 mol of inorganic P/min from 
phytic acid at pH 4.5 and 60 °C.  
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6.2.9 Statistical analysis  
The experiment was a 2 x 2 x 2 factorial arrangement, with dietary phytase, β-
glucan and vaccination being the main factors. The data were subjected to 
randomized complete block design using a linear mixed model procedure of 
Restricted Maximum Likelihood (REML, GenStat Release 13th Ed, UK) with a 95% 
confidence level (P<0.05) (Steel, 1997). Pigs were the experimental unit for all 
immune responses and pathology lesions. Pen was the experimental unit for growth 
performance and nutrient digestibility metrics. Clinical observation data were 
categorized into binary data and then analysed using a two sample binomial test 
comparison (Steel, 1997).  
6.3 Results 
6.3.1 Room temperature and clinical health 
Overall, pigs were healthy during the entire trial. Occasional scouring was 
observed and treated orally with 200mL electrolytes (Vytrate, Jurox, Rutherford, 
Australia) for affected pigs. However, scouring was not attributed to any specific diet.  
6.3.2 Production performances 
Performance data is shown in Table 12.  At the start of the trial (d-7) pigs 
weighed an average of 8 kg ± 0.65 (kg ± SE) with no differences between the total 
bodyweights in each randomised group. Overall, vaccinated pigs demonstrated lower 
average weight gain during weeks 4 and 5 (694.6 and 746 g/day, respectively) when 
compared with unvaccinated pigs (724.1 and 803.7 g/day).This might be due to the 
fact that unvaccinated pigs had higher daily feed intake (1383 g/ day) than the 
vaccinated groups (1184 g/ day).  
 Prior to slaughter, live bodyweight averaged 27.8 kg across all groups with pigs 
from the group G2 (glucan and vaccinated) showing the lowest average weights (26.3 
kg). This group (G2) also had the lowest hot standard carcass weights (HSCW) of 19.2 
kg, but there were no significant differences across groups (20.5 kg). Similarly, no 
differences were found for carcass dressing percentage. The respective carcass 
dressing percentage for the 8 groups were 73.2% (G1), 72.9% (G2), 72.9% (G3), 
74.1% (G4), 74.5% (G5), 72.8% (G6), 73.5% (G7), 72.5% (G8). 
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Table 11- Individual average daily weight gain (ADG, g/day), average daily feed intake (FI, g/day) 
and feed weigh: gain ratio (FCR, g feed/g weight) over the 5 week trial (week 1=vaccination) 
within groups.  
 Vaccinated groups                                                 Non vaccinated groups   
 
G1 
(+P+B) 
G2        
(-P+B) 
G3 
(+P-B) 
G4 
(-P-B) 
G5 
(+P+B) 
G6        
(-P+B) 
G7 
(+P-B) 
G8 
(-P-B) 
SEM 
P 
(<0.05) 
Week 1 
ADG 319.6 318.2 344.5 385.8 369.4 323.2 343.5 383.5 31.9 NS 
FI 463.9 433.1 518.7 491.4 487.7 454.6 503.0 464.0 32.2 NS 
FCR 1.46 1.37 1.5 1.29 1.32 1.41 1.47 1.23 0.08 NS 
Week 2 
ADG 465.2b 417.9a 471.2b 526.2c 473.7b 497.4bc 493.0bc 478.0b 38.6 0.034 
FI 660.8a 625.3a 760.1c 715.1bc 677.6ab 663.7a 705.3b 688.3b 44.2 <0.001 
FCR 1.42 1.51 1.61 1.37 1.43 1.34 1.44 1.45 0.08 NS 
Week 3 
ADG 611.9b 535.0a 579.2a 559.5a 609.5b 548.2a 603.3b 560.4a 43.2 0.015 
FI 947.0c 829.7a 967.2c 916.7b 956.3c 922.2b 961.3c 925.7b 51.2 <0.001 
FCR 1.56 1.55 1.67 1.64 1.57 1.7 1.61 1.65 0.07 NS 
Week 4 
ADG 717.9ab 664.3a 666.7a 729.8b 694.0a 745.8c 739.9bc 725.3b 37.2 0.027 
FI 1114.4a 1078.5a 1124.8a 1143.5b 1151.5b 1186.4b 1251.4b 1146.4b 54.8 <0.001 
FCR 1.58 1.63 1.69 1.57 1.66 1.59 1.7 1.58 0.06 NS 
Week 5 
ADG 840.9c 759.1b 752.4b 699.0a 773.2b 814.5c 847.1c 838.4c 23.1 <0.001 
FI 1428.2 1342.3 1382.6 1377.6 1418.3 1486.3 1479.8 1386.1 162.2 NS 
FCR 1.75a 1.77ab 1.83b 1.99b 1.84b 1.85b 1.76ab 1.67a 0.08 0.047 
Overall main effects ADG FI FCR      
Vaccinated         
Vacc + 620.0 1137 1.84      
Vacc - 647.8 1175 1.81      
P (<0.05) NS NS NS      
Phytase         
Phytase + 641.5 1178 1.83      
Phytase - 626.3 1134 1.81      
P (<0.05) NS NS NS      
Glucan         
Glucan + 630.7 1137 1.81      
Glucan - 637.0 1175 1.85      
P(<0.05) NS NS NS      
Interactions (P<0.05)         
P*V NS NS NS      
V*B NS NS NS      
B*P NS NS NS      
P*V*B NS NS NS      
1 Means in the same row without common superscripts are significantly different (P<0.05); 2 NS: Not significant 
(P>0.05); P: Phytase; B: β-glucan; V: vaccination  
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6.3.3 Nutrient digestibility 
The effects of dietary treatment on the apparent ileal digestibility (AID) of 
nitrogen (N) and the minerals Ca, P, Mg, Na, K, Fe, Cu, Mn, Zn and Sr are presented in 
Table 13. No main effects of phytase, β-glucan or vaccination were found. However, 
three way interactions were found for the AID of Mg, K, Fe, and Cu with the highest 
AID of Mg observed for the phytase supplemented and vaccinated groups G1 and G3. 
Similarly, the highest AID of K was detected in phytase supplemented groups (G1, G3, 
G5 and G7) and for AID of Fe the group G5 had the highest coefficient.  
Table 12- The apparent ileal digestibility coefficients of nitrogen (N) and minerals in pigs  
vaccinated (V) and unvaccinated, with or without β-glucan yeast (+/- B) and phytase (+/- P)1,2. 
Groups N Ca P Mg Na K Fe Cu Mn Zn Sr 
G1 (+P+B) 0.48 0.78 0.61 0.48b -0.07 0.63ab 0.33a 0.28b 0.47 0.52 0.69 
G2 (-P+B) 0.46 0.76 0.57 0.42a -0.07 0.55a 0.44b 0.22ab 0.41 0.49 0.60 
G3 (+P-B) 0.54 0.79 0.63 0.50b -0.08 0.67b 0.25a 0.30b 0.38 0.43 0.54 
G4 (-P-B) 0.52 0.76 0.59 0.43a -0.06 0.59a 0.36ab 0.24b 0.32 0.39 0.45 
G5 (+P+B) 0.43 0.76 0.55 0.43a -0.03 0.68b 0.47b 0.19a 0.37 0.40 0.47 
G6 (-P+B) 0.42 0.73 0.51 0.37a -0.09 0.57a 0.35a 0.13a 0.31 0.37 0.39 
G7 (+P-B) 0.49 0.76 0.56 0.42a -0.10 0.72b 0.38ab 0.21ab 0.28 0.31 0.61 
G8 (-P-B) 0.48 0.73 0.52 0.35a -0.06 0.61a 0.27a 0.15a 0.22 0.27 0.52 
SEM 0.08 0.05 0.05 0.08 0.11 0.08 0.09 0.07 0.06 0.07 0.07 
P(<0.05) NS NS NS 0.046 NS 0.045 0.032 0.038 NS NS 0.068 
Vaccinated                       
Vacc + 0.49 0.78 0.65 0.48 0.10 0.71 0.30 0.29 0.31 0.31 0.57 
Vacc - 0.44 0.77 0.62 0.47 0.14 0.69 0.37 0.28 0.27 0.29 0.58 
P (<0.05) NS NS NS NS NS NS NS NS NS NS NS 
Phytase                       
Phytase + 0.47 0.79 0.66 0.48 0.03 0.72 0.38 0.31 0.30 0.37 0.60 
Phytase - 0.46 0.76 0.61 0.47 0.02 0.68 0.25 0.25 0.28 0.24 0.55 
P (<0.05) NS NS NS NS NS NS NS NS NS NS NS 
Glucan                       
Glucan + 0.44 0.79 0.64 0.50 0.03 0.70 0.36 0.28 0.30 0.33 0.60 
Glucan - 0.50 0.77 0.63 0.45 0.02 0.70 0.35 0.29 0.28 0.27 0.55 
P(<0.05) NS NS NS NS NS NS NS NS NS NS NS 
Interactions (P<0.05)         
P*V NS NS NS NS NS NS NS NS NS NS NS 
V*B NS NS NS NS NS NS NS NS NS NS NS 
B*P NS NS NS NS NS NS NS NS NS NS NS 
P*V*B NS NS NS NS NS NS NS NS NS NS NS 
1 Values in the same column without common superscripts are significant different (P<0.05); NS: Not significant 
(P>0.05); P: Phytase; B: β-glucan; V: vaccination 
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6.3.4 Systemic immune responses 
Pigs were seronegative at day 0 and 7 post-vaccination (Table 14). After 25 
days pv, vaccinated pigs had higher L. intracellularis-IgG responses then unvaccinated 
pigs (PI: 35% and 8.8%, respectively). The highest percentage inhibitions (PI) for 
Lawsonia intracellularis specific IgG were observed on day 25 in groups G1, G3 (41 
and 35.5%) when compared to other two vaccinated groups (G2 and G4, 10.8% and 
16.2%). Vaccinating pigs increased specific IgG concentrations when compared to 
non-vaccinated pigs. In addition, a tendency for higher IgG responses were also 
observed in phytase and β-glucan supplemented pigs, leading to a phytase-β-glucan-
vaccination interaction (Table 14). 
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Table 13 – Mean concentrations for the main effects and interactions of Lawsonia intracellularis 
IgG in serum, as percentage inhibition (PI, %), within groups vaccinated and unvaccinated, with 
or without β-glucan yeast (+/- B) and phytase (+/- P). 
  IgG (PI, %)1,2 
 Treatment day 0 day 7 day 25 
V
a
cc
in
a
te
d
 G1 (+P+B) -1.0 1.3 41.0c 
G2 (-P+B) -0.9 -0.1 10.8a 
G3 (+P-B) -6.5 -4.2 35.6c 
G4 (-P -B) -6.3 -5.6 16.2ab 
U
n
va
cc
in
a
te
d
 G5 (+P+B) -9.5 -7.4 18.2b 
G6 (-P+B) -11.2 -2.0 22.8b 
G7 (+P-B) -4.3 6.6 7.4a 
G8 (-P-B) -6.0 5.0 23.4b 
 SEM 2.0 5.3 8.4 
 P (<0.05) NS NS <0.001 
 Main effects   
 Vaccination   
 Vacc + -11.1 1.8 35.0a 
 Vacc - -8.4 0.6 8.3b 
 P (<0.05) NS NS <0.001 
 Phytase    
 Phytase + -10.8 -1.0 22.2 
 Phytase - -8.7 3.2 20.4 
 P (<0.05) NS NS NS 
  Glucan    
 Glucan + -8.7 -1.4 26.6 
 Glucan - -10.7 0.4 16.1 
 P (<0.05) NS NS NS 
 Interactions    
 P*V NS NS NS 
 V*B NS NS NS 
 B*P NS NS NS 
 P*V*B NS NS 0.024 
1 Negative percentage means indicates that the unknown sample has less antibody concentration that the negative 
control available on the kit.2 Values in the same column without common superscripts are significant different 
(P<0.05);  3 NS: Not significant (P>0.05);  
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6.3.5 Local mucosal immune responses         
Local immune responses are summarized in Table 15. In unvaccinated groups, 
β-glucan supplementation substantially increased concentrations of IFN-γ, TNF-α and 
TGF- β1 (group 6) compared to un-supplemented group 8 while phytase had no 
significant effect (group 7), unless animals were vaccinated (group 3, Table 15). 
Vaccinated pigs had higher mucosal IgG immune concentrations than unvaccinated 
pigs at day 28 pv (PI: 21% and 13.4%, respectively). Pigs supplemented with phytase 
generated higher L. intracellularis specific IgG concentrations in the ileal mucosal 
scrapings compared to non-supplemented pigs (PI: 24.7% and 10.3%, respectively). 
In addition, pigs fed β-glucan had higher mucosal IgG antibody responses than non-
supplemented pigs (20.4 and 14.6 pg/ml, respectively). Similarly, mucosal IgA titres 
were increased in pigs supplemented with β-glucan (22.3 pg/mL) when compared 
with the non-supplemented cohort (16.7 pg/mL). Interactions between phytase and 
vaccination were observed, as vaccinating pigs had increased L. intracellularis IgG 
responses when compared to non-vaccination and titres were further increased by 
adding phytase to the pig diets. 
Cytokine immune responses revealed that vaccinated pigs produced 
significantly higher mucosal concentrations of TNF-α, IL-6 and IL-10 (TNF-α, 20.4; IL-
6, 18.9 and IL-10, 85.5) than unvaccinated animals (TNF-α, 9.3: IL-6, 14.3 and IL-10, 
67.0) (Table 15). Vaccinated pigs also tended to have higher concentrations of 
mucosal IFN-γ and TGF- β1 in mucosal secretions than control animals (IFN-γ; 113.2 
vs. 87.4 pg/mL, respectively; TGF- β1; 143.3 vs. 103.1 pg/mL, respectively). Pigs 
supplemented with β-glucan also had higher concentrations of IFN-γ (147.1pg/ml) 
and TNF-α (20.6) cytokines in ileal mucosal scrapings when compared with 
unsupplemented groups (IFN-γ =53.2 and TNF-α TNF=8.9 pg/ml). L. intracellularis 
vaccination increased TNF-α response in ileal mucosa when compared with 
unvaccinated pigs and a further increased response was observed when β-glucan was 
added, leading to a vaccination-β-glucan interaction. In addition, pigs consuming 
diets with added phytase generated higher IFN-γ concentrations (118. 8 pg/mL) in 
mucosal secretions compared to pigs without phytase in the diet (81.4pg/mL). These 
results and also the increasing IFN-γ responses associated with supplementation of 
phytase in pigs feed resulted in a phytase-β-glucan interaction.  
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Table 14- The mean concentrations for the main effects and interactions of Lawsonia 
intracellularis IgG (PI, %) and IgA (Titre) and cytokines (pg/mL) in ileal mucosa within groups 
vaccinated and unvaccinated, with or without β-glucan yeast (+/- B) and phytase (+/- P). 
  Cytokines1,2 Li-Antibody 
 Groups IFN-γ TNF-α TGF-β1 IL-10 IL-6 IgG IgA 
V
a
cc
in
a
te
d
 G1 (+P+B) 199.3c 26.,3 292.8c 80.4 21.2 36.78a 22.52 
G2 (-P+B) 121.7c 26.7 78.1b 84.2 19.7 24.18b 17.23 
G3 (+P-B) 65.7a 14.2 145.1c 60.3 18.2 16.39c 17.75 
G4 (-P -B) 66.1a 14.6 55.4a 63.8 16.7 9.75d 16.88 
U
n
va
cc
in
a
te
d
 G5 (+P+B) 174.6c 15.0 54.7a 87.1 16.8 20.48b 21.22 
G6 (-P+B) 174.5c 15.5 79.2b 90.6 15.3 18.26bc 27.92 
G7 (+P-B) 41.0a 3.0 60.5a 66.9 13.7 8.98d 15.28 
G8 (-P-B) 97.0b 3.4 65.1a 70.5 12.3 6.69d 17.23 
 SEM 20.5 8.9 17.6 14.1 6.3 4.8 7.2 
 P (<0.05) <0.001 NS <0.001 NS NS <0.001 NS 
 Main factor       
 Vaccination       
 Vacc + 113.2 20.4a 144.3 85.5a 18.9a 21.78a 20.4 
 Vacc - 87.4 9.3b 107.1 67.0b 14.3b 13.47b 18.59 
 P (<0.05) NS 0.02 NS 0.04 0.04 <0.001 NS 
 Phytase       
 Phytase + 118.8 14.6 139.9 74.1 17.3 24.79a 19.93 
 Phytase - 81.4 14.8 120.4 77.9 15.8 10.35b 19.11 
 P (<0.05) NS NS NS NS NS 0.002 NS 
 Glucan       
 Glucan + 147.1 20.6 116.6 72.5 18.2 20.42a 22.34a 
 Glucan - 53.2 8.9 143.0 79.4 15.0 14.63b 16.76b 
 P (<0.05) <0.001 0.006 NS NS NS <0.001 0.03 
 Interactions       
 P*V NS NS NS NS NS 0.045 NS 
 V*B NS 0.004 NS NS NS NS NS 
 B*P 0.008 NS NS NS NS NS NS 
 P*V*B NS NS NS NS NS NS NS 
1 Values in the same column without common superscripts are significant different (P<0.05); 2 NS: Not significant 
(P>0.05);  
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6.3.6 L. intracellularis shedding 
At day 0, pigs were not shedding Lawsonia intracellularis. However, by day 25 
two pigs from room 1 (pen G2 and G4) and two pigs from room 4 (pen G6 and G7) 
were shedding between 5.9x103 and 3.1x103 L. intracellularis per gram of faeces. 
However, ileal sections were negative for L. intracellularis antigen staining (IHC) from 
these animals at necropsy after 28 days pv. Although strict quarantine procedures 
were followed it may be possible that several pigs may have been recently infected 
on-farm prior to transport and this resulted in low shedding, no lesions and a relative 
low L intracellularis IgG response in the serum.  
6.3.7 Pathology results  
Pathology results from goblet cells counts (Figure 32) showed small differences 
between groups (Figure 33). Stained ileal sections from groups G1 (112.1), G2 
(116.3) and G5 (111.9) showed the highest per field counts of goblet cells per field, 
and the lowest counts were found in groups G3 (91.5), G4 (100.4) and G5 (105.5). 
 
 
Figure 32: Ileal section (40x mag.), showing visualization of goblets cells (arrows) within 
enterocytes of pig (#B171) from G2 group, supplemented with β-glucan and L. intracellularis 
(vaccinated) after 28 days post-vaccination.  
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Figure 33: Mean goblet cells counts in ileal sections and mean from each group (G1-G8). 
 
6.4 Discussion 
In this study, the supplementation of 100 ppm Saccharomyces cerevisae yeast 
beta-glucan and 2,000 FTU/kg microbial phytase to weaner diets increased the 
mucosal immune response to an attenuated Lawsonia intracellularis vaccine, as 
evidenced by the significant increases in L. intracellularis specific IgG and the 
cytokines, IFN-γ and TNF-α in ileal mucosa. From the available literature, this is the 
first study to evaluate the response to L. intracellularis vaccination in pig’s fed diets 
supplemented with both these additives. Although, the effect of β-glucan on humoral 
and cellular immune cells is well studied, the effect of microbial phytase on immune 
response in pigs is relatively limited. As expected, vaccination enhanced the 
concentrations of L. intracellularis specific IgG in the serum and mucosa and these 
serological results are consistent with previous findings reported in Chapters 4 and 5. 
6.4.1 Potential effect of phytase on vaccination  
In this study, pigs consuming diets with phytase generated higher L. 
intracellularis specific IgG concentrations in mucosal scrapings compared with pigs 
fed the diets without phytase. This increase may possibly be associated with the 
activation of the innate immunity due to increased nutritional availability. Phytate 
can interfere with digestibility and chelate to nutrients, directly affecting its 
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absorption and utilization of nutrients (Simons et al., 1990). Therefore, the use of an 
enzyme phytase to break down phytate is used to release nutrients bound to phytate 
and potentially increase their digestion and utilization in the gut. It is possible that 
the increased bioavailability of nutrients in the gut (with phytase) will allow 
additional nutrients to be redirected for immune cell growth and replication. For 
instance, Zn its known to affect the recruitment of naïve T cells and cytokines 
synthesis (Peterson et al., 2008). As well as, the free inositol molecule has been 
speculated to somehow up-regulate cell division and differentiation (Menniti et al., 
1993) and to stimulate respiratory burst, bacterial killing and recovery by releasing 
IL-8, TNF-α and IL-6 and TGF-β1 cytokines (Eggleton, 1999). In the current study we 
observed higher pro-inflammatory cytokine IFN-γ concentrations in ileal mucosa 
(118. 8 pg/mL) in pigs fed diets that were supplemented with phytase than pigs fed 
the un-supplemented diet (81.4pg/mL). Pro-inflammatory cytokines have been 
shown to orchestrate the mechanisms responsible for supply of nutrients for 
proliferation of lymphocyte and macrophage population during periods of immune 
challenge (Klasing and Korver, 1997; Spurlock, 1997). Liu et al., (2008) evaluated the 
effect of phytase (500 FTU/kg) on the immune responses of broilers that were 
vaccinated with Newcastle disease virus (NDV) and fed a high phytate diet (0.44% 
phytate P). Their results showed that phytase supplementation increase intestinal 
secretory IgA, as well as increased CD3+CD4+ and CD3+CD8+ T lymphocyte numbers 
in serum on day 28 after vaccination (Liu et al., 2008).  
The CD4+ Th1 cells produce pro-inflammatory IL-2, IFN-γ and TNF-α cytokines 
promoting cell mediated immune responses against intracellular pathogens,  whereas 
CD8+ T mediate cytotoxic killing of infected cells (Emery and Collins, 2011). However, 
mucosa scrapings from the duodenum, jejunum and ileum of birds fed diets 
supplemented with 2,000 FTU/ kg did not express cytokines (IL1β and IL-6) nor 
innate immunity receptors TLR 2 and TLR 4 genes (Olukosi et al., 2013). In their 
study, birds were not challenged or vaccinated. Therefore it is plausible that if any 
changes in cytokine or innate immunity receptors did occur these may have been too 
subtle to detect. Shaw et al., (2011) reported that birds fed 500FTU/kg phytase added 
to broilers diets following an Eimeria sp. challenge had no effect on oocyst shedding.  
However, the average lesion scores of infected birds fed phytase were reduced in the 
caecum by 18 days post challenge. In addition, cytokine IL-17 sRNA expression in the 
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duodenum was increased in phytase supplemented broilers. IL-17 and T-reg cells are 
normally involved in the inflammatory regulation in the gut which accompanies 
neutrophil recruitment and activity against pathogens (Basso et al., 2009),  as well as 
promoting secretion of cytokines TGF-β and IL-10 by CD4+ Th2 cells (Emery and 
Collins, 2011). Since IL-17 is produced from T-reg T-cells, and activates production of 
TGF-β, these results may concur with our findings that phytase supplemented pigs 
exhibited a trend to higher TGF-β concentrations (139pg/mL) than non-
supplemented animals (120 pg/mL). Therefore, the results in this trial could be 
related to local gut restoration and wound healing as a consequence of the vaccine 
“stimulation” in the gut lumen.   
 
6.4.2 Diet effect on growth performance and digestibility 
 This study did not observe any increases in growth performance (ADFI, ADG 
and FCR) of pigs supplemented with phytase or β-glucan. Similarly, previous studies 
observed minimal effects on pig performance (FI, ADG and FCR) when pigs were fed 
β-glucan (0.25%) from either Laminaria digitata or Saccharomyces cerevisae β-glucan 
(Boling et al., 2000; Woyengo et al., 2008). The observations of growth performance 
effects of β-glucan could also be related to the source, the length and dose of 
supplementation. The available commercial E. coli phytases increased growth 
performances (ADG) by 33% when given to nursery pigs until 3 weeks (Jones et al., 
2010). Similarly, supplementing E. coli-phytase (2,500 FTU/kg) to P deficient diets 
(0.15%P) had increased ADG and FCR in weaner pigs during the 28 days trial (Veum 
et al., 2006). However, modest changes on ADG and FCR were observed in weaner 
pigs supplemented with 2,000 FTU/kg of E. coli derived phytase added to P deficient 
corn based diets (0.53% P) (Beaulieu et al., 2007). Possibly subtle differences in these 
phytase responses on growth performance could be due to differences in 
experimental designs and the effects are more pronounced when dietary deficiencies 
are corrected.  
In this study, no main effects of phytase, β-glucan or vaccination were found in 
nutrient digestibility in pigs. However, three way interactions were found for the AID 
of Mg, K, Fe, and Cu with the highest AID of Mg observed for the phytase 
supplemented and vaccinated groups G1 and G3. Madrid et al., (2013) investigated 
the effect of microbial phytase (500 FTU/kg) addition to low total phosphorus diet on 
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apparent faecal mineral digestibility. Results demonstrated that pigs supplemented 
with phytase had improved growth performance, however, increases in mineral 
digestibility retention was limited to P and Cu (39% and 33%, respectively). Adeola 
et al. (1995) also observed that supplemental phytase did not affect the retention, as 
percentage of intake, of either Zn or Mg.  
     
6.4.3 Diet effect on general health  
During this study, pigs were overall healthy and with occasional scouring, but 
without lesions and overall without L. intracellularis shedding after vaccination. The 
anti-nutritive compound phytate has been related to increase mucin excretion and it 
is suggested that the enzyme phytase could reverse this effect (Onyango et al., 2009; 
Selle et al., 2012). The quantity and quality of mucin produced by goblet cells, within 
the intestinal lumen has been directly correlated to protection against mechanical 
and chemical damage and pathogen invasions (Belley et al., 1999). Therefore, while 
excessive mucin excretion may compromise intestinal mucosa integrity, the opposite 
is also true, the absence of mucin could lead to increased pathogen attachment (Kim 
and Ho, 2010). Walk et al.,(2011) observed no effect of in feed E. coli 6-phytase (1,000 
FTU/kg) and Eimeria sp. vaccination on the number of goblet cells in the duodenum 
of birds 7 days post-vaccination. Similarly, in this study, no effect of numbers of 
goblet cells within the ileal mucosa was observed by histopathology. A tendency for 
increased number of goblet cells in β-glucan supplemented pigs was observed in ileal 
mucosa (mean 111) compared with the un-supplemented cohort (100). Smith et al., 
(2011) demonstrated that dietary supplementation of 300ppm of seaweed derived 
Laminarin sp. in pigs led to significant increases in MUC2 and MUC4 gene expression 
in ileum. The mechanisms by which glucans influence mucin production are not yet 
understood, but it has been speculated that alterations in the intestinal microbiota 
could influence mucin synthesis and secretion (Enss et al., 1994; Rice et al., 2005). 
 
6.4.4 Effect of β-glucan on L. intracellularis vaccination  
The activation of the mononuclear phagocyte system and protective 
inflammatory cytokines by β-glucans in humans and pigs has been directly correlated 
with innate immune responses (Decuypere et al., 1998; Brown and Gordon, 2001). 
Human whole blood incubated with soluble yeast β-glucan demonstrated an increase 
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in the production of pro-inflammatory cytokines TNF-α, IL-6, IL-8 and monocyte 
tissue factor (Adachi et al., 1994; Young et al., 2001). Similarly, Sonck et al., (2010) 
observed proliferation of lymphocytes, neutrophils and monocytes, with TNF-α and 
IL-1β production after porcine PMBCs were incubated with S. cerevisae β-glucans 
(200 μg/mL). In the current study, pigs fed β-glucan had raised mucosal L. 
intracellularis IgG antibody responses when compared with non-supplemented pigs 
(20.4 and 14.6 pg/ml, respectively). Mucosal IgA (22.3 and 16.7 pg/mL) 
concentrations were similar. The presence of immunoglobulin A and G antibodies in 
the intestinal lumen is often associated with increased protection against enteric 
pathogens (Jemmott and McClelland, 1989; Husband et al., 1996). Purified β-glucan 
from the same source (AB Vista), produced higher haemagglutination inhibition (HI) 
titres against Newcastle disease 14 days post-challenge in yeast supplemented 
broilers, compared with un-supplemented animals (Haldar et al., 2011). However, the 
effects of β-glucans on immunity are not reliably repeatable and so their ability to act 
against specific diseases cannot be predicted with any certainty. The administration 
of 90 mg/kg of purified yeast (1,3/1,6)-D-glucan to neonatal piglets that were 
vaccinated against human influenza, had no effect on intestinal or immune 
development of T cell phenotypes or cytokine gene expression and did not improve 
the antibody response to vaccination during the 21 day trial (Hester et al., 2012). 
Conversely, Stuyven et al., (2009), observed that in-feed β-glucan (Macrogard®, 
500g/ton) protected piglets against ETEC-F4 (E. coli) infection, and induced 
increased concentrations of F4 specific serum antibody. However, further research is 
required to specifically associate the effect S. cerevisae yeast β-glucan to proliferative 
enteropathy protection in pigs.   
 
Dendritic cell- associated C type lectin-1 (dectin-1) has been implicated as the 
pattern recognition receptor mostly expressed in porcine monocytes and other APCs 
that bind β-glucans (Sonck et al., 2009). The subsequent activation of NF-κB in 
monocytes and linkage of TLR2, results in enhanced phagocytosis, oxidative burst 
and cytokine production (Brown and Gordon, 2001; Sonck et al., 2009). These are in 
agreement to our findings of higher concentrations of IFN-γ (147.1pg/ml) and TNF-α 
(20.6) cytokines in ileal mucosa from pigs supplemented with β-glucan compared 
with un-supplemented groups (IFN=53.2 and TNF=8.9 pg/ml). Possibly yeast 
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activation of the innate immune function could lead to greater induction of acquired 
immunity and protection against specific diseases. For instance, reduced clinical signs 
and increased PRRS specific IFN-γ in PBMCs incubated with a high molecular β-1,3-
1,6-glucan preparation in vitro was observed 50 days after a challenge infection with 
PRRS virus (Xiao et al., 2004). However, the β-glucan structure and chemical 
composition can modulate their effects on growth performance, health and immunity 
(Sonck et al., 2011). Additionally, variations in the immune responses studied could 
be also be related to the dose of supplementation. Concentrations of IgM, IgA or CD4+ 
and CD8+ T-cells in ileal tissues (by IHC) of finishing pigs were not modified by the 
addition of S. cerevisae β-glucan (at 0.03% and 0.3%, AntafermMG®) (Sauerwein et 
al., 2007). However when 2.5% S. cerevisae β-glucan (EnergyPlus®) was given to 7 
days old piglets, an increased in TNF-α and IL-β1 mRNA expression in ileal tissues 
was detected (Eicher et al., 2006). 
In conclusion, the supplementation of Saccharomyces cerevisae yeast beta-
glucan and microbial phytase added to weaner diet affected the mucosal and 
systemic Lawsonia intracellularis local immune response after vaccination. This study 
showed that L. intracellularis vaccination with an attenuated infection to growing 
pigs may be influenced by diet.  It is possible that dietary components influence the 
efficacy of concomitantly innate and acquired immune responses against specific 
pathogen and protection. However, further research is required to confirm these 
finding and relate to specific disease protection.  
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 Chapter 7 General discussion 
As the current limitations on the use of in-feed antibiotics become more 
widely accepted and implemented, sanitary methods and vaccination assume a 
greater importance to maintain the productivity and profitability of pig herds. 
Currently, control of proliferative enteropathy relies on antibiotic medication and 
vaccination. As pressures to reduce antimicrobial growth promoters continue, the 
use of vaccination is considered the best alternative to protect herds from disease. 
The results in this thesis provide novel information on the effects of vaccine dose 
response, route of immunisation and in-feed additives on the systemic and local 
mucosal responses to vaccination with an attenuated bacterium. The experimental 
design also addressed whether an immune response could be confidently correlated 
with successful vaccination (i.e. the magnitude of the responses is predictive of 
protective immunity). The investigations in this thesis have expanded the limited 
information available in the immunological responses to the attenuated Lawsonia 
intracellularis vaccine Enterisol® ileitis in pigs. 
If they are to remove in-feed antibiotics and rely on vaccines to prevent disease, 
producers need to be assured that pigs are protected after vaccination. To define the 
protective immune responses and the adequate level of protection induced in 
experimental and on-farm vaccination with ten-times dose of L. intracellularis (105.9 
TCID50) were performed. The dose reliably induces detectable local and systemic 
antibody and cytokine responses (Chapters 4 and 5). From the data in chapter 4, the 
induction of these responses indicates that protective immunity is generated. Since 
sampling of mucosal responses is not practical, the detection of Lawsonia-specific 
serum antibodies is a feasible indicative of protective immunity after infection 
(Collins and Love, 2007). Additionally, using a standard dose of L. intracellularis (104.9 
TCID50) induced low concentrations of L. intracellularis antibody in the ileal mucosa 
and did not stimulate detectable concentrations of mucosal cytokines (Nogueira et al., 
2013 ). So, from the results in this thesis and from other approaches such as gene 
expression (Jacobson et al., 2011a) and flow cytometry (Cordes et al., 2012), a 
reliable immune correlate or biomarker for on-farm use could not be recommended. 
The dose-dependent induction of protection against virulent L. intracellularis 
challenge was demonstrated by a significant reduction of PE lesion scores and the 
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magnitude and duration of bacterial shedding in faeces in all vaccinated pigs. 
Previous studies have related the lower initial oral challenge dose (103 L. 
intracellularis) with minimal clinical expression and delayed bacterial shedding in 
faeces and reduced histological changes when compared with higher doses (1010 L. 
intracellularis) (Collins et al., 2001).  
Additionally, there were significant variations in the concentrations of 
responses depending on the individual pig, experiment or herd (pen or on-farm) and 
the timing of the sample collection. Variation in antibody titres generated after 
natural infection is well-described as being affected by sampling time and original 
infective dose (related to severity of the primary infection) (in chapters 4 and 5; 
Guedes and Gebhart, 2003b; Collins and Love, 2007). Timing of sampling is critical, 
especially when attempts to account for individual pig variation require a quantum of 
animals to be sacrificed to determine mucosal responses. The studies included in this 
thesis was limited to sampling prior to 21 days after vaccination (days 7, 9-10 or 17) 
since previous reports documented detectable serum responses by this time (Kroll et 
al., 2004; Walter et al., 2005). It was gratifying to detect significant differences in 
mucosal cytokine responses at 9 and 17 days after vaccination, even though the 
spectrum of responses appeared to reflect the dynamics of immune activity. Here, 
some pigs appeared by day 17 to be resolving pathology (higher IL-10) while others 
remained activated with increased TNF-α and IFN-γ.  The Lawsonia intracellularis 
specific IgG concentrations in ileal mucosal secretions also ranged from 14% and 
45% in experimental and on farm trials after 17 days post-vaccination; and around 
21% after 28 days post- vaccination.  
L. intracellularis pathogenesis in the intestinal mucosa is not understood, but 
individual differences in the gut microflora of these piglets could explain some 
variability in infection rates and immune reactivity (Molbak et al., 2008). The 
description of the proportion of microbial and L. intracellularis populations in the 
pigs in this study was thwarted by technical difficulties in optimizing a 16S microbial 
population real-time PCR. However, given the effects of L. intracellularis on carcass 
characteristics (Collins et al., 2009; Collins et al., 2010a), it would be a useful adjunct 
to this work in attempting to define the effects of infection on gastrointestinal 
microflora and vice-versa.  
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As part of routine farm management, piglets are often vaccinated while they’re 
still suckling to overcome the need to remove antibiotics for a week around 
vaccination. In some herds, this leads to reduced vaccine efficacy because maternal 
antibodies transferred to the piglet in the sow’s milk can inactivate the vaccine. 
Efficacy data on alternative sites for delivering mucosal vaccines, such as intranasal, 
intraperitoneal and intrarectal vaccination may allow producers to vaccinate and 
protect weaner pigs from ileitis without needing to remove antibiotics used to treat 
other infections. This thesis demonstrated the success of intramuscular (IM) 
vaccination and noted the systemic and local immunological responses after 
intraperitoneal (IP) inoculation of the L. intracellularis vaccine paralleled those 
induced by oral vaccination. These IM and IP routes would presumably act by 
neutralising antibody and blocking L. intracellularis attachment and colonisation. In 
horses, intra-rectal vaccination with Enterisol® Ileitis  induced high  titres (120) of L. 
intracellularis IgG responses by IPMA (Pusterla et al., 2012b). The intraperitoneal 
route of vaccination has been previously used to protect against disease in pig herds 
(Sheldrake et al., 1993; Djordjevic et al., 1997). An intraperitoneal vaccination against 
Salmonella sp. observed protection and increased IgG and IgA serum responses that 
were comparable to those in orally vaccinated birds (Muir et al., 1998). As noted in 
chapter 5, the comparable spectrum of immune responses generated after 
vaccination and the subsequent protection after challenge seen in Chapter 4 data 
strongly suggested that significant protection against L. intracellularis would occur 
after intraperitoneal vaccination. In fact, anecdotal industry personal communication 
would indicate that this may occur. 
It was highly likely that the inoculation of L. intracellularis intramuscular or 
intraperitoneal would probably kill the organism quickly. With inactivated or subunit 
vaccines (or killed attenuated vaccines), the addition of an adjuvant to the L. 
intracellularis vaccine would possibly induce greater mucosal immune responses and 
further protection. As observed previously, killed L. intracellularis in incomplete 
Freunds adjuvant vaccine given intramuscularly to pigs reduced faecal L. 
intracellularis counts by 98.5% (Dale et al., 1997). Additionally, whereas L. 
intracellularis oral live vaccine is very efficient in protecting pigs against proliferative 
enteropathy disease and increasing growth performances, an inactivated killed 
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vaccine could also induce protection. One of the benefits of using inactivated vaccines 
is the ability to amplify the responses against specific pathogens strains by combining 
different pathogens in one unique suspension. However, type of antigen to be used, 
cost of production and practicability of administration needs to be also considered. 
Recently, a patent has been registered presenting an inactivated Lawsonia 
intracellularis, Mycoplasma hyopneumoniae and PCV2 combo vaccine given 
intramuscularly. These initial studies demonstrated to be positive in protecting pigs 
against PE disease (reducing lesions and clinical signs), however, still information 
regarding field efficiency is needed.  
Another approach to the replacement of in-feed antibiotics is to uniformly and 
non-specifically, heighten the immune “competence” to combat pathogens within pig 
herds by in-feed additives. Chapter 6 was the first approach to evaluate the effect of 
Saccharomyces cerevisae derived β-glucan and microbial phytase on the responses to 
vaccination with Lawsonia intracellularis. Any synergic effect of immunomodulators 
in feed to amplify responses after oral vaccination is particularly appealing given the 
significance of gastrointestinal pathogens on pig production. This type of approach 
and its effect on productivity has been an area of increasing research in international 
pig production (Gallois et al., 2009; Heo et al., 2013). In this study, pigs consuming a 
weaner diet with added β-glucan raised mucosal L. intracellularis specific IgG 
antibody responses when compared with non-supplemented pigs, again indicating 
immunity against L. intracellularis challenge (in line with chapter 4). However, 
results from one trial are not sufficient and further investigation would be required 
to make predictive assertions about the interaction of diet and their application 
towards improving mucosal immunity in pigs. The effects of β-glucan are mediated 
through innate immunity by receptors-mediated interactions with macrophages, 
neutrophils and/or monocytes (Brown and Gordon, 2005), and were supported from 
the study in Chapter 6 which also found higher concentrations of IFN-γ and TNF-α in 
ileal secretions.   
 
Phytases have been used in poultry and pigs herds to degrade plant phytate-P 
to release P, which would otherwise be expelled in the faeces. And since phytate is 
 137 
 
able to chelate many cations, its hydrolysis has been associated with improved 
mineral utilization. Pigs consuming a weaner diet plus phytase generated higher L. 
intracellularis specific IgG concentrations in ileal mucosa secretions compared with 
pigs eating the standard diet. Again, comparing titres with those reported in chapter 
4, it would anticipate protection against L. intracellularis disease in all groups 
vaccinated. The detection of specific IgG as an indicator of vaccine stimulation and the 
generation of protective immunity, possibly the supplementation with β-glucan could 
increase the antibody response generated by a standard dose of Enterisol® Ileitis to a 
detectable level and provide the relevant immune biomarker. The continual 
activation of the innate immune system in a state of readiness by feed additives (such 
as β-glucan in chapter 6) could possibly require greater energy input and the 
enhanced inflammatory sensitivity may detract from weight gains. A better method 
might be to increase the efficiency of digestion with phytase which did not promote 
inflammatory cytokine production (group 7 pigs in chapter 6) and enhance the 
availability of nutrients for immunity without compromising growth.  
The implementation of strategies to induce the development of immunity to L. 
intracellularis by vaccination, as part of a farm health plan, leads to improved animal 
health, welfare and productivity while reducing reliance on antibiotics for preventing 
disease outbreaks. The results in this thesis have provided confirmation that 
alternative routes of vaccination as well as different approaches to nutritional 
strategies could provide alternative means to augment the induction of mucosal 
immune responses after vaccination. 
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Clinical Observation Record  Study Number:                                    
Room #  
Group Pig ID Diarrhoea Score Behaviour Body Condition Score 
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
  1       2       3       4 1      2     3    4 1        2        3  
 
Diarrhoea Score Behaviour  Body Condition 
1 = none  1 = normal          1 = normal                                                                                                                           
2 = semi-solid, no blood 2 = slight to moderately depressed, 
will stand 
2 = mild to moderately 
gaunt (thin) 
3 = watery, no blood/dark 
faeces 
3 = severely depressed or 
recumbent                   
 3 = severely gaunt 
4 = blood tinged faeces, loose 
or formed 
4 = excitable  
Note: If an animal is dead, record “found dead” in comments column and assign total score of 
20 
 
Observed by________________________________ Date _________________  
     
Recorded by _______________________________ Date _____________________ 
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